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Current treatments for chronic inflammatory diseases including chronic obstructive 
pulmonary disease (COPD), acute respiratory distress syndrome (ARDS) and cystic 
fibrosis (CF) are non-specific and generally ineffective, thus the need to identify novel 
targets to develop more effective clinical treatments is essential. The excessive tissue 
damage characteristic of respiratory chronic inflammatory diseases is caused by the 
inappropriate retention of neutrophils in the lungs, however the underlying mechanisms 
are not fully understood. The identification of novel neutrophil migration patterns 
including neutrophil swarming and reverse migration add complexity to the modulation 
of neutrophil migration and retention within inflamed tissue, the precise molecular 
mechanisms of which remain to be fully elucidated.  
 
Here I used a zebrafish model of spontaneously resolving inflammation to study the effect 
of differential neutrophil migration on the outcome of inflammation. I aimed to 
characterise the neutrophil swarming response and investigate the initiation of 
swarming by cell death signalling. Furthermore I investigated the hypothesis that the 
CXCR4/CXCL12 signalling axis generates a neutrophil retention signal at the wound site. 
Inflammation was induced in larvae by tail-fin transection and differential neutrophil 
migration patterns were observed using transgenic reporter zebrafish lines. 
CXCR4/CXCL12 signalling was inhibited using the compound AMD3100 which was 
administered by injection or incubation. 
Here I identified that neutrophil swarming occurs following the migration of neutrophils 
to the wound site in three distinct phases. I demonstrated that swarms are initiated by 
‘pioneer’ neutrophils and began to investigate cell death in the context of swarm 
initiation. Zebrafish neutrophils predominantly express the Cxcr4b receptor, whose 
ligand Cxcl12a is detected at the wound site in injured larvae. Pharmacological inhibition 
of CXCR4 accelerates inflammation resolution by accelerating neutrophil reverse 
migration. The findings of this study suggest that CXCR4/CXCL12 signalling may play an 
important role in neutrophil retention at sites of inflammation, and provides one of the 
first attempts at characterising the neutrophil swarming response. Furthermore this 
work has formed the basis for future studies to dissect a role for CXCR4/CXCL12 








First I would like to thank my wonderful supervisors Steve Renshaw, Phil Elks and Cat 
Loynes for the continuous guidance, support and advice they have provided throughout 
my PhD. To Steve for being the wisest person I know, and to Phil for teaching me to take 
it on the chin. Extra special thanks to Cat for being the best ‘boss’, role-model, and friend, 
and for teaching me never to drink a bad glass of wine again.  
To all the amazing post-docs and research team in the lab, for teaching me everything I 
know, letting me steal last minute reagents, smiling whilst eating my terrible baked goods 
and for providing a friendly, warm and wonderful place to work. 
Next to all the students past and present who have provided entertainment, help, joy and 
coffee breaks, and encouraged the consumption of excessive amounts of cake on an 
almost-daily basis. Special thanks to Josh, Joey and Kyle, for the films, quizzes and for 
turning me into the nerd I am today. To Rebecca and Liam for the all gigs, wine and 
adulting. To Kate and Holly, for being there during the stressful times and being 
constantly amazing supportive friends who I am so lucky to have met. To Hannah Roddie 
for all the laughs, gigs, silly times and consistently coming to the pub.  
Massive thanks to my family for their continuous love, patience and support, especially 
to my mum for being at the end of the phone 24/7. Thank you for supporting me in every 
way and enabling me to have the most amazing 3 years. I hope this thesis may give you all 
some insight into what on earth I have been doing for the last 3 years, I promise I will 
come and visit more .  
To The National and JK Rowling, for creating Trouble Will Find Me and Harry Potter. Both 
of which provided the background noise for writing the thesis, both of which I never want 
to hear again.  
To the Leadmill for being the finest establishment in the country.  
To Leo for keeping me smiling when I was at my grumpiest, continually providing 
encouragement, love and support, and reminding of the fun more important things in life.  
And finally to my amazing sister Melissa, whose constant support, encouragement and 
confidence carried me through the hardest parts. Thanks for cooking me veggie sausages 
and boiled eggs, for sitting with me in the office, for bringing me coffee, for being there 
doing a jigsaw, for cleaning my room and washing my clothes, for drinking awful wine 
after a bad week, and for being the best friend in the world. I promise I will clean the 
kitchen after I’ve printed my thesis.  
5 
 
List of abbreviations 
AA Arachidonic acid 
ANOVA Analysis of variance 
ARDS Acute respiratory disease syndrome 
Cas9 CRISPR associated protein 9 
CF Cystic fibrosis 
COPD Chronic obstructive pulmonary disease 
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats 
CRISPRi CRISPR interference 
CXCL C-X-C chemokine 
CXCR C-X-C chemokine receptor 
DAMP Damage associated molecular pattern 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dpf Days post-fertilisation 
E3 Embryo medium 
eGFP Enhanced GFP 
fMLP Formyl-Methionyl-Leucyl-Phenylalanine 
FPKM Fragments per kilobase of exon per million fragments mapped 
FRET Forster resonance energy transfer 
G-CSF Granulocyte-colony stimulating factor 
GFP Green fluorescent protein 
GM-CSF Granulocyte macrophage colony-stimulating factor 
GPCR G protein coupled receptor 
h Hours 
HIF Hypoxia inducible factor 
hpf Hours post-fertilisation 
hpi Hours post-injury 
IL Interleukin 
LMP Low melting point 
LPS Lipopolysaccharide 
LT Leukotriene 
LTB4 leukotriene B4 




MPO Myeloperoxidase (human) 
mpx Myeloid-specific peroxidase (zebrafish) 
mRNA Messenger RNA 
n Number of individual subjects 
NADPH Nicotinamide Adenine Dinucleotide Phosphate 
NET Neutrophil extracellular trap 
NF-KB Nuclear factor-kappa light chain enhancer of activated B cells 
ns Not significant 
NSAID Non-steroidal anti-inflammatory drug 
P Calculated probability value 
PAMP Pathogen associated molecular pattern 
PBS Phosphate buffered saline 
PBT Phosphate buffered saline + Tween 
PFA Paraformaldehyde 
PG Prostaglandin 
PRR Pattern recognition receptor 
r Pearson correlation coefficient 
RNA Ribonucleic acid 
RNAseq RNA-sequencing 
ROI Region of interest 
ROS Reactive Oxygen Species 
SEM Standard error of the mean 
temp Temperature 
Tg Transgenic 
TIIA Tanshinone IIA 
TNFα Tumour necrosis factor alpha 
TLR Toll like receptor 
UAS Upstream activating sequence 
vol Volume 
WHIM Warts, hypogammaglobulinaemia, infection and myelokathesis 
WISH Whole mount in situ hybridisation 
WHO World Health Organisation 





Acknowledgements ................................................................................................................................. 4 
List of abbreviations ................................................................................................................................ 5 
List of figures ............................................................................................................................................ 12 
1 Introduction .......................................................................................................................................... 14 
1.1 The immune response ................................................................................................................. 14 
1.1.1 The innate immune system ............................................................................................... 14 
1.1.2 The adaptive immune system .......................................................................................... 15 
1.2 The inflammatory response .................................................................................................. 15 
1.3 Hypoxia signalling ...................................................................................................................... 16 
1.4 Inflammatory mediators ......................................................................................................... 16 
 Chemokines ............................................................................................................................ 17 
 Lipid mediators ...................................................................................................................... 19 
1.5 Initiation of inflammation ...................................................................................................... 20 
 Toll like receptors ................................................................................................................. 21 
 Nod Like Receptors ............................................................................................................. 22 
1.6 The neutrophil ........................................................................................................................... 23 
1.1.3 Neutrophil life cycle ............................................................................................................ 23 
1.1.4 Neutrophil recruitment ..................................................................................................... 27 
1.1.5 Neutrophil migration in interstitial tissue .................................................................. 28 
1.7 Neutrophil function ................................................................................................................. 30 
1.1.6 Phagocytosis ........................................................................................................................... 31 
1.1.7 Degranulation ......................................................................................................................... 31 
1.1.8 ROS production .................................................................................................................... 32 
1.1.9 NET formation ....................................................................................................................... 32 
1.8 Neutrophil swarming .............................................................................................................. 36 
1.1.10 Swarm initiation by cell death signalling ................................................................ 39 
 Swarm amplification by relay signalling ......................................................................40 
 Swarm aggregation and integrin signalling ................................................................40 
 Swarm resolution ................................................................................................................. 41 
 Physiological roles of neutrophil swarming ............................................................... 42 
1.9 Inflammation resolution ......................................................................................................... 42 
 Neutrophil apoptosis .......................................................................................................... 43 
 Neutrophil reverse migration.......................................................................................... 44 
 Retention signalling hypothesis ...................................................................................... 47 
1.10 The zebrafish............................................................................................................................... 51 
8 
 
 Transgenic zebrafish lines to study inflammation ............................................... 51 
 Disadvantages of the zebrafish model .................................................................... 53 
 Zebrafish mutagenesis .................................................................................................. 54 
1.11 Thesis aims ................................................................................................................................. 56 
2 Materials and methods ................................................................................................................... 57 
2.1 Reagents .......................................................................................................................................57 
2.2 Zebrafish husbandry ................................................................................................................57 
2.3 Zebrafish anaesthesia .............................................................................................................57 
 Tail-fin transection .............................................................................................................. 58 
 Non-standard methods of tail-fin transection ......................................................... 59 
 Microinjection of embryos ............................................................................................... 59 
 Microinjection of larvae ................................................................................................ 60 
 Equation to determine dose of compounds for microinjection ................... 60 
 Compound incubation ................................................................................................... 61 
 Mounting of larvae for microscopy ........................................................................... 61 
2.4 Neutrophil behavioural assays ............................................................................................ 62 
 Neutrophil recruitment assays ....................................................................................... 62 
 Inflammation resolution assays ................................................................................. 62 
 Percentage resolution calculation ............................................................................ 62 
 Analysis of total body neutrophil count .................................................................. 63 
 Reverse migration assay ............................................................................................... 63 
 Fixation of larvae ............................................................................................................. 64 
 Whole mount in situ hybridisation ................................................................................ 64 
 Propidium iodide staining of larvae ......................................................................... 65 
2.5 Microcscopy ............................................................................................................................... 65 
 Timelapse imaging of neutrophil recruitment.......................................................... 65 
 Imaging of the caudal hematopoietic tissue in mpx:GFP larvae .................... 66 
 Application of binary layers to time courses ........................................................ 66 
 Automated assay to detect object area .................................................................. 66 
 Tracking of neutrophils during recruitment to wound sites .......................... 66 
 Fluoresence resonance energy transfer (FRET) imaging ................................ 67 
 Ratiometric Imaging of HyPer ......................................................................................... 68 
 Confocal imaging of red and green fluorescence ............................................... 68 
2.6 Molecular Biology ..................................................................................................................... 68 
 Whole mount in situ hybridisation (WISH) probe synthesis .............................. 68 
 Transformation ................................................................................................................ 69 
 DNA purification .............................................................................................................. 70 
9 
 
2.7 Analysis of RNA expression in zebrafish neutrophils .................................................. 70 
2.8 Development of transgenic lines ........................................................................................ 70 
2.9 Software ...................................................................................................................................... 70 
2.10 Statistical analysis ..................................................................................................................... 71 
3 Pioneer neutrophils initiate the swarming response to tissue injury in zebrafish 
larvae ............................................................................................................................................................... 72 
3.1 Introduction and aims ............................................................................................................ 72 
3.2 Neutrophil swarming is observed in response to tail-fin transection in 
zebrafish larvae ....................................................................................................................................... 73 
3.3 An unbiased assay to detect neutrophil swarming ...................................................... 76 
3.4 Multiple neutrophil swarms can form at the wound site and neutrophils can 
move between competing swarms ................................................................................................. 79 
3.5 Neutrophil swarming occurs in response to a range of inflammatory stimuli.. 79 
3.6 Dynamics of neutrophil swarming in zebrafish larvae ................................................ 83 
 Phase 1: Scouting .................................................................................................................. 83 
 Phase 2: Initiation ............................................................................................................ 83 
 Pioneer neutrophils undergo a morphological change at the wound site 
which is not seen in non-pioneer neutrophils ........................................................................ 92 
 Pioneer neutrophils migrate differently to non-pioneer neutrophils during 
the initiation phase............................................................................................................................ 92 
 Neutrophil migratory behaviour during the scouting phase is the same 
between pioneer and non-pioneer neutrophils..................................................................... 95 
 Migratory behavioural changes between the scouting and initiation phases 
are observed in pioneer neutrophils but not non-pioneer neutrophils ....................... 95 
 Phase 3: Swarm aggregation ..................................................................................... 100 
3.7 Quantification of aggregation phase phenotype ......................................................... 106 
3.8 Investigating the spatio-temporal dynamics of the swarming response........... 109 
 Pioneer neutrophils change morphology within 60µm of the wound edge .. 111 
3.9 A zebrafish reporter line to investigate hydrogen peroxide concentration in 
pioneer neutrophils .............................................................................................................................. 114 
3.10 Exogenous hydrogen peroxide increases HyPer ratio .............................................. 114 
3.11 Investigating pioneer cell death as a mechanism for neutrophil swarm 
initiation .................................................................................................................................................... 118 
3.12 Pioneer neutrophils do not become propidium iodide positive during swarm 
initiation .................................................................................................................................................... 119 
 Determining a dose of propidium iodide for live imaging ............................... 119 
3.13 Pioneer neutrophils are not undergoing caspase-3 mediated apoptosis prior 
to swarming ............................................................................................................................................ 124 
3.14 A neutrophil specific histone2a reporter to visualise neutrophil extracellular 
trap formation ........................................................................................................................................ 127 
3.15 Conclusions and chapter discussion .............................................................................. 130 
10 
 
 Neutrophil swarming is observed at the wound site in zebrafish larvae ...131 
 Characterisation of the neutrophil swarming response in zebrafish larvae
 132 
3.16 Investigating cell death in the context of swarm initiation ...................................... 142 
 Pioneer neutrophils are not propidium iodide positive .................................. 142 
 Pioneer neutrophils are not undergoing caspase-3 mediated apoptosis 143 
3.17 Future work and conclusions ............................................................................................. 144 
4 Elucidating the mechanisms governing neutrophil reverse migration ....................... 146 
4.1 Introduction and aims ........................................................................................................... 146 
4.2 Cxcr4b and Cxcl12a are strong candidates for retention signalling .................... 149 
 CXCR4 and CXCL12 are conserved between humans and zebrafish ............ 149 
 Neutrophil expression of Cxcl12 and Cxcr4 ........................................................ 149 
 Cxcl12a is expressed at the wound site in zebrafish larvae............................ 154 
 The cxcl12a:GFP transgene is not expressed by neutrophils in detectable 
levels 154 
 CXCL12a mRNA is detected at the wound site in injured larvae ..................159 
 Generation of a Cxcr4b transgenic reporter line using the GAL4 UAS 
system 159 
4.3 Using the compound AMD3100 to inhibit the CXCR4/CXCL12 signalling axis . 167 
 Inhibition of CXCR4/CXCL12 signalling does not affect haematopoiesis 
during early development ............................................................................................................. 167 
 Inhibition of CXCR4/CXCL12 signalling does not affect neutrophil 
colonisation of the caudal hematopoietic tissue .................................................................. 167 
 Inhibition of CXCR4/CXCL12 signalling does not affect neutrophil 
retention in the CHT .......................................................................................................................170 
 Inhibition of CXCR4/CXCL12 signalling increases neutrophil recruitment 
to the wound site ............................................................................................................................. 172 
 Inhibition of CXCR4/CXCL12 signalling accelerates inflammation 
resolution ............................................................................................................................................ 172 
 Inhibition of CXCR4/CXCL12 signalling accelerates neutrophil reverse 
migration ............................................................................................................................................. 177 
 ..................................................................................................................................................................... 178 
4.4 Chapter discussion ................................................................................................................ 180 
 Cxcr4b and Cxcl12a are strong candidates for retention signalling at the 
wound site.......................................................................................................................................... 180 
 Cxcl12a is produced at the wound site in zebrafish larvae............................. 181 
 Production of Cxcl12a:eGFP by neutrophils ........................................................ 183 
 Generation of a Cxcr4b transgenic reporter line using the Gal4 UAS 
system 184 
4.5 Using AMD3100 to inhibit the CXCR4/CXCL12 signalling axis in zebrafish ........ 186 
11 
 
 Transient inhibition of CXCR4/CXCL12 signalling does not affect 
haematopoiesis during early development ........................................................................... 186 
 Inhibition of CXCR4/CXCL12 signalling does not affect CHT colonisation 
by neutrophils ................................................................................................................................... 187 
 Inhibition of CXCR4/CXCL12 does not affect neutrophil retention in the 
CHT 187 
 Inhibition of CXCR4/CXCL12 signalling increases neutrophil recruitment 
to the wound site ............................................................................................................................. 188 
 Inhibition of CXCR4/CXCL12 signalling accelerates inflammation 
resolution by promoting reverse migration .......................................................................... 189 
5 Final discussion and future work ............................................................................................... 193 
5.1 Characterisation of the neutrophil swarming response in zebrafish ................. 193 
5.2 Investigating cell death signalling in the context of swarm initiation .................. 194 
5.3 Elucidating the mechanisms governing neutrophil reverse migration .............. 196 
 Cxcr4b and Cxcl12a are strong candidates for retention signaling in 
zebrafish.............................................................................................................................................. 196 
 Inhibition of the CXCR4/CXCL12 signaling axis accelerates inflammation 
resolution ........................................................................................................................................... 197 
 Final conclusions and closing remarks .................................................................. 198 





List of figures  
Figure 1.1 : Outside-in signalling through G Protein coupled receptors. ............................ 18 
Figure 1.2: Neutrophil release from the bone marrow is regulated by a tug-of-war 
between CXCR2 and CXCR4 signalling. ....................................................................... 26 
Figure 1.3: Neutrophil extracellular trap formation during NETosis. ................................ 34 
Figure 1.4: Proposed 5- stage model of the neutrophil swarming response ......................38 
Figure 1.5 Retention signalling hypothesis. ......................................................................... 50 
Figure 2.1: Tail fin transection of zebrafish larvae .............................................................. 58 
Figure 2.2: Non-standard methods of tail fin transection .................................................. 59 
Figure 2.3: Microinjection of DNA and RNA into embryos at the one cell stage ............... 60 
Figure 2.4: Equation used to work out injection concentrations ....................................... 61 
Figure 2.5: Equation for calculating % resolution of inflammation ................................... 62 
Figure 2.6 Quantification of neutrophil reverse migration ................................................ 64 
Figure 3.1: Dynamics of the neutrophilic response to tissue injury ................................... 75 
Figure 3.2: Neutrophil clusters are observed at the wound site ........................................ 77 
Figure 3.3: An automated assay to detect neutrophil clusters at the wound site ............. 78 
Figure 3.4: Multiple neutrophils swarms can form at the wound site .............................. 80 
Figure 3.5: Neutrophils migrate between competing swarms ........................................... 81 
Figure 3.6: Neutrophil swarms form following a range of inflammatory stimuli ............. 82 
Figure 3.7: Dynamics of neutrophil swarming in zebrafish ................................................ 84 
Figure 3.8: Neutrophil scouting occurs within minutes following tail fin transection ..... 85 
Figure 3.9: Neutrophils direct their migration towards a pioneer neutrophil to initiate 
the swarming response ................................................................................................ 87 
Figure 3.10: Pioneer neutrophils change phenotype at the wound site (example 1) ......... 88 
Figure 3.11: Pioneer neutrophils change phenotype at the wound (example 2) ................ 89 
Figure 3.12: Pioneer neutrophils change phenotype at the wound site (example 3) ........ 90 
Figure 3.13: Pioneer neutrophils change phenotype at the wound site; proof of principle
 ....................................................................................................................................... 91 
Figure 3.14: Tracking neutrophil migration during the scouting and swarm initiation 
phases ............................................................................................................................ 93 
Figure 3.15: Migratory behaviours of pioneer neutrophils are different to non-pioneer 
neutrophils during the swarm initiation phase........................................................... 94 
Figure 3.16: Migratory behaviour during the scouting phase is not different between 
pioneer and non-pioneer neutrophils ..........................................................................96 
Figure 3.17: Migratory behaviour of pioneer neutrophils is reduced during the swarm 
initiation phase ............................................................................................................. 97 
Figure 3.18: Migratory behaviours of non-pioneer neutrophils are unchanged during the 
scouting and initiation phases .....................................................................................99 
Figure 3.19: The neutrophil swarm aggregation phase ...................................................... 101 
Figure 3.20: Neutrophil swarms can be persistent during the aggregation phase ......... 102 
Figure 3.21: Neutrophil swarms can be transient during the aggregation phase ............ 103 
Figure 3.22: Exploring the frequency of persistent and transient swarming .................. 104 
Figure 3.23: Observing neutrophil swarming at a static time point ................................ 105 
Figure 3.24: Evaluation of neutrophil counts in persistent and transient swarms ......... 107 
Figure 3.25: Evaluation of neutrophil swarm area in persistent and transient swarms 108 
Figure 3.26: Characterisation of the temporal component of neutrophil swarming ...... 110 
Figure 3.27: Investigating the position of swarm formation at the wound site................ 113 
Figure 3.28: Exogenous hydrogen peroxide increases HyPer ratio ................................... 116 
Figure 3.29: Pioneer neutrophil hydrogen peroxide concentration can be measured 
during swarm initiation ............................................................................................... 117 
Figure 3.30: Determining a non-toxic dose of propidium iodide for live imaging ........... 120 
Figure 3.31: Propidium iodide labels a population of cells at the wound site .................. 122 
Figure 3.32: Pioneer neutrophils are not propidium iodide positive prior to swarm 
formation .................................................................................................................... 123 
13 
 
Figure 3.33: Pioneer neutrophils are not undergoing caspase-3 mediated apoptosis .... 125 
Figure 3.34: Neutrophils which lose their NFRET signal do not initiate swarming ......... 126 
Figure 3.35: A histone2a.mCherry constructs labels the nucleus of neutrophils ........... 128 
Figure 3.36: Histone.mCherry labelled neutrophls recruit to inflammatory sites.......... 129 
Figure 3.37 Graphical schematic of the neutrophil swarming response in zebrafish ..... 135 
Figure 4.1: Protein sequence alignment of human and zebrafish CXCR4 ......................... 150 
Figure 4.2: Protein sequence alignment of human and zebrafish CXCL12 ........................ 151 
Figure 4.3: Expression of cxcr4 in zebrafish neutrophils during early development ...... 152 
Figure 4.4 Expression of cxcl12 in zebrafish neutrophils during early development ....... 153 
Figure 4.5: Expression profile of Cxcl12a in a transgenic reporter line ............................ 156 
Figure 4.6: Investigating Cxcl12a expression in injured larvae ......................................... 157 
Figure 4.7: Cxcl12a:eGFP is not expressed by neutrophils ................................................ 158 
Figure 4.8: Whole mount in situ hybridisation to assess cxcl12a expression at the wound 
site ............................................................................................................................... 160 
Figure 4.9: Expression of the Cxcr4b.GFP construct in the CHT of larvae ....................... 162 
Figure 4.10: Expression of the cxcr4b-GFP transgene is neutrophil specific ................... 163 
Figure 4.11: A WHIM phenotype is recapitulated in neutrophils expressing the cxcr4b-GFP 
transgene ..................................................................................................................... 164 
Figure 4.12: Neutrophils which don’t express the cxcr4b-GFP transgene are recruited to 
the wound site ............................................................................................................. 166 
Figure 4.13: Inhibition of CXCR4/CXCL12 signalling does not affect haematopoiesis 
during early development ........................................................................................... 168 
Figure 4.14: Inhibition of CXCR4/CXCL12 signalling does not affect neutrophil 
colonisation to the CHT .............................................................................................. 169 
Figure 4.15: Inhibition of CXCR4/CXCL12 signalling does not affect neutrophil retention 
in the CHT ..................................................................................................................... 171 
Figure 4.16: Inhibition of CXCR4/CXCL12 signalling increases neutrophil recruitment to 
the wound site ............................................................................................................. 173 
Figure 4.17: Inhibition of CXCR4 signalling by injection of AMD3100 accelerates 
inflammation resolution ............................................................................................. 174 
Figure 4.18: Inhibition of CXCR4 signalling by incubation of AMD3100 increases 
inflammation resolution ............................................................................................. 176 
Figure 4.19: Inhibition of CXCR4 by AMD3100 injection accelerates neutrophil reverse 
migration at 2dpf ........................................................................................................ 178 
Figure 4.20: Inhibition of CXCR4 by AMD3100 incubation accelerates neutrophil reverse 






1.1 The immune response 
The immune system protects the body from threats including bacteria, fungi and viruses 
by recognising and responding to antigens recognised as non-self. There are two arms of 
the immune response; the innate and adaptive responses. The innate response exists in 
all metazoan organisms and provides a rapid response to conserved patterns expressed 
on pathogens (Barton, 2008) whilst the adaptive response is antigen-specific and has 
evolved in vertebrates to generate a targeted response to specific pathogens (Cooper 
and Alder, 2006). The pathways involved in immune cell signalling have been in existence 
since before the divergence of humans and plants, indicating that between all species 
there will be some conservation of signalling molecules. Both arms of the immune system 
are regulated tightly by a range of mediators which ensure that the immune response is 
activated only when necessary and for the appropriate length of time to prevent a 
chronic immune response driving host tissue damage.  
1.1.1 The innate immune system 
The innate immune system is comprised of a system of physical and chemical barriers to 
infectious agents. The physical barring of pathogens from entry into the host by epithelial 
surfaces provides the first line of defence against pathogen entry to the host (Guttman 
and Finlay, 2009). Loss of epithelial cell integrity renders the host susceptible to infection 
as pathogens can invade where the epithelial layer is broken.  A group of cells have 
evolved to defend the host against pathogens following their breach of the epithelial 
layer. Specifically, mast cells, phagocytes, dendritic cells and natural killer cells evolved 
long before the emergence of higher organisms including mice, rats and humans. These 
innate immune cells elicit a multitude of anti-microbial mechanisms in response to non-
self molecular patterns conserved on pathogens as well as damaged cells  (Medzhitov 
and Janeway, 2002). The vertebrate innate immune response plays a crucial role in the 
recognition of a broad range of pathogen and damage associated molecular patterns 
(DAMPs and PAMPs) (Mogensen, 2009). The major functions of innate immunity in 
vertebrates are identification of foreign substances by specialised white blood cells, 
production of cytokines to recruit immune cells to sites of infection, activation of the 
complement cascade and activation of the adaptive immune response by antigen 
presentation.  The ability to distinguish self from non-self in order to mount an effective 
response is one of the most basic functions of the innate immune system.   
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1.1.2 The adaptive immune system 
The adaptive immune system exists in vertebrates and is comprised of a system of highly 
specialised humoral and cell-mediated defence mechanisms which function to provide 
long-term defence against specific pathogens. The adaptive response occurs over a 
longer period of time than the innate response and is essential for removing microbes 
through recognition of antigens which are not recognised by innate immune cells (Clark 
and Kupper, 2005). The major functions of the adaptive immune response include 
recognition of non-self molecules through antigen presentation, generation of a tailored 
immune response to target specific pathogens or infected cells, and the development of 
immunological memory. The immune memory acquired following an adaptive response 
to specific pathogens provides the host with long-lasting defence against previously 
encountered pathogens which enables an enhanced response following subsequent 
exposure (McFall-Ngai, 2007). Enhancing the adaptive immune response is the basis for 
vaccination, recognised as the most effective method of preventing disease (WHO, 2011). 
Pioneering work by the physician Edward Jenner following his work on cowpox and 
smallpox began a medical revolution leading to development of the vaccine, stemming 
from the Latin word ‘vacca’ for cow (Riedel, 2005).  
1.2 The inflammatory response 
Inflammation  is a multicomponent response initiated following tissue damage induced 
by trauma, bacteria, heat or toxins (Medzhitov and Horng, 2009). The inflammatory 
response is triggered by the detection of an inflammatory stimulus by innate immune cell 
receptors. The activation of the inflammatory response results in the production of 
mediators which modulate a multitude of physiological processes to regulate local 
changes to the tissue environment creating a tissue environment which is unfavourable 
to pathogens. The combined effect of these inflammatory mediators is the substantial 
increase in blood supply to the inflamed tissue, an increase in capillary permeability and 
the migration of leukocytes into the inflamed tissue. This results in the classic symptoms 
of inflammation heat (calor), redness (rubor), pain (dolor), swelling (tumor) and loss of 
function. A build-up of inflammatory exudate following the extravasation of fluid into the 
tissue, increases vascular permeability and contributes to the swelling observed in 
inflamed tissue. Vascular permeability is regulated by inflammatory cytokines such as 
histamines and bradykinin, released primarily by mast cells following activation by 
neuropeptides or bacterial products (Claesson-Welsh, 2015, Nathan, 2002a) . Bradykinin 
is also responsible for stimulation of nerve endings associated with pain at the 
inflammatory site (Medzhitov, 2010).  Other pro-inflammatory cytokines released include 
TNF-α, IL-1 and Il-6 which regulate the permeability of the vasculature by activating 
16 
 
endothelial cells and leukocytes, promoting the transmigration of blood cells into the 
tissue (Medzhitov, 2008).  
During inflammation, the first innate immune cells to be recruited to inflamed tissue are 
neutrophils, where they function to prevent pathogens from establishing a foothold in 
the host tissue and remove any infectious agents. The anti-microbial effects of 
neutrophils are essential in order to contain infection. Their lack of specificity, however, 
can lead to tissue damage when their behaviour becomes dysregulated. It is crucial that 
the inflammatory response successfully resolves following removal of the initiating 
stimulus to prevent permanent and irreversible host tissue damage. Persistent 
inflammation and inappropriate behaviour of innate immune cells are associated with 
the pathogenesis of chronic inflammatory diseases including rheumatoid arthritis and 
COPD (Serhan, 2007).  
1.3 Hypoxia signalling 
Under normal or healthy tissue conditions cells are exposed to around 5% oxygen, a 
requirement for the aerobic metabolism and function of all aerobic organisms 
(McKeown, 2014). Hypoxia is a shortage in oxygen availability when cells receive less than 
2% oxygen, and is observed in states of physiological and pathological stress including 
altitude, ischemia, cancer, infection and inflammation (Majmundar et al., 2010). A 
decrease in oxygen availability in hypoxic tissue can be harmful, hence cells must be able 
to rapidly adapt to the new tissue environment and alter energy expenditure demands 
to match oxygen supply. The main cellular players which modulate the response to 
hypoxia are the hypoxia inducible factor (HIF) family of transcription factors, which 
activate the transcription of a myriad of downstream responsive genes whose promoters 
contain hypoxia responsive elements (HREs) (Wenger et al., 2005). Many HIF responsive 
genes are involved in the reprogramming of cellular metabolism and restoration of 
oxygen supply through the modulation of processes including angiogenesis, secretion of 
survival factors and cell cycle arrest (Ortiz-Barahona et al., 2010). 
1.4 Inflammatory mediators 
Following the initiation of inflammation, sentinel cells pre-stationed in the tissue intensify 
and propagate the inflammatory response (Nathan, 2002b).  Cells including mast cells 
and macrophages release soluble chemical mediators into the tissue to promote local 
morphological and biochemical changes to the tissue environment, as well as causing 
systemic effects. The combined effect of these mediators is the recruitment of 




The chemokines are a family of chemotactic cytokines which control the migration of all 
immune cells (Griffith et al., 2014). Chemotaxis was first defined as the directional 
migration of leukocytes along a chemokine gradient (Pfeffer, 1884). Production of 
chemokines such as c5a, fMLP, LTB4 and the CXC family of chemokines is induced by 
infectious stimuli including bacterial LPS, as well as pro-inflammatory cytokines TNFα 
and IL-1β produced by damaged cells (Furie and Randolph, 1995). The secretion of 
cytokines and chemokines from cells at sites of injury or infection promote the influx of 
other innate immune cells. 
The chemokine family consists of approximately 50 chemokine ligands which stimulate 
the recruitment of cells expressing cognate chemokine receptors. Two major chemokine 
sub-families have been identified based on the position of their first 2 conserved cysteine 
residues at the N-terminus; the major C-X-C (α chemokines) and the C-C family (β-
chemokines) as well as the minor sub-families CX3C  (δ chemokines) and C (γ 
chemokines) (Ransohoff, 2009). Chemokines elicit their function by binding to their 
receptors which are members of the G protein coupled receptor family.  
1.1.2.1 G protein coupled receptor signalling  
The GPCR family is the largest family of receptors in the human genome, which encodes 
over 800 GPCR genes. GPCRs are 7 transmembrane spanning cell surface receptors 
coupled to intracellular g-protein partners, which transduce external signals through 
conformational changes induced by ligand binding. G proteins activate downstream 
signalling pathways through the recruitment of cellular enzymes and second messengers 
(Hanlon and Andrew, 2015). Outside-in signalling through GPCRs is summarised in Figure 
1.1.  
G-proteins are heterotrimeric proteins comprised of Gα, β and γ subunits closely 
associated with the intracellular face of GPCRs on the plasma membrane. In its inactive 
state, the Gα-subunit is bound to a Gβγ dimer and guanine diphosphate (GDP), which 
facilitates its tethering to the plasma membrane. Activation of G proteins is facilitated by 
guanine nucleotide exchange factors (GEFs) which exchange bound GDP for guanine 
triphosphate (GTP). GPCRs function as GEFs following ligand induced conformational 
changes, enabling these receptors to facilitate exchange of GDP for GTP on the Gα 
subunit and subsequent G protein activation (McCudden et al., 2005). GTP bound Gα-
subunits dissociate from their Gβγ subunits, both of which can interact with downstream 
effector proteins in the membrane to transduce secondary messenger signals. Gα 
regulates its own activity through intrinsically expressing a guanosine triphosphatase 
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(GTPase) which hydrolyses GTP back to GDP, subsequently inactivating the Gα subunit. 
GDP bound Gα subunits re-form an inactive heterotrimer with a Gβγ subunit in the 
membrane and signalling is terminated. Phosphorylation of the GPCR by GRKs stimulate 




Figure 1.1 : Outside-in signalling through G Protein coupled receptors. 
Adapted from Hanlon and Andrew, 2015. (A) In their basal state, GPCRs are 7 
transmembrane spanning proteins which are not bound to ligand. (B) Ligand binding 
induces a conformational change in the GPCR. The GPCR is now able to act as a guanine 
nucleotide exchange factor (GEF) to facilitate the exchange of GDP for GTP on the Gα 
subunit of the associated G protein. (C) Activation of the G protein and dissociation of 
the Gα subunit from the Gβγ  subunits. (D) Interaction of G protein subunits with 
downstream effectors and activation of second messenger signalling ‘outside-in 
signalling’. (E) Hydrolysis of GTP to GDP on Gα subunit promotes the re-association of 
the G protein and its inactivation. Phosphorylation of the GPCR by GRKs. (F) GPCR 
phosphorylation stimulates B-arrestin binding and subsequent internalisation of the 






Ligand activated GPCR internalisation is a characteristic feature of GPCR signalling, 
which regulates cell sensitivity to chemokine gradients through the recycling of cell 
surface receptors. In the absence of ligand, GPCRs are internalised at a constitutive level 
followed by degradation or recycling.  Upon ligand binding, internalisation of GPCRs is 
enhanced and trafficking of receptors to and from the membrane occurs at a more rapid 
rate (Neel et al., 2005). This internalisation of receptors plays a crucial role in cell 
signalling through negatively regulating the expression level of membrane receptors, thus 
preventing over-activation of downstream pathways (Sorkin and von Zastrow, 2009). 
 Lipid mediators  
A family of lipid mediators known as the eicosanoids are highly involved in regulating a 
large number of processes in promoting and resolving inflammation, as well as a 
multitude of homeostatic processes including vascular homeostasis, platelet aggregation 
and a protective role in the gut mucosa (Harizi et al., 2008). In the context of 
inflammation, the biosynthesis of eicosanoids is increased in inflamed tissues by innate 
immune cells including macrophages and neutrophils which harbour the machinery 
required to metabolise arachidonic acid bound to the cell membrane. These potent lipid 
mediators regulate immune processes such as cytokine production, cell migration, 
proliferation and inflammation resolution (Dennis and Norris, 2015). Dysregulation of 
eicosanoid production is implicated in many diseases including asthma (Wan and Wu, 
2007), cancer (Greene et al., 2011) and rheumatoid arthritis (Korotkova and Jakobsson, 
2014).  
 The cyclooxygenase pathway and prostaglandins 
Arachidonic acid is released from phospholipid membrane bilayers following the 
cleavage of membrane phospholipids by the enzyme phospholipase A2.  Free arachidonic 
acid is available for oxidative metabolism by two distinct pathways to produce the 
eicosanoid families of prostaglandins and thromboxanes, or leukotrienes and lipoxins, 
through the action of either cyclooxygenase or lipoxygenase enzymes respectively 
(Dennis and Norris, 2015). 
Cyclooxygenase enzymes COX-1 and COX-2  are differentially expressed in tissues 
(Crofford, 1997). COX-1 is expressed constitutively and is involved in homeostatic 
processes including vascular haemostasis and gastroprotection from acid produced 
during digestion (Peskar et al., 2003). COX-2 is induced during inflammation and 
promotes the formation of pro-inflammatory prostaglandins which are able to exert their 
effect through mediating autocrine and paracrine signalling loops (Ricciotti and 
FitzGerald, 2011). There are reports of a COX-3 enzyme which many groups argue is the 
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target of paracetamol, although its role in eicosanoid production remains controversial 
(Schwab et al., 2003).  
Downstream products of COX activity form prostaglandin precursors, which through a 
series of intermediate metabolic steps, produce prostaglandins PGD2, PGE2, PGF2 and 
PGI2 PGG2 as well as thromboxane A2 (Marnett et al., 1999). Prostaglandins can alter 
vasodilation, platelet aggregation and increasing vascular permeability. TXA2 is 
responsible for the vasoconstriction, platelet aggregation and bronchoconstriction seen 
in asthma (Simmons, 2004). 
 The lipoxygenase pathway and leukotrienes 
Leukotrienes are another family of lipid mediators produced by the metabolism of 
arachidonic acid, which have inflammatory functions including leukocyte recruitment, 
vasodilation and intercellular relay signalling (Lämmermann et al., 2013; Medzhitov, 
2008). The leukotriene family can be classified into the cysteinyl leukotrienes LTC4, LTD4 
and LTE4, and a second family consisting of LTB4. The cysteinyl leukotrienes have a 
profound effect on airway function and play a large role in the pathogenesis of asthma 
through bronchoconstriction (Ogawa and Calhoun, 2006).  
Leukotrienes are synthesised through the metabolism of arachidonic acid by the 
lipoxygenase enzymes, of which humans have 3. This family of enzymes oxygenate 
arachidonic acid on different residues, resulting in the formation of different leukotriene 
isoforms. The lipoxygenases are differentially expressed within different peripheral 
blood cells resulting in the production of different arachidonic acid metabolites 
produced by different cell types (Serhan and Sheppard, 1990).   
LTB4 exerts its role in inflammation by acting predominantly on receptors expressed on 
neutrophils. LTB4 signalling activates pathways involved in neutrophil chemotaxis and 
activation, neutrophil-endothelial cell interactions, reactive oxygen species production 
and degranulation (Sharma and Mohammed, 2006). Recently LTB4 has been identified as 
a signal relay molecule which augments neutrophil chemotaxis to formyl peptides 
(Afonso et al., 2012), and as one of the factors mediating intercellular signal relay during 
the neutrophil swarming response (Lämmermann et al., 2013). 
1.5 Initiation of inflammation  
An acute inflammatory response is observed within the first few hours following tissue 
injury during which time the body orchestrates a complex series of events that function 
to remove any threat to the host and restore tissue homeostasis. Inflammation can be 
activated by both exogenous and endogenous stimuli, both of which present different 
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challenges to the host. Whilst infection of the host by microbes requires the immune 
system to rapidly remove the pathogen, the inflammatory response must rapidly repair 
host cells to prevent bacteria from establishing  a foothold in the host following their 
breaching of protective epithelial layers (Newton and Dixit, 2012).  
The inflammatory response is triggered by the activation of pattern recognition 
receptors (PRRs) expressed on tissue resident immune cells including mast cells, 
macrophages and dendritic cells. These evolutionarily conserved receptors recognise 
prokaryotic patterns known as pathogen associated molecular patterns (PAMPs) on 
pathogens including lipopolysaccharide (LPS), bacterial flagellin, lipoteichoic acid and 
peptidoglycan. Equally PRRs recognise damage associated molecular patterns (DAMPs) 
secreted in damaged tissues by necrotic cells such as heat shock proteins, β-defensin 
and HMGB1 (Lotze and Tracey, 2005). This enables the innate immune system to 
distinguish pathogens and damaged cells from healthy host cells. 
PRRs such as toll-like receptors , nod-like receptors and mannose receptors can sense 
PAMPs and DAMPs (Kumar et al., 2011). Activation of PRRs by PAMPs induces the 
production of transcription factors, including NF-κB and interferon regulatory factors 
(IRFs) initiating opsonisation, phagocytosis and pro-inflammatory cytokine production 
(Barton, 2008). Activation of pattern recognition receptors by DAMPs induces 
downstream signalling, ultimately driving the expression of pro-inflammatory genes 
including TNF-α and IL-1. Expression further activates the inflammatory response 
through cytokine production and immune cell activation (Nathan, 2002b).  
Regardless of the initiating stimulus, signalling through PRRs play a crucial role in 
establishing an inflammatory setting in order to contain the infection and activate the 
adaptive immune response (Barton, 2008).  
 Toll like receptors 
The toll like receptors are single-pass membrane glycoproteins of the type 1 membrane 
glycoprotein family which function primarily to detect a broad range of bacterial 
components. TLRs are found on the outer or endosomal membranes of cells where they 
function as monomers, homodimers or heterodimers, signalling through which produces 
a cytokine response (Marie Moresco et al., 2011). 
There have been 12 TLRs found to be expressed in mammalian cells, the majority of which 
are expressed on cells of the innate immune system including macrophages and 
neutrophils. Of the identified human TLR family members, most have been well 
characterised. TLR4 was the first receptor to be characterised by Bruce Beutler who 
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identified that TLR4 could recognise LPS on gram-negative bacteria (Poltorak et al., 
1998). 
Ligand activation of TLRs ultimately induces the phagocytosis of the foreign pathogen and 
activation of pro-inflammatory signalling pathways. Depending on the adaptor proteins 
recruited to the intracellular domain of the TLR, following ligand activation, there is either 
a myd88 dependent activation of the NF-kB signalling pathway and cytokine release, or 
activation of the TRIF pathway leading to activation of IRFs and interferon production 
(Piccinini and Midwood, 2010). Interestingly, some TLR ligands are host-derived, such as 
the intracellular components of necrotic cells, highlighting the role of these receptors in 
damage signalling as well as pathogen sensing (Mori et al., 2015),. 
 Nod Like Receptors  
PRRs can also be intracellular, which are useful if the pathogen has been internalised by 
the cell. The nucleotide oligomerization domain-like (NOD-like) receptors (NLRs) are a 
family of intracellular PRRs which function in a comparable manner to the TLRs (Franchi 
et al., 2010). Nod1 and Nod2 recognise peptidoglycan moieties on gram negative and 
positive bacteria respectively  (Franchi et al., 2009). Signalling through some of the NLRs 
activates NF-kB signalling to enhance expression of pro-inflammatory genes including IL-
6, IL-1β and TNFα (Nathan, 2002). Conversely activation of other intracellular NLRs 
triggers the assembly of a protein complex known as the inflammasome, ultimately 
resulting in processing of inflammatory mediators such as IL-1β, IL-18 and IL-33 
(Medzhitov, 2007).  
Mutations in the gene encoding Nod2 are found in a small proportion of individuals with 
Crohn’s disease. These mutations effect the leucine rich region of the receptor, which is 
proposed to alter recognition of microbial components in the gut as well as over-
activating NF-kB in monocytes (Hugot et al., 2001). Mutations in the nucleotide binding 
domain of Nod2 are associated with Blau syndrome, a rare autosomal dominant disorder 
characterized by early-onset granulomatous arthritis, uveitis and skin rash (Miceli-
Richard et al., 2001), although the mechanisms underlying disease when caused by this 
mutation are currently not understood. 
Regardless of the initiating stimulus, the activation of the immune response ultimately 
leads to the recruitment of leukocytes from the blood to the site of inflammation, the 
first of which is the neutrophil.  
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1.6 The neutrophil  
The granulocyte family of white blood cells were discovered following advances in cell-
staining techniques which were utilised by scientist Paul Ehrlich in the late nineteenth 
century (Kay, 2016). Initially, the neutrophil was thought to act as a promoter of infection 
by interacting with invading bacteria, where the effects were considered detrimental to 
host tissues. However, in 1893 evolutionary biologist Elie Metchnikoff proved that, 
following his research using starfish embryos, phagocytes played a key role in the 
clearance of foreign material and were found to have key roles as antimicrobial 
molecules during the immune response (Mečnikov, 1892). Developments over the last 
century have led to the current understanding that the neutrophil plays a crucial role in 
inflammation and immunity (Kolaczkowska and Kubes, 2013). Neutrophils are the most 
prevalent of the immune cells in the circulation and play a crucial role in the innate 
immune response where they are recruited to the site of damage within minutes of 
trauma (Su and Richmond, 2015). The destructive mechanisms inflicted by neutrophils 
are immediate and their lack of specificity can be detrimental to tissue resident cells if 
unregulated. Failure of the immune system to resolve neutrophilic inflammation is 
damaging to host cells in multiple organ systems (Alessandri et al., 2013).    
1.1.3 Neutrophil life cycle  
Neutrophil lifespan is regulated by its production during granulopoiesis, storage in bone 
marrow in mammals, release into the circulation, clearance from the blood and finally, 
destruction (Summers et al., 2010). 
 Granulopoiesis 
The granulocyte family of mature polymorphonuclear neutrophils, basophils, and 
eosinophils are produced from precursor myeloblasts during a series of maturational 
steps. Macrophages and neutrophils are produced from the same progenitor cells, with 
their fate being determined by the expression of myeloid transcription factors in 
individual niches within the bone marrow. Granulocyte colony stimulating factor (G-CSF) 
is the principal regulator of granulocyte production from hematopoietic stem cells which 
in humans occurs in the venous sinuses of bone marrow. G-CSF induces the 
differentiation of hematopoietic stem cells, such that they commit to the myeloid lineage, 
and regulates the proliferation of granulocytic precursors (Summers et al., 2010). The 
crucial role of G-CSF in modulating neutrophil production is demonstrated in humans 
with dominant negative G-CSF receptor mutations, whereby they suffer from congenital 




 Neutrophil trafficking from bone marrow 
It is estimated that between 5x1010 and 10x1010 neutrophils are produced in human bone 
marrow every day (Summers et al., 2010). In addition to the bone marrow reserve where 
the majority of neutrophils are found, there exists a marginated pool of neutrophils in 
the capillary beds of organs including the spleen, liver and lungs. Circulating neutrophil 
numbers in the blood are tightly regulated by balancing the bone marrow retention, 
release and clearance from the circulation. Retention signals in this context are 
generated through the production of ligand by stromal cell populations in the marrow, 
which signal through G protein coupled receptors to maintain neutrophils in the bone 
marrow niche. The CXCR4/CXCL12 signalling axis plays a crucial role in modulating the 
homeostasis of neutrophils, the important role of which is highlighted in patients with 
Warts, hypogammaglobulinaemia, infection and myelokathesis (WHIM) syndrome. Gain 
of function WHIM mutations result in increased CXCR4 signalling, the consequence of 
which is severe neutropenia with increased neutrophil retention in the bone marrow 
(Kawai and Malech, 2009). 
 
CXCL12 signals through neutrophil cell surface CXCR4 receptors, with the ligand being 
constitutively produced by stromal cell populations in the bone marrow (Day and Link, 
2012).  This signalling retains immature neutrophils in the hematopoietic niche under 
normal physiological conditions.  There is growing evidence to suggest that crosstalk 
between CXCR4/CXCL12 and the VLA-4/VCAM1 signalling axis modulates neutrophil 
adhesions in the bone marrow. Bone marrow neutrophils express the α4-integrin VLA-4 
which binds to its major ligand vascular cell adhesion molecule 1 (VCAM1) expressed on 
bone marrow stromal cells (Day and Link, 2012). CXCL12 and VCAM1 are co-localised in 
murine bone marrow and the expression profile of VLA-4 of neutrophils decreases with 
age, matching that of CXCR4. Furthermore CXCR4 augments VLA-4 adhesion to VCAM-1 
in vitro and blockade of both CXCR4 and VLA-4 caused synergistic neutrophil egress from 
bone marrow (Petty et al., 2009).  
Loss of functional G-CSF receptors has been shown to cause severe neutropenia in mice 
and humans (Druhan et al., 2005; Lieschke et al., 1994). G-CSF regulates the release of 
neutrophils from bone marrow through modulation of the CXCR4/CXCL12 signalling axis. 
Mature neutrophils express high levels of G-CSF and low levels of CXCR4 (Summers et 
al., 2010). Administration of G-CSF to mice reduces stromal cell production of CXCL12 
(Semerad et al., 2002) and decreases CXCR4 expression on myeloid cells (Kim et al., 
2006) resulting in attenuated neutrophil responses to CXCL12 gradients in bone marrow 
and subsequent release into the circulation.   
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A combination of G-CSF and CXCR4 antagonists are used therapeutically to release 
hematopoietic stem cells from bone marrow. As mentioned, G-CSF reduces CXCL12 
production by bone marrow stromal cells, but in combination with a CXCR4 antagonist, 
retention signals are interrupted, resulting in the synergistic release of HSCs from the 
bone marrow which can be used for transplantation (Broxmeyer et al., 2005).   
More recently an antagonistic role of the CXCR2 signalling axis has been implicated in 
neutrophil release from the bone marrow. Perfusion of the CXCR2 ligand MIP-2 induced 
the rapid release of neutrophils from rat femoral bone marrow (Deininger et al., 2005). 
Murine CXCR2-/- neutrophils are retained preferentially over wildtype neutrophils in the 
bone marrow of chimera mice. This phenotype was not observed in double CXCR2-/- 
CXCR4-/- neutrophils which were mobilised constitutively, highlighting the dominant role 
of CXCR4 signalling in neutrophil release and retention (Eash et al., 2010).  
It has been proposed that opposing cues from the two signalling axis modulates 
neutrophil egress from bone marrow in a tug-of-war scenario (Figure 1.2). In this model, 
endothelial derived chemokines such as CXCL1 and 2 direct neutrophil migration 
towards the vasculature and drive egress from the bone marrow, whilst osteoblast 
derived chemokines, such as CXCL12, promote neutrophil retention. In a normal 
physiological state, the balance of signalling favours neutrophil retention through 
dominant CXCR4/CXCL12 signalling. The balance is tipped in infection or inflammation 
by the production of pro-inflammatory cytokine G-CSF which increases CXCL2 
expression by endothelial cells and reduces CXCR4/CXLC12 expression,  promoting 







Figure 1.2: Neutrophil release from the bone marrow is regulated by a 
tug-of-war between CXCR2 and CXCR4 signalling. 
Adapted from Sadik et al., 2011. CXCL12 signalling through CXCR4 promotes the 
retention of neutrophils in the bone marrow (A), whilst CXCR2 signalling through 
endothelial derived chemokines CXCl1 and 2 promote neutrophil release into the 
circulation (B). The granulocyte-colony stimulating factor (G-CSF) adjusts the 
balance of CXCR4 and CXCR2 by reducing CXCL12 production by osteoblasts (A), 




 Neutrophil homing and clearance 
The half-life of circulating neutrophils in humans was traditionally believed to be around 
8 hours (Dancey et al., 1976).  Deuterium labelling of neutrophils provided evidence ti 
suggest that under homeostatic conditions circulating neutrophils have a half-life of 5.4 
days (Pillay et al., 2010). However, this study was met with much contention due to 
fundamental problems with the mathematical modelling used to calculate the 
peripheral blood lifespan of neutrophils and the ability of deuterium to label newly 
dividing neutrophil precursors, and is thus still a subject of debate (Tofts et al., 2011).  
Under basal conditions, mature neutrophils home back to the bone marrow where they 
undergo apoptosis and are phagocytosed by stromal macrophages (Summers et al., 
2010). There is evidence to suggest that the homing behaviour of mature neutrophils is 
dependent on their upregulated expression of CXCR4 which acts as a homing signal to 
promote the migration of neutrophils to CXCL12 enriched bone marrow niches, although 
this process has not been fully defined.  
1.1.4 Neutrophil recruitment  
In healthy adults, <2% of neutrophils are found in the circulation (Sadik et al., 2011). Those 
which are circulating do so in an inactive state, causing no harm to host tissue (Wright et 
al., 2010). During inflammation neutrophils are rapidly recruited to sites of tissue damage 
or infection in a multi stage series of events. The neutrophil recruitment cascade is 
modulated by a range of overlapping signals which guide neutrophils to the inflammatory 
site.  
Cellular stress and systemic inflammation promote the egress of neutrophils from the 
bone marrow through the production of pro-inflammatory mediators such as TNF-α, IL-
8, C5a and LTB4, as well as G-CSF and CXCR2 agonists MIP-2 and CXCL1 produced at 
inflammatory sites (Burdon et al., 2008).  Priming of neutrophils prevents their 
inappropriate degradation and matches neutrophil function to the level of threat.  
 Leukocyte adhesion cascade 
Neutrophil recruitment to inflamed tissue is initiated by the activation of endothelial cells 
lining the lumen of blood vessels by inflammatory mediators such as histamine and 
cytokines.  The process of neutrophil recruitment to inflamed tissue has been extensively 
studied and occurs via a process known as the leukocyte adhesion cascade.  The 
leukocyte adhesion cascade is a well-defined sequence of events whereby neutrophils 
form interactions with activated luminal endothelial cells along which they roll, before 
forming firm adhesions. Tethered neutrophils then transmigrate through the endothelial 
layer and into the interstitial tissue (Ley et al., 2007).  
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In healthy blood vessels, neutrophils circulate passively in the centre of the vessel due to 
laminar flow. During inflammation, blood flow is reduced in post-capillary venules due to 
changes in haemodynamics. Reduced flow increases the chances of neutrophils coming 
into contact with the endothelial cells lining the vessel wall (Muller, 2013).  
Activated endothelial cells alter their surface expression of adhesion molecules such as 
P and E selectin on the luminal surface (Lorenzon et al., 1998).The binding of P and E 
selectin to their glycosylated ligands on the neutrophil surface forms weak interactions 
such that neutrophils bind tentatively to the endothelium which they slowly move along 
in a process known as rolling.  
Neutrophils roll along the surface of the endothelium in the direction of blood flow where 
they are primed and activated. Full activation of neutrophils involves priming by pro-
inflammatory factors including cytokines, growth factors and bacterial products (Hallett 
and Lloyds, 1995). Neutrophil priming maximises neutrophil function by activating the 
NADPH  oxidase pathway and promoting appropriate degranulation (Kelly et al., 2007).  
Neutrophil activation is mediated by haptotactic gradients of endothelial chemokines 
which signal via CXCR2, heparin sulphate proteoglycans and duffy antigen receptor for 
chemokines (DARC). Activated neutrophils increase their expression of cell surface 
integrins that show higher affinity for their ligands, including immunoglobulin-like cell 
adhesion molecules (ICAMs) expressed by endothelial cells. Adhered neutrophils then 
transmigrate through intracellular junctions in the endothelium and into the interstitial 
tissue (Schenkel et al., 2004).   
1.1.5 Neutrophil migration in interstitial tissue 
Upon entry into the interstitial tissue, a complex array of chemoattractant signals, 
including bacterial and tissue derived chemoattractant signals, guide neutrophils 
through the extracellular matrix towards the source of chemokine production (Sadik et 
al., 2011).  Neutrophils respond to chemoattractant gradients through the activation of 
cell surface chemoattractant G protein coupled receptors (GPCRs). Signalling through 
these receptors induces calcium mobilisation from intracellular stores and downstream 
signalling, resulting in actin polymerisation at the point in the cell where chemokine 
concentration is highest.  
A key signalling axis which modulates the chemotaxis of neutrophils through the 
interstitial tissue is the CXCR1/2-CXCL8 signalling axis, which activates intracellular 
signalling pathways to regulate neutrophil motility. CXCR1 and CXCR2 are GPCRs which 
are activated by CXCL8 and bind to each with different binding affinities (Holmes et al., 
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1991; Murphy and Tiffany, 1991). CXCR2 knockout mice have a diminished neutrophil 
response to viral infection in the lung (Wareing et al., 2007). Genetic and pharmacological 
inhibition of CXCR2 signalling in zebrafish larvae prevents the recruitment of neutrophils 
to CXCL8 produced at inflammatory sites following tail-fin transection (de Oliveira et al., 
2013).  
Chemotaxis of neutrophils requires temporal and spatial regulation of external signals 
through prioritising competing chemoattractant gradients in order to polarise and 
migrate in the required direction (Hind et al., 2016).  In the interstitium, a range of 
chemoattractants including CXCL8, LTB4 and fMLP are derived from host cells and 
pathogens. The migration of neutrophils towards individual chemokines has been well 
characterised, however, due to limitations in assays used to study neutrophil chemotaxis 
towards multiple chemoattractants, less is known about how neutrophils prioritise these 
competing signals. Hierarchical neutrophil responses have been observed following 
exposure to competing chemokine gradients such that end point chemoattractants 
which emerge in the immediate vicinity of an invading pathogen such as fMLP or C5a 
override the intermediary signals derived from host cells such as CXCL8 and LTB4 (Kim 
and Haynes, 2012).  
To achieve forward migration, neutrophils polarise by forming a leading edge 
(pseudopod) at the highest concentration of chemoattractant, and a trailing edge 
(uropod).  At the leading edge the extension of broad lamellipodia or spike-like filopodia 
form adhesions with the substratum, processes which are controlled by the 
rearrangement of the actin cytoskeleton (Ridley et al., 2003). The f-actin polymerisation 
at the leading edge required for neutrophil migration is mediated by the formation of the 
Arp2/3 complex which redistributes to the region of the neutrophil where the highest 
concentration of chemoattractant is sensed (Weiner et al., 1999). At the trailing edge, Rac 
signalling modulates the degradation of adhesion molecules and actin polymerisation 
allows the back of the cell to contract  (Ridley et al., 2003). Upon encountering a 
chemotactic gradient, neutrophils like many eukaryotic cells polarise by accumulating 
the lipid PtdIns(3,4,5)P3 (PIP3) to the membrane where the highest concentration 
gradient is sensed (Servant et al., 2000). Initially it was believed that external chemokine 
gradients induced the formation of pseudopods to direct the cell towards the highest 
concentration of chemoattractant. However, more recent findings suggest that 
pseudopods form independently, and the detection of external gradients promotes the 
maintenance of existing pseudopods to drive movement in the required direction (Insall, 
2010). Cross talk between a multitude of downstream signalling pathways modulates the 
cytoskeletal rearrangements required for neutrophil migration  (Cho et al., 2014).  
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Two key signalling pathways have been identified in neutrophil migration. The 
phosphatidylinositol-3-OH kinase (PI3K) phosphatase pathway is activated by tissue-
derived chemokines, whilst the p38 mitogen-activated protein kinase (MAPK) pathway is 
activated by bacterial derived chemokines. In recent years, it has become apparent that 
neutrophils elicit differential responses to competing chemokine gradients (Kim and 
Haynes, 2012). Signalling through p38 MAPK is able to over-ride the PI3K signalling 
pathway, suggesting that bacterial derived chemokines are prioritised by neutrophils 
(Heit et al., 2002a). The preferential migration of neutrophils to opposing gradients is 
modulated in part by the phosphatase PTEN which is distributed around the 
circumference of the neutrophil where it inhibits PI3K  signalling at the cell surface (Heit 
et al., 2008).  
Advances in in vitro assays used to expose human neutrophils to competing chemokine 
gradients has identified that neutrophils are activated more rapidly in response to fMLP 
gradients compared to LTB4  (Cho et al., 2014). Tracking of human neutrophils in vitro in 
competing gradients suggests a signalling hierarchy exists, whereby neutrophils 
prioritise end-point chemoattractants such as pathogen derived fMLP over gradients of 
intermediary endogenous chemokines such as CXCL8, CXCL2 and LTB4 (Kim and Haynes, 
2012). These end target chemoattractants drive neutrophil migration preferentially 
towards bacterial infection by activating the p38/MAPK pathway rather than the 
PI3K/AKT pathway, which is activated by intermediary chemoattractants (Heit et al., 
2002b). This is modulated by the phosphatase PTEN which is distributed throughout the 
circumference of the entire neutrophil following exposure to competing end-point 
chemoattractants. PTEN inhibits PI3K signalling at the leading edge, such that migration 
is driven via the p38/MAPK pathway towards bacterial derived chemoattractants. The 
role of PTEN in gradient prioritisation is demonstrated in PTEN-/- neutrophils which are 
unable to prioritise chemokine gradients (Heit et al., 2008). Whilst the dynamics of 
neutrophil migration under competing gradients are beginning to be dissected (Cho et 
al., 2014), the complex integration of chemical signals by neutrophils remains to be fully 
elucidated.    
1.7 Neutrophil function 
During inflammation, neutrophils are activated and their longevity increases, such that 
they are able to function as effective anti-microbial cells to defend the host against 
infection using multiple mechanisms. These include the phagocytosis of pathogens, 
production of reactive oxygen species and degranulation, formation of extracellular traps 
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to capture pathogens outside of the cell and neutrophil swarming (Kolaczkowska and 
Kubes, 2013).  
1.1.6 Phagocytosis 
Neutrophils, along with macrophages, are members of the phagocyte family of immune 
cells which have the ability to recognise and engulf opsonised pathogens. Following 
recognition by cell surface receptors, actin cytoskeletal rearrangements lead to the 
formation of a membrane derived vacuole to encompass the receptor ligand complex, 
which is internalised by and destroyed intracellularly through degradative enzymes. 
Pathogens opsonised by immunoglobulins are recognised by neutrophil Fc receptors 
whilst those opsonised by complement are recognised by complement receptors (van 
Kessel et al., 2014). Binding of TLRs to conserved DAMPs also triggers phagocytosis. 
Internalised vacuoles or ‘phagosomes’ undergo a lengthy maturation step in which a 
potent anti-microbial environment is created through fusion of the phagosome with 
secretory vesicles and granules, such that the mature phagosome contains the 
machinery to destroy and degrade its internal cargo (Lee et al., 2003). 
1.1.7 Degranulation 
The cytoplasm of a neutrophil contains a host of granules containing cytotoxic 
substances critical for neutrophil function as anti-microbial cells. Cytotoxic substances 
are delivered to the phagosome to assist intracellular pathogen killing, or to the cell 
surface where they are expelled into the tissue to degrade extracellular matrix 
components or facilitate extracellular killing (Häger et al., 2010). Of all the anti-microbial 
effects of neutrophils, degranulation is the process which must be most tightly regulated 
as the release of toxic granule components into the tissue is damaging to the host 
(Faurschou and Borregaard, 2003).  
Neutrophils have three types of cytoplasmic granules which differ in internal 
composition, propensity for mobilisation and time of formation (Häger et al., 2010). Initial 
classification of neutrophil granules was based on their myeloperoxidase (MPO) content. 
Azurophilic (primary) granules stain positive for MPO whilst specific (secondary) and 
gelatinase (tertiary) do not (Borregaard and Cowland, 1997). Classification of granules is 
flexible as neutrophil granule formation is a continuum whereby primary granules 
develop and share granule components with tertiary granules (Borregaard and Cowland, 
1997). Primary granules are formed during the early stages of granulopoiesis and contain 
enzymes for digestive and bactericidal functions including MPO, α-defensins, cathepsin 
G and proteinase-3 (Falloon and Gallin, 1986). Secondary and tertiary granules are 
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formed later in neutrophil development and are characterised by the presence of 
lactoferrin and gelatinase respectively.  
The physiological role of neutrophil granules is demonstrated in patients with neutrophil-
specific granule deficiency, a rare congenital disorder characterised by increased 
susceptibility to pyogenic infection and persistent infections by staphylococcus aureus 
and Pseudomonas aeruginosa  (Gallin et al., 1982). 
1.1.8 ROS production 
Reactive oxygen species are produced in neutrophils via a respiratory burst. Following 
the phagocytosis of pathogens, neutrophils undergo a burst of oxygen consumption, the 
majority of which is converted to highly reactive oxygen species (Klebanoff, 2005). The 
NADPH oxidase complex is assembled in phagosomes where it catalyses the reactions 
resulting in the formation of hydrogen peroxide, the superoxide anion and subsequent 
downstream reactive oxygen species inside the phagosome (Dahlgren and Karlsson, 
1999). Inside the phagosome, the activity of myeloperoxidase released following the 
degranulation of primary granules catalyses the formation of the potent anti-microbial 
substance hypochlorous acid from hydrogen peroxide and chloride (Klebanoff, 2005).    
NADPH oxidase can also be recruited to the plasma membrane where it assembles and 
catalyses the production of reactive oxygen species which are released by neutrophils 
into the tissue to destroy extracellular pathogens, however ROS release into tissue is 
responsible for the tissue-damaging properties of neutrophils (El-Benna et al., 2008). 
Inactivation of the NADPH oxidase complex by anti-inflammatory signalling molecules 
limits the production of ROS and avoids extensive host tissue damage.  
The crucial role of NADPH oxidase in controlling infection is demonstrated in patients 
with chronic granulomatous disease (CGD) who suffer from recurrent infections due to 
mutations in their NADPH oxidase gene (Volpp et al., 1988).  
1.1.9 NET formation 
A more recently identified neutrophil defence mechanism is the formation and release 
of extracellular traps to capture and destroy pathogens extracellularly. Neutrophil 
extracellular traps are web-like chromatin structures embedded with granule proteins 
released by activated neutrophils. NETs were first visualised in vitro using electron 
microscopy, where it was identified that activated but not naïve neutrophils made 
prominent extracellular structures following stimulation by interleukin-8 (IL-8), phorbol 
myristate acetate (PMA), or lipopolysaccharide (LPS) as well as gram positive or gram 
negative bacteria (Brinkmann et al., 2004). Since the identification of extracellular traps 
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in neutrophils, it has been identified that other cell types including eosinophils (Yousefi 
et al., 2008), macrophages (Chow et al., 2010) and mast cells (von Kockritz-Blickwede et 
al., 2008) are capable of extracellular trap formation. 
NETs are composed of a backbone of nuclear chromatin and histones, embedded with 
antimicrobial proteins capable of killing a wide range of microbes. These include 
neutrophil elastase, cathepsin G, proteinases, defensins, lactoferrin and (MPO) 
(Remijsen et al., 2011). The release of NETs by neutrophils in vitro occurs within 2-4 hours 
following activation (Fuchs et al., 2007). In vitro NETs can be degraded by DNAses, and 
some pathogens have evolved strategies to evade capture by NETs through the 
production of DNAses (Beiter et al., 2006) or modifications to cell wall structures 
(Wartha et al., 2007).  
 
The antimicrobial activity of extracellular traps has been demonstrated in many settings, 
however the extent with which NETs contribute to pathogen killing is a topic of 
controversy. Interestingly, there exists evidence of extracellular trap formation being 
detrimental to the host through the induction of autoimmune responses, for example, in 
systemic lupus erythematosus and rheumatoid arthritis (Zhong et al., 2007).  
 
In some circumstances NETs can form in the context of cell death (Fuchs et al., 2007). 
The process of extracellular trap release has been termed ETosis, or NETosis for 
neutrophils specifically, after the identification that in some contexts, extracellular trap 
release from neutrophils is accompanied by the programmed cell death of the neutrophil 
(Wartha and Henriques-Normark, 2008). It is currently understood that when NET 
formation occurs in the context of cell death, this cell death programme is distinct from 
apoptosis and necrosis, and occurs independently of caspases and certain kinases such 
as RIP-1 (Remijsen et al., 2011). NETosis begins with the activation of surface receptors 
and the adhesion of the neutrophil to the substratum (Figure 1.3A-B). This is followed by 
decondensation of nuclear chromatin and disintegration of nuclear and granular 
membranes. In the cytoplasm, granular membranes are disrupted, allowing the leakage 
of granule components including MPO and neutrophil elastase into the cytoplasm (Figure 
1.3C). This also facilitates the release of the chromatin leaking from the nucleus into the 
tissues (Fuchs et al., 2007). The neutrophil then rounds up and the plasma membrane 
ruptures, expelling the nuclear material embedded with granule proteins into the 








Figure 1.3: Neutrophil extracellular trap formation during NETosis. 
Adapted from Brinkmann and Zychlinsky 2012. (A) Neutrophil activation 
leads to morphological changes. (B) Neutrophils flatten and adhere to the 
substratum and granule components are released. (C) Nuclear chromatin 
decondenses, the nucleus loses its lobules and the intracellular 
membranes disintegrate causing nuclear contents to mix with the 
cytoplasm. (D) Rupture of the plasma membrane causes expulsion of the 







Whilst some of the cellular processes which modulate NETosis have been dissected, 
many aspects still remain unresolved (Goldmann and Medina, 2012). The current 
understanding is that NETosis is mediated by histone citrullination, superoxide 
production and autophagy in neutrophils where apoptotic machinery is inhibited 
(Remijsen et al., 2011).  The crucial role of ROS production by NADPH oxidase in NETosis 
is demonstrated in patients with Chronic Granulomatous Disease, who have impaired 
NET production (Fuchs et al., 2007). There is evidence to suggest that ROS production 
blocks the apoptotic pathway in neutrophils as some reactive oxygen species inhibit 
caspases (Fadeel et al., 1998; Hampton et al., 2002). Downstream of NADPH oxidase and 
superoxide generation, a role for MPO in extracellular trap formation has also been 
identified as neutrophils from MPO deficient donors have a reduced capacity to form 
extracellular traps (Metzler et al., 2011).   
Histone citrullination at arginine residues by the enzyme peptidylarginine deiminase 
(PAD4) drives nuclear decondensation. ROS production by NADPH oxidase in activated 
neutrophlis activates PAD4. Inhibition of PAD4 in HL-60 cells reduces histone 
hypercitrullination and NET formation (Wang et al., 2009). Furthermore, neutrophils in 
PAD4 deficient mice are unable to form NETs (Li et al., 2010). 
An essential role of autophagy in NETosis is emerging, as recent evidence identified that 
pharmacological inhibition of autophagy prevents the intracellular chromatin 
decondensation essential for NET formation and NETosis (Remijsen et al., 2011). How 
autophagy synergizes with ROS production to regulate chromatin decondensation 
remains unclear, although it has been suggested that Ca2+ leakage from disrupted ER 
membranes may promote PAD4 activity and histone citrullination (Remijsen et al., 2011).  
Conversely, evidence from initial NET studies suggests that in some contexts 
extracellular traps are released by viable neutrophils, as no cytosolic proteins were found 
in NETS and most cells excluded vital dyes. These NETs were induced rapidly following 
stimulation with neutrophil survival factors such as IL-8 and LPS (Brinkmann et al., 2004). 
More recent investigations have identified that the source of chromatin from NETs 
released by viable cells is from mitochondria rather than the nucleus. This type of viable 
NET production was induced by GM-CSF followed by TLR4 or C5a receptor stimulation, 






It is suggested that NET production by viable or dying cells should be considered as two 
separate entities. The reasons why only some neutrophils produce NETs is currently not 
understood, although it is likely that tissue context, neutrophil age and the heterogeneity 
of neutrophils could all contribute (Remijsen et al., 2011).  
1.8 Neutrophil swarming 
Recent advances in in vivo imaging of neutrophil dynamics within interstitial tissues have 
identified that neutrophils coordinate their behaviour to arrange themselves into 
clusters. The dynamics of this clustering behaviour has been compared to the swarming 
behaviour seen in insects and birds, and has therefore been termed neutrophil swarming 
(Lämmermann et al., 2013).  
Neutrophil swarms are the result of migration patterns coordinated through relay 
signalling between neutrophils through the production of self-generated 
chemoattractant gradients. Thus far the lipid leukotriene B4 has been identified as one 
such relay signal,  which is sensed by neutrophils over long range through auto-signalling 
(Lämmermann et al., 2013).  
It has been proposed that swarm formation is a host-protective mechanism with an 
important role in limiting the extent of microbial infections (Chtanova et al., 2008) 
(Lämmermann, 2015). On the other hand neutrophil swarming comes at the cost of host 
tissue integrity, as large dense clusters of activated neutrophils can inevitably lead to 
tissue damage (Kreisel et al., 2010). Neutrophil swarming at intravascular lesions of 
Candida albicans has been linked to capillaritis with pulmonary haemorrhage. Clustering 
is absent in mice lacking the LTB4 receptor and capillaritis is attenuated following 
inhibition of LTB4 signalling, highlighting that dysregulation of neutrophil swarming can be 
detrimental to the host (Lee et al., 2018).   Regardless of their precise role it is clear that 
neutrophil swarming has a crucial role in regulating the balance between host protection 
and tissue destruction. Understanding the molecular controls of these novel neutrophil 
migratory behaviours may provide further insight into the drivers of neutrophil mediated 









Although there are relatively few studies describing the modulation of neutrophil  
swarming due to its recent discovery, it is clear that neutrophil swarming is a highly 
regulated process coordinated by chemokines, lipids and integrins (Lämmermann et al., 
2013). Intravital imaging studies have revealed that neutrophil clustering at inflammatory 
sites occurs following multi-step attraction cascades whose precise sequence varies 
depending on the precise tissue context (Lämmermann, 2015). 
Evidence from studies in the ear dermis of mice suggest that neutrophil swarming is a 5-
step cascade of events (Lämmermann et al., 2013). Thus far a series of sequential events 
has been proposed to describe the formation of neutrophil swarms, although 
confirmation of these stages in other systems is important (Kienle and Lämmermann, 
2016). Initial recruitment of scouting neutrophils proximal to the wound site is observed 
rapidly following the introduction of an inflammatory stimulus and is modulated through 
the release of chemoattractant molecules from damaged cells and pathogens at the 
wound site. This first phase of chemotaxis is followed by a substantial neutrophil 
response whereby the vast numbers of highly directed neutrophils from sites distal to 
the wound site are recruited. These neutrophils migrate with increased directionality 
and speed, and coordinate themselves within the tissue environment to form large dense 
neutrophil clusters (Lämmermann et al., 2013). Initial amplification of neutrophil 
recruitment correlates with the appearance of a propidium iodide positive lesion at the 
wound site, suggesting a role for cell death in early signal propagation.  
This is followed by paracrine signalling between neutrophils through the release of the 
lipid LTB4 which amplifies recruitment signals over long range distances, resulting in a 
large influx of highly directed neutrophil migration followed by accumulation and cluster 
formation. The scouting and amplification stages are followed by an aggregation phase in 
which integrin receptors maintain cluster structure and integrity whilst neutrophils 
remodel the extracellular matrix surrounding the swarm to form a tight collagen-free 
wound seal, followed by swarm resolution which correlates with macrophage 








Figure 1.4: Proposed 5- stage model of the neutrophil swarming response 
Adapted from Lammermann et al., 2015. (A) Neutrophils proximal to sites of local tissue 
damage sense short range chemotactic signals which induce their recruitment. (B) The 
death of dew dying neutrophils releases a first wave of amplification signals. (C) 
Clustering neutrophils secrete LTB4 which acts as a relay signal to amplify recruitment 
signals to neutrophils over long distances. (D) Aggregating neutrophils displace collagen 
fibers and clusters persist to form a tight wound seal dependent on LTB4, CXCR2 
ligands, FPR2 ligands and integrins. (E) Macrophages appear around the outside of 




The current understanding is that neutrophil swarming is dependent on the tissue 
context in the inflamed tissue. The coordinated behaviour of neutrophils required for 
swarm formation occurs following the optimal combination of guidance factors from 
tissue lesions, and release of chemoattractant molecules from bystander cells and dying 
cells at the wound site (Kienle and Lämmermann, 2016).  In vitro microfluidic studies have 
identified that human neutrophil swarming can be induced on a chip by zymosan beads, 
and that induction of swarming is dependent on the size of and distance between the 
beads, highlighting the role of gradient sensing and tissue context in regulating neutrophil 
migratory behaviours (Reátegui et al., 2017). 
The key regulators of neutrophil swarming identified thus far, are cell death signalling 
which plays a role in swarm initiation, relay signalling through the release of LTB4 and the 
role of integrin receptors to maintain cluster structure and integrity (Lämmermann, 
2015).  
1.1.10 Swarm initiation by cell death signalling 
The recent identification of neutrophil swarming behaviour means that few studies have 
been able to dissect the molecular cues which govern this process, largely due to 
limitations in experimental systems required to understand the complexities of the 
swarming response.  
Cell death signalling has been implicated in the initiation of neutrophil swarming to focal 
tissue damage in mice. The death of a few neutrophils in the inflamed tissue environment 
was enough to induce the chemotactic transition, leading to highly directed neutrophil 
migration characteristic of the swarming response. The appearance of propidium iodide 
positive lesions at the wound site correlates with the influx of highly directed neutrophil 
migration leading to swarm formation, suggesting a role for non-programmed cell death 
in swarm initiation (Lämmermann et al., 2013). 
Necrosis is a form of uncontrolled cell death which occurs through autolysis and release 
of cellular components into the extracellular tissue. Different in almost every respect to 
programmed cell death, necrosis is the outcome of the direct effect of extreme stresses 
including heat, mechanical stress, nutrient deprivation or osmotic shock to the cell. The 
sequence of events leading to necrotic cell death include the swelling of the cytoplasm 
followed by the rupture of the plasma membrane and organelle breakdown. The 
liberation of factors from these dead cells into the tissue alerts cells of the immune 
system, initiating a local inflammatory response which often results in collateral tissue 
damage. Unlike apoptotic cells which are usually cleared rapidly by phagocytosis, 
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necrotic cells are removed incompletely through macropinocytosis, leaving much of their 
cellular debris behind (Golstein and Kroemer, 2007). 
The precise chemotactic factors secreted by dying cells are currently unknown. A role 
for cell death signalling by NAD+ released by dying cells has been proposed. NAD+ is 
catabolised to cyclic ADP-ribose (cADPR) by neutrophils, where it has a role as a second 
messenger to mobilise calcium from intracellular stores (Lee, 1997). Inhibition of cADPR 
in neutrophils impairs the characteristic amplification of neutrophil recruitment seen in 
wildtype neutrophil swarming response (Ng et al., 2011). The role of NAD+ in swarm 
initiation has been investigated in mice, although currently no single receptor which 
utilises cADPR for calcium mobilisation has been implicated in modulating neutrophil 
recruitment amplification (Lämmermann et al., 2013).    
 Swarm amplification by relay signalling 
The precise mechanisms governing swarm amplification are still being elucidated, 
however there now exists clear evidence that neutrophils modulate this phenomenon 
through intercellular relay signal communication. In particular, the role of LTB4  as a signal 
relay molecule between neutrophils has been defined. GPCR signalling is essential in 
swarm amplification, as genetic depletion of the G-αi2  subunit in neutrophils, impaired 
the late recruitment of neutrophils during swarm amplification (Lämmermann et al., 
2013). The role of many GPCRs in modulating swarm formation was investigated, 
however only neutrophils lacking the LTB4 receptor have been shown to exhibit impaired 
neutrophil swarming responses. Neutrophils lacking the high affinity receptor for 
leukotriene B4, BLT-1, showed no defect in their ability to recruit to focal tissue damage 
during the early phases of recruitment. However during the second phase of signal 
amplification these BLT-1 deficient neutrophil did not exhibit the bi-phasic response to 
focal damage seen in wildtype neutrophils, and recruitment of neutrophils from distal 
sites was impaired (Lämmermann et al., 2013). In this model neutrophils are a major 
source of LTB4  essential in auto-signalling during swarm amplification.  
 Swarm aggregation and integrin signalling 
In terms of the outcome of neutrophil swarming, neutrophil swarms in mice and human 
neutrophils can be transient or persistent. Transient swarms have been observed at sites 
of infection, where pathogens and dead cells are randomly distributed. These swarms 
persist for less time than the swarms observed at sites of focal tissue damage, where 




The migration of individual neutrophils once inside clusters is drastically reduced and 
neutrophils begin to aggregate on top of one another. The tight association of swarming 
neutrophils is mediated by neutrophil-derived chemokines, lipids and other sources of 
chemokines. Movement in the clusters at this stage is dependent on Gαi2 signalling, as 
neutrophils depleted of this subunit were excluded from clusters during the aggregation 
phase whilst control neutrophils continued to aggregate. More specifically a role for the 
β2  integrin family has been identified in regulating the homotypic adhesions in neutrophil 
clusters (Lämmermann et al., 2013). During swarming, as well as producing large amounts 
of LTB4, human neutrophils produce lipoxin A4, resolvin E3, and prostaglandins D2 and E2 
(Reátegui et al., 2017). A role for lipoxin A4 produced by neutrophil swarms during the 
aggregation phase has been identified in modulating swarm size in vitro, suggesting a role 
for pro-resolving lipid mediators in swarm modulation at its later stages (Reátegui et al., 
2017).  
The formation of substantial neutrophil aggregates results in the remodelling of tissues 
in the swarm environment. The extracellular matrix underlying the neutrophil swarm is 
remodelled by factors released by the aggregating neutrophils. Evidence suggests that 
neutrophil-induced proteolysis is driven by factors such as neutrophil elastase induced 
by LTB4 (Lämmermann et al., 2013). It has been proposed that cluster maintenance is 
modulated by signalling through multiple GPCRs to promote neutrophil adhesions and 
persistent clustering (Lämmermann, 2015).  
 Swarm resolution 
The mechanisms which result in the cessation of neutrophil clustering are unknown, 
although one possible explanation is that neutrophil-derived signals responsible for 
maintaining neutrophils in stable aggregates are overridden by other competing 
attractant signals within the inflammatory environment (Lämmermann, 2015). Potential 
modulation could be the antagonism of LTB4 signalling in neutrophils to prevent 
additional neutrophils from joining the cluster, or activation of receptors involved in 
inflammation resolution to drive the dissipation of swarms (Lämmermann, 2015).  
Profiling of cytokine and chemokines released by human neutrophils during swarming in 
vitro has identified that pro-resolving lipid mediators such as lipoxin A4, resolvin E3 and 
prostaglandins D2 and E2 are produced during the swarming response. A specific role 
for lipoxins A4 in modulating swarm stop signals has been identified, as neutrophils pre-
treated with lipoxins A4 prior to swarming assays form substantially smaller neutrophil 
clusters (Reátegui et al., 2017).  
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The mechanisms which govern the persistence of swarming remain to be elucidated. In 
vitro human neutrophil assays are being used to profile the mediators released from 
swarming neutrophils compared to non-swarming neutrophils, and thus far 45 have been 
identified, which may play a role in the start and stop signals required for the swarming 
response (Reátegui et al., 2017). 
 Physiological roles of neutrophil swarming 
The precise physiological role for swarming is not known, although arguments are 
currently being made for both host-protective and host-damaging outcomes. It has been 
suggested that, like all aspects of neutrophilic inflammation, swarming is a double-edged 
sword, the role of which is important in preventing bacteria from establishing a foothold 
in the host (Reátegui et al., 2017).  The role of swarming as a host-protective mechanism 
has been demonstrated in zebrafish where neutrophil clustering at sites of microbial 
infection has been observed (Chtanova et al., 2008). On the other hand, neutrophil 
swarming comes at the cost of host tissue integrity, as large dense clusters of activated 
neutrophils can inevitably lead to tissue damage (Kreisel et al., 2010).  
Regardless of the dynamics of neutrophil recruitment to, and behaviour in, the interstitial 
tissue, having completed their role as anti-inflammatory foot soldiers, neutrophils must 
be removed from the inflammatory site to enable the restoration of tissue homeostasis.  
1.9 Inflammation resolution 
During inflammation, neutrophil survival factors produced by the local inflammatory 
environment modulate the longevity of neutrophils to ensure they successfully perform 
their anti-microbial roles at sites of infection and tissue damage. Survival factors are both 
host- and pathogen-derived signals, including GM-CSF, G-CSF, IL-2, IFNγ, IL-1β and TNF-α 
(Geering et al., 2013).  
 
Following the neutralisation of an inflammatory stimulus, a series of coordinated 
processes must occur to promote the restoration of tissue integrity. For tissue 
homeostasis to be restored, neutrophil recruitment from the blood must cease, the 
production of pro-inflammatory factors must be inhibited, and extravasated neutrophils 
at the inflammatory site must be removed (Ortega-Gómez et al., 2013). These processes 
are mediated by chemokine depletion at the wound site, as well as neutrophil and 
macrophage derived mechanisms such as neutrophil apoptosis, uptake of apoptotic 
bodies by macrophages and macrophage class switching (Ortega-Gómez et al., 2013).  
Depletion of chemokine production at inflammatory sites abrogates further neutrophil 
recruitment. The local chemokine concentration sensed by neutrophils is reduced by the 
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catabolism of chemokines through their proteolysis, or through chemokine 
sequestration by neutrophil decoy receptors (Ortega-Gómez et al., 2013). 
 
Having performed their role at the inflammatory site, neutrophils may undergo apoptosis 
and are removed from the tissue by macrophages. Apoptotic neutrophils release factors 
such as annexin A1 and lactoferrin, which directly inhibit neutrophil recruitment to 
promote the restoration of tissue homeostasis (Bournazou et al., 2008; Dalli et al., 2008). 
Apoptotic neutrophils are also thought to express ‘find me’ and ‘eat me’ signals which 
promote their clearance by scavenger phagocytes (Ravichandran, 2010). The uptake of 
apoptotic bodies by macrophages in a process known as efferocytosis triggers their class 
switching from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. 
M2 polarised macrophages have a distinct transcriptomic profile, with genes involved in 
antigen processing and presentation, T and B cell recruitment and inflammatory cell 
clearance being upregulated (Stables et al., 2011).  They also produce anti-inflammatory 
cytokines such as TGF-β, IL10, and prostaglandin E2 (PGE2) (Fadok et al., 1998).  
 
 Neutrophil apoptosis 
Apoptosis is the process by which cells perform programmed suicide by activating 
intracellular pathways, resulting in the collapse of the cytoskeleton, defragmentation of 
nuclear DNA and cell shrinkage - all key characteristic of apoptotic cells (Hengartner, 
2000). Apoptosis can be activated by external and internal factors which ultimately result 
in the activation of a caspase cascade, degrading cellular organelles in a tightly controlled 
manner. 
The caspase family of proteases mediate the biochemical modifications orchestrated in 
cells during apoptosis. The caspases are a highly conserved family of proteins which are 
synthesised in cells as precursor procaspases lacking protease activity. Constitutive 
production of inactive caspases allows cells to rapidly activate their apoptotic machinery 
following a death stimulus. The inactive caspases gain function through a cascade of 
proteolytic cleavage events which ultimately results in the degradation of cellular 
organelles. The initiator caspases  (typically caspases 8, 9 and 10) exist early in the 
proteolytic cascade, where they exert their protease activity to activate downstream 
effector caspases through cleavage from pro caspases to active caspases (Witko-Sarsat 
et al., 2011). Once activated, the effector caspases (caspase 3, 6 and 7) are able to cleave 
key functional proteins following their activation, resulting in the characteristic 
morphological changes seen in apoptotic cells. (McIlwain et al., 2013). Neutrophil 
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apoptosis occurs via either the extrinsic or intrinsic apoptosis pathways which are 
activated by different stimuli.  
 The extrinsic apoptosis pathway 
The extrinsic apoptotic pathway involves the induction of caspase mediated cell death 
through the activation of cell death receptors by other cells. Extracellular ligands 
including TNF and FAS ligand bind to their receptors, TNF related apoptosis-inducing 
receptor (TNFR) and FAS receptor, respectively. Following the activation of these death 
receptors, conformational changes result in the activation of intracellular associated 
receptor death domains and the recruitment of proteins including effector procaspases 
8 and 10 to form a complex known as the death-inducing signalling complex (DISC). The 
clustering of these proteins in the DISC results in the activation of procaspases 8 and 10 
to trigger the proteolytic caspase, resulting in the activation of effector caspases to drive 
the degradation of cellular organelles (Cohen, 1997; Renshaw et al., 2003).  
 The Intrinsic apoptosis pathway 
The intrinsic or mitochondrial apoptotic pathway is activated in response to intracellular 
stresses including DNA damage, growth factor withdrawal and oncogenic stress.  The 
intrinsic pathway is characterised by the release of pro-apoptotic agents into the 
cytoplasm following mitochondrial permeabilisation, where they trigger the assembly of 
the apoptosome. Intrinsic apoptosis is regulated by the BCL-2 family of pro and anti-
apoptotic proteins. The release of pro-apoptotic agents from the mitochondria is 
dependent on the formation of membrane pores or channels through the aggregation of 
pro-apoptotic BCL-2 proteins Bax and Bak. The channel forming activity of these 
constitutively expressed proteins is repressed in healthy cells by anti-apoptotic BCL-2 
proteins which bind to and sequester their activity, preventing the cell from triggering 
the apoptotic machinery. Cellular stressors drive the expression of a second family of 
pro-apoptotic BCL-2 proteins including Bim, Bid, Puma, Noxa and Bad. These proteins 
bind to and sequester the activity of the anti-apoptotic BCL-2 proteins, resulting in the 
restoration of the channel forming functions of Bak and Bax to drive the cell down the 
apoptosis pathway through the release of pro-apoptotic agents, including cytochrome c, 
apoptotic‐protease activating factor‐1 (APAF-1) and second mitochondria-derived 
activator of caspases (SMAC) into the cytoplasm (KILE, 2009). 
 Neutrophil reverse migration 
Human neutrophils are now recognised to have alternative fates in addition to apoptosis 
following their role at inflammatory sites. Reverse migration is the term used to describe 
the retrograde migration of neutrophils away from an inflammatory site. Encompassed 
within this term are the migratory behaviours of neutrophils ranging from those which 
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have completely reversed their polarity, to those making a U-turn (Nourshargh et al., 
2016).  
Neutrophil reverse migration was first identified in a zebrafish model of tail fin injury, 
where neutrophil motility away from injured tissue was reported (Mathias et al., 2006). 
There now exists strong evidence for reverse migration which has now been observed in 
vivo in many models including mice (Wang et al., 2017; Woodfin et al., 2011), human 
neutrophils (Buckley et al., 2006) and zebrafish embryos (Elks et al., 2011; Mathias et al., 
2006).  
 Modes of reverse migration 
For a neutrophil to migrate from an inflammatory site, there are multiple environmental 
cues to integrate and barriers for neutrophils to breach, hence neutrophil reverse 
migration has several modes. The first stage of reverse migration involves the movement 
of neutrophils from inflammatory sites in the tissue, through the surrounding interstitial 
tissue. The dispersal of neutrophils into the interstitial tissue has been proposed to be a 
mechanism by which the inflammatory burden is dissipated (Nourshargh et al., 2016). To 
re-enter the circulation following movement through the tissue, neutrophils must breach 
the pericyte layer separating the interstitium and the vascular lumen. Once in the sub-
capillary space between the pericytes and the lumen, neutrophils must finally migrate 
back through the endothelial layer, a process termed reverse transendothelial migration 
(rTEM).  
Evidence for all modes of reverse migration is building, however currently there is 
uncertainty with regards to the mechanisms which govern all modes of reverse 
migration, and whether these modes share common mechanisms. Of the work carried 
out to dissect the molecular control of reverse migration, mechanisms governing reverse 
luminal crawling and reverse transendothelial migration are being elucidated, and there 
exists evidence to suggest signalling pathways which control reverse interstitial 
migration. 
 Reverse transendothelial migration 
Reverse transendothelial migration is likely to be modulated by multiple mechanisms. 
The endothelial junction protein JAM-C has been implicated in reverse transendothelial 
migration, evidence from human and murine models suggests that neutrophils exhibit 
significant rTEM when JAM-C function is diminished (Woodfin et al., 2011). Redistribution 
of JAM-C from endothelial cell junctions has been reported in some acute inflammatory 
conditions, as well as through cleavage by neutrophil elastase. It has been proposed from 
these studies that JAM-C modulates the barrier function of endothelial cells such that 
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expression of JAM-C maintains endothelial cells in a polarised manner, resulting in a one-
way gate to allow migration of neutrophils from the lumen into the tissue. The current 
hypothesis is that removal of endothelial JAM-C from endothelial junctions alters their 
junctional integrity and therefore barrier function, enabling rTEM. The mechanisms 
mediating luminal-to-abluminal migration through JAM-C during neutrophil recruitment 
are not fully understood, but have been speculated about (Nourshargh et al., 2016).  
Another scenario has been proposed to explain reverse transendothelial migration, in 
which neutrophils in the sub-endothelial capillaries between the lumen and pericytes 
migrate back through the endothelium. It has been proposed that in this scenario 
neutrophils migrate back into the lumen due to diminished chemokine gradients to 
provide guidance signals to promote migration, for example during inflammation 
resolution. Conversely, rTEM could be a result of impaired integration of environmental 
cues due to receptor or downstream signalling desensitisation following prolonged 
exposure to gradients, for example in prolonged or excessive inflammation (Nourshargh 
et al., 2016). 
 Reverse interstitial migration 
Reverse interstitial migration describes the retrograde movement of neutrophils 
through the interstitium away from the inflammatory site. Two competing hypotheses 
are currently being dissected to explain this phenomenon. The first, is that neutrophils 
respond to both chemotactic or chemorepulsive gradients, and reverse interstitial 
migration occurs due to fugetactic gradients repelling neutrophils from inflammatory 
sites (Powell et al., 2017; Tauzin et al., 2014). The second is that neutrophils become 
desensitised to chemotactic gradients through modulation of surface receptors or 
signalling pathways, and revert back to their default patrolling behaviours during reverse 
interstitial migration (Holmes et al., 2012). Evidence currently exists to support both 
hypotheses, and it is possible that the high redundancy of the immune system would 
allow for both of these methods of modulation to occur synergistically to drive 
inflammation resolution. 
Evidence from zebrafish studies implicate a role for macrophage-produced reactive 
oxygen species (ROS) signalling in driving neutrophil reverse migration via a contact-
dependent mechanism. Macrophage recruitment to inflammatory sites is important in 
driving inflammation resolution through the action of redox-SFK (Src family kinase), 
although neutrophils reverse migration still occurs in the absence of macrophage 
contact, suggesting a role for other factors in driving this process (Tauzin et al., 2014). 
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A specific role for the CXCR2/CXCL8 signalling axis has been identified in zebrafish 
larvae, where reverse migration is impaired in Cxcr2 and Cxcl8 deficient neutrophils. 
Evidence from this study suggests that macrophages or other cells at the wound site 
produce pro-resolving factors, such as Cxcl8, which drive reverse migration. 
Macrophages at the wound site were unable to drive reverse migration as previously 
reported (Tauzin et al., 2014) in the absence of CXCR2/CXCL8 signalling (Powell et al., 
2017).  
The precise action by which CXCR2/CXCL8 signalling drives reverse migration is not fully 
understood. It is suggested that rather than acting to directly repel neutrophils, exposure 
to Cxcl8 alters neutrophil chemokinesis. In vitro findings identified that priming of 
neutrophils by pre-exposure of neutrophils to CXCL8 impairs their migration along 
CXCL8 gradients, promoting their random motility in both directions along the gradient 
(Powell et al., 2017). These findings support the hypothesis that neutrophils at 
inflammatory sites switch from active migration by chemotaxis, to a random migration 
mode, a theory based on the mathematical modelling of neutrophil reverse migration in 
zebrafish (Holmes et al., 2012).  
 
 Retention signalling hypothesis  
Neutrophils experience a range of extracellular signals at the inflammatory site which 
allows them to coordinate their behaviour. There is a growing body of evidence to 
suggest that a subset of these signals may be responsible for the retention of neutrophils 
at sites of inflammation through the provision of spatiotemporal guidance cues, which 
tell neutrophils where the wound site is.  
Hypoxia inducible factor (HIF) signalling has been identified as a master regulator of 
neutrophil reverse interstitial migration in zebrafish. Activation of HIF signalling at 
inflammatory sites is a well characterised process which in primary human neutrophils, 
mice, and zebrafish is shown to result in the prolonged survival and activity of neutrophils 
(Walmsley et al., 2005). In zebrafish larvae, stabilisation of HIF-1α using both 
pharmacological and genetic approaches delays the resolution of inflammation induced 
by tail-fin transection, by reducing both neutrophil apoptosis and reverse migration (Elks 
et al., 2011). This study indicates that downstream targets of HIF signalling retain 
neutrophils at inflammatory sites.   
Recent findings in zebrafish demonstrate that reverse migration can be targeted 
therapeutically to accelerate the resolution of inflammation. The compound Tanshinone 
IIA, derived from a Chinese medicinal herb, is able to accelerate both neutrophil 
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apoptosis and reverse migration to drive inflammation resolution in zebrafish.  The pro-
resolving effects of Tanshinone IIA were able to override the pro-inflammatory signalling 
generated through HIF1a stabilisation to drive reverse migration even in a model of 
chronic inflammation. 
Mathematical analysis of neutrophil positions in zebrafish larvae was performed to 
identify cell migration dynamics in the context of neutrophil reverse migration (Holmes 
et al., 2012). Dynamic modelling was performed based on simulations which estimated 
whether neutrophil movement away from wound sites best fit a mathematical model 
whereby neutrophils randomly redistribute into the tissue, or a model in which 
neutrophils are actively driven away by fugetactic gradients. Evidence from this study 
suggests that neutrophil reverse migration is the stochastic redistribution of neutrophils 
into the surrounding tissue, rather than their active migration away from the wound site 
(Holmes et al., 2012). These data suggest that neutrophils lose their responsiveness to 
local chemotactic gradients over and redistribute into the tissue (Holmes et al., 2012). 
Taken together the evidence from these studies suggests that a downstream target of 
HIF-1α which can be targeted therapeutically generates a neutrophil retention signal. We 
hypothesise that desensitisation of neutrophils to ‘retention signals’ causes their removal 
from inflammatory sites by reverse migration. Retention signals could overlap with 
neutrophil survival signals which modulate prolong neutrophil lifespan at sites of 
inflammation. 
Hypothetically, generation of a neutrophil retention signal at the wound site requires two 
parts. The first being the detection of a gradient at the wound site by neutrophils, which 
tells them where the wound site is, and the second is the tuneable sensitivity of 
neutrophils to these gradients, allowing them to become desensitised. A retention signal 
could be achieved by an upregulation of ligand produced at the wound site, an 
upregulation of receptors on the neutrophil surface to increase neutrophil sensitivity to 
a ligand gradient, or a combination of the two. Equally, desensitisation of the neutrophil 
to a retention signal could arise from a decrease in ligand production at the wound site, 
a decrease in receptor expression on the cell surface, a decrease in ligand availability 
through the expression of decoy receptors, or a combination of all three.  
Intracellular signalling in response to extracellular ligand occurs following ligand binding 
to GPCRs which induces a conformational change in the receptor and G protein 
activation. Cellular desensitisation to extracellular ligand through receptor 
internalisation is a characteristic feature of signalling through G protein coupled 
receptors. The chemokine receptors are a family of GPCRs of many of which are 
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expressed on the surface of neutrophils (Futosi et al., 2013). The role of many of these 
GPCRs in inflammation have been well characterised (Su and Richmond, 2015; Wareing 
et al., 2007). 
Therapeutically targeting neutrophil reverse migration would be a successful way to 
drive inflammation resolution to treat chronic inflammatory diseases. It is possible that 
reverse migration plays a larger role in inflammation resolution than apoptosis or 
draining of neutrophils to lymph nodes. By targeting neutrophil reverse migration, initial 
recruitment to the inflammatory site would not be effected so the host remains 
protected against infection, and reverse migrated neutrophils would behave like tissue 
resident neutrophils without causing damage to other tissues.   
Further work to elucidate the mechanisms underlying the reverse migration is required 
to fully understand the complex array of signalling which drives the movement of 
neutrophils away from inflammatory sites. During this project I will investigate the 
hypothesis that neutrophils are desensitised to retention signals generated through G 
protein coupled receptor signalling through ligand mediated receptor internalisation, 






Figure 1.5 Retention signalling hypothesis. 
(A) Image of photoconverted neutrophils at the wound site in a 3dpf zebrafish larvae to 
provide context to the hypothesis. (B) Neutrophils integrate numerous signals to 
choreograph their movement within complex 3D structures, which in zebrafish occurs 
by the presentation of directional cues in soluble form or haptotactic gradients. We 
propose that a subset of these gradients acts as a retention signal to tell neutrophils 
where the wound site is. (C) Neutrophils sense retention signals in the form of 
chemokines through GPCRs which retain them at the wound site during inflammation. 
(D) A characteristic feature of GPCR signalling is ligand mediated receptor 
internalisation. We hypothesise that neutrophils become desensitised to retention 
signals through receptor internalisation. (E) Decreased receptors on the neutrophil 
surface leads to decreased retention signalling, and the migration of neutrophils into the 
surrounding tissues.   
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1.10 The zebrafish 
The zebrafish (Danio rerio) has emerged as an excellent model to study many vertebrate 
processes and is used widely as a model in labs throughout the world (Henry et al., 2013). 
The ease with which zebrafish can be genetically and pharmacologically manipulated 
along with their optical transparency, small size and fast generation time make zebrafish 
a powerful model system for the study of many developmental processes. Molecular 
biologist Dr. George Streisinger produced the first zebrafish clone in the 1970’s which 
was originally used by the developmental biology community for in vivo early vertebrae 
development (Streisinger et al., 1981). Today, the zebrafish is recognised as a model 
organism for studies across multiple fields including behavioural genetics (Norton and 
Bally-Cuif, 2010), organogenesis, (Thisse and Zon, 2002) and infection and immunity 
(Trede et al., 2004). 
 Transgenic zebrafish lines to study inflammation 
To study immune cell behaviour during inflammation in vertebrates, the zebrafish 
circumvents limitations associated with imaging of murine tissues. There is high 
homology of multiple cells of the innate immune system, which is competent from the 
early stages of development, between the zebrafish and mammals (Loynes et al., 2010). 
This combined with the 4 week period in which the immune system of the larvae is 
entirely reliant on the innate immune response, makes the zebrafish an apt model to 
study inflammation (de Oliveira et al., 2013). Furthermore, the external fertilisation of 
larvae and ease with which genetic manipulations can be introduced into the genome 
mean that genes of interest can be easily manipulated to investigate their function.   
There are 450 million years of divergence between zebrafish and humans, yet there 
exists a remarkable degree of conservation between the two immune systems (Kumar 
and Hedges, 1998). The pathways governing hematopoiesis are highly conserved, and a 
large number of the transcription factors which modulate hematopoiesis in mammals 
have orthologues in zebrafish (Davidson and Zon, 2004). Like other vertebrates, 
zebrafish have primitive and definitive waves of hematopoiesis (de Jong and Zon, 2005). 
Primitive hematopoiesis occurs in the intermediate cell mass (ICM) and the anterior 
lateral mesoderm (ALM), where the production of erythrocytes occurs in the ICM and 
myeloid cells in the ALM (Lieschke et al., 2002). The definitive wave begins in the aorta-
gonad-mesonephros at around 2dpf. During definitive hematopoiesis, self-renewing 
pluriopotent HSCs are produced. After colonization and maturation steps during larval 
development, these blood cells colonize the adult kidney marrow, which is the zebrafish 
equivalent of human bone marrow (Chen and Zon, 2009). 
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Unlike other invertebrate models used to study inflammation and immune disease such 
as Caenorhabditis elegans and Drosophila melanogaster, zebrafish possess an adaptive 
immune system (Lieschke and Currie, 2007). Along with their adaptive humoral and 
cellular immune responses, the zebrafish innate immune system shares similarities with 
that of mammals with immune cells including macrophages and neutrophils, as well as 
TLRs, complement factors and homologues to mammalian cytokines including TNFa and 
IL1b (Lieschke and Currie, 2007). 
Zebrafish neutrophils share characteristic morphological features of human neutrophils 
such as segmented nuclei and cytoplasmic granules. Like other teleosts, zebrafish 
possess two types of granulocyte. One population of neutrophil granulocytes or 
heterophils have a multilobulated segmented nucleus which comprised more than 95% 
of circulating granulocytes, and a smaller population of eosinophil granulocytes with a 
peripheral nonsegmented nucleus (Lieschke et al., 2001). Functionally zebrafish 
neutrophils are analogous to human neutrophils, being recruited to sites of injury and 
infection where they produce reactive oxygen species, degranulate and phagocytose 
pathogens (Lieschke et al., 2001). Primitive neutrophilic granulocytes are detected in the 
circulation in zebrafish larvae by 48hpf whilst eosinophilic granulocytes aren’t detected 
until 5dpf (Lieschke et al., 2001).  
Zebrafish heterophil granulocytes are morphologically similar to human neutrophils, 
with segmented nuclei and cytoplasmic granules. A zebrafish specific myeloperoxidase 
homologue is expressed specifically in neutrophils, and is detected at around 18hpf in the 
posterior intermediate cell mass. From 24hpf mpx positive cells can be detected within 
the vasculature and then become visible throughout the whole embryo, enabling the 
visualisation and study of neutrophils from early stages of development (Bennett et al., 
2001).  
Understanding of the pathophysiology of the immune system has been accelerated by 
the development of transgenic zebrafish models which are today used by many research 
groups (Henry et al., 2013). Perhaps the most attractive feature of the zebrafish is their 
optical transparency during early stages of development, which enables the visualisation 
of fluorescently labelled cell populations in vivo in real time (Renshaw et al., 2006). 
Identification of the zebrafish myeloperoxidase promoter which drives gene expression 
in all neutrophils enabled the development of a stable transgenic line using BAC 
recombineering to drive the expression of GFP in neutrophils specifically (Renshaw et al., 
2006). This novel transgenic line has been used by many groups to observe the 
neutrophilic inflammatory response to tissue injury and infection and has provided 
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advances in the understanding of many aspects of neutrophil biology (Dalli et al., 2008; 
Elks et al., 2011; Robertson et al., 2014).  
Limitations of this transgenic line are that individual neutrophil populations cannot be 
distinguished during the recruitment and resolution phases of inflammation. To 
overcome these limitations, transgenic lines expressing photoactivatable fluorophores 
such as dendra2 or kaede, under neutrophil specific promoters lyz or mpx have been 
developed (Elks et al., 2011; Mathias et al., 2006). The photoconvertible properties of the 
fluorescent protein kaede enable neutrophils recruited to inflammatory sites to be 
converted from green to red fluorescence following excitation by UV light. This enables 
the tracking of the red population of cells which have visited the inflammatory site, to be 
tracked during the resolution of inflammation and is susceptible to pharmacological and 
genetic manipulations. These transgenic lines have provided an invaluable tool to study 
the behaviour of neutrophils following their activity at inflammatory sites (Ellett et al., 
2015; Holmes et al., 2012). 
Injury to the tail-fin of zebrafish larvae initiates an acute neutrophilic inflammatory 
response which resolves with similar kinetics to that of mammals (Renshaw and Loynes, 
2006). Reverse migration in zebrafish is quantifiable using a photoconversion system in 
which neutrophils driving the photoswitchable protein kaede can be converted from 
green to red fluorescence at the wound site using UV light (Elks et al., 2011; Robertson et 
al., 2014). Photoconverted cells which have been to the wound site can then be tracked 
during the inflammation resolution phase, providing a read out of neutrophil reverse 
migration.  
The function of zebrafish gene products can be investigated using chemical compounds 
through incubation in zebrafish water or injected directly into their blood circulation. 
Neutrophil apoptosis and reverse migration can be manipulated in zebrafish larvae using 
chemical compounds to accelerate or delay these processes (Elks et al., 2011; Robertson 
et al., 2014). Future studies using these tools will enable the elucidation of the 
mechanisms which govern the migratory behaviours of neutrophils during the 
inflammatory response. 
 Disadvantages of the zebrafish model 
As with every model organism, there are disadvantages to using the zebrafish model. 
Zebrafish are evolutionarily more distant from humans than mammalian models 
including mice and rats, hence findings from zebrafish studies likely need to be replicated 
in mammalian systems before translating to human therapies. Zebrafish are ectothermic, 
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meaning their circadian clock and physiological response to temperature changes differs 
to mammals (Lahiri et al., 2005) 
The zebrafish genome underwent a duplication event following the divergence of teleosts 
and mammals, consequently zebrafish are polypoid for many of their genes (Taylor et al., 
2003). This feature of zebrafish genetics often hinders the generation of knockout 
strains, as approaches to disrupt one gene copy may not disrupt the second copy. 
Furthermore a high degree of genetic diversity has been observed between individual 
zebrafish genomes, even within fish of the same strain (Guryev et al., 2006).  
There currently exist a limited number of cross-reacting antibodies for use in zebrafish, 
meaning that it is difficult to study protein expression (Staudt et al., 2015). To circumvent 
this, whole mount in situ hybridisation is an approach used to study the expression 
pattern of the mRNA for proteins of interest. Despite these disadvantages, the zebrafish 
is used widely in the scientific community to model human disease.  
 Zebrafish mutagenesis 
The zebrafish is highly amenable to genetic manipulation, where forward and reverse 
genetic approaches have been used to understand gene function in biology (Lawson and 
Wolfe, 2011). Targeted mutations can be introduced into the zebrafish genome using 
approaches such as zinc-finger nucleases (Meng et al., 2008), TILLING (Moens et al., 
2008) and TALENs (Sander et al., 2011). Morpholino-modified antisense oligonucleotides 
or injection of mRNA can be used to study the function of candidate genes transiently 
before committing to generate a stable mutant zebrafish line (Nasevicius and Ekker, 
2000). The current gold standard for genetic approaches to gene is CRISPR.  
 CRISPR/Cas9 
Advances in genome editing technology such as CRISPR (clustered regularly interspaced 
short palandromic repeats)/ Cas9 technology have resulted in the ability to genetically 
manipulate genes of interest rapidly and with ease (Cong et al., 2013). The streptococcus 
pyogenes type II CRISPR/Cas9 system is an adaptive immune mechanism by which 
s.pyogenes can respond to and remove foreign genetic material (Mojica et al., 2005). 
Immunity to bacteriophage or plasmid infection in s.pyogenes is provided by the CRISPR 
loci which contains many protospacer sequences of DNA with specificity to viral or 
plasmid DNA between palindromic DNA repeats (Bolotin et al., 2005). These protospacer 
sequences are transcribed and specificity is achieved by trans-activating cRNAs (tracr 
RNAs) which cleave the RNA to create crRNAs of approximately 20 base pairs in length. 
These crRNAs guide the Cas9 nuclease to the foreign DNA where it is able to introduce a 
double stranded break, providing sequence specific immunity against bacteriophage 
55 
 
DNA (Marraffini, 2016). The CRISPR/Cas9 system is able to introduce mutations into the 
genome through exploiting cellular DNA repair machinery mechanisms. Double stranded 
breaks are repaired by cellular machinery including homology directed repair, or non-
homologous end joining (NHEJ).  
Homologous recombination integrates exogenous repair templates into the genome to 
repair the double stranded break. This machinery can be exploited by providing  new 
DNA sequences to be inserted into the genome, however the occurrence of this DNA 
repair machinery is rare and hence integration of the sequences is relatively inefficient 
(Gratz et al., 2014). Improvements to this system, for example by inhibiting the NHEJ 
machinery to drive homologous recombination, hold promise for the future of gene 
therapy (Zhang et al., 2017). NHEJ is the most common double stranded break repair 
process, however it is error prone and often results in DNA insertions or deletions 
(InDels) at the DNA break site. If the InDel results in a loss of function mutation including 
in-frame insertions, deletions or frame shift to introduce a premature stop codon, the 
function of the gene is altered (Su et al., 2016).  This system has been adapted for use in 
organisms including mammalian cells, yeast, mice and zebrafish.  By combining the 
spacer and tracer RNAs into one synthetic guide RNA, any genomic locus can be targeted 
by directing the Cas9 to any 20 base pair sequence directly upstream of a protospacer 
adjacent motif (PAM) sequence  (Ran et al., 2013).  
 CRISPR interference 
Modifications of the Cas9 nuclease through mutating its two nuclease domains HNH and 
RuvC have expanded the gene editing capabilities of the CRISPR/Cas9 system (Qi et al., 
2013). A catalytically dead version of Cas9 ‘dCas9’ which has no nuclease activity has been 
developed which is able to sterically block gene transcription through preventing 
transcription elongation (Larson et al., 2013). Synthetic guide RNAs are used to target the 
dCas9 to the genomic region of interest, where it interferes with the binding of key 
transcription factors to prevent transcription (Qi et al., 2013). Furthermore, modified 
versions of dCas9 containing transcriptional activators such as VP64, or repressors such 
as KRAB, can be used to activate or repress transcription more successfully (Dominguez 
et al., 2015). Repurposing of the Cas9 in this way has created a method of RNA-guided 
transcriptional regulation without altering the genome. This approach to knock down 
genes has potential for cell specific expression of the dCas9 to create cell-specific gene 
repression, as well as inducible dCas9 to control the time at which genes are repressed. 
The dCas9 has been shown to inhibit transcription successfully in bacteria, however 
repression in mammalian cells was only modest, hence the development of modified 
dCas9 fused to transcriptional repressors such as the Krüppel-associated box (KRAB) 
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(Gilbert et al., 2013). CRISPRi offers simplified approach for rapid and reversible genetic 
manipulation which holds huge promise for the future. 
Currently both CRISPR/Cas9 and CRISPRi technologies are used widely in the zebrafish 
community to target genes of interest using guide RNAs to interrupt gene function at 
specific loci. The development of CRISPR interference technology means that targeted 
gene knockdown in specific lineages is now possible. Transgenic zebrafish lines driving a 
dead cas9 under cell-specific promoters will be used in future to achieve a transient 
silencing of gene expression in cells of interest.  
1.11 Thesis aims  
Neutrophil persistence at inflammatory sites is a major contributor to the pathogenesis 
of chronic inflammatory disease. The current therapies available to treat inflammatory 
disease do not target the neutrophilic component of these diseases, and this is perhaps 
why they are not effective in curing the diseases. Novel neutrophil behaviours including 
neutrophil reverse migration and neutrophil swarming have been identified in the last 
decade, which when understood more comprehensively, will open up a new range of 
therapeutic targets to accelerate the removal of neutrophils from inflammatory sites to 
treat the neutrophilic component of inflammatory disease.  
I hypothesised that by using the zebrafish to study both neutrophil swarming and reverse 
migration, I could identify novel pathways involved in the inappropriate retention of 
neutrophils at inflammatory sites. The aims of this thesis are:   
- To define and characterise the neutrophil swarming response in zebrafish 
- To investigate the initiation of neutrophil swarming in order to identify key 
signalling pathways which amplify neutrophil recruitment to wound sites 
- To investigate the role of the CXCR4/CXCL12 signalling axis in modulating 





2 Materials and methods 
2.1 Reagents 
All reagents and chemicals were purchased from Sigma Aldrich (Poole, UK) unless stated 
otherwise.  
2.2 Zebrafish husbandry  
All zebrafish were raised in the Bateson Centre at the University of Sheffield in UK Home 
Office approved aquaria and maintained following standard protocols (Nüsslein-Volhard 
and Dahm, 2002). Tanks were kept at 28oC with a continuous re-circulating water supply 
and a daily light cycle of 14 hours of light and 10 hours of dark. Zebrafish > 13 days post 
fertilisation (dpf) were given a diet of live artemia which was provided twice daily, whilst 
zebrafish >5dpf were fed Tetra A-Z powdered fish food.   
To acquire zebrafish embryos, mating set up (described below) was carried in out in the 
evening before the light cycle changed, and embryos were collected the following 
morning. ‘Marbling’ adult tanks was commonly used to acquire embryos and was 
performed by placing a small tank of marbles into adult tanks containing between 10 and 
40 fish. Adults lay eggs into the marbles which sit on top of a grid to allow embryos to 
filter through for collection. Alternatively, two adult fish of different genders were placed 
into a small mating tank separated by a divider which was removed when the light cycle 
changed in the morning, and embryos were filtered by a plastic grid into the space below 
for collection. Embryos at the same stage of development were then sorted into petri 
dishes, with 50-60 embryos per dish, in approximately 30mls of E3 media and kept in an 
incubator at a temperature of 28°c.   
To sacrifice embryos at the end of an experiment or because they were approaching 5.2 
dpf, embryos were anaesthetised using 0.017% 3-amino benzoic acid ethyl ester, or 
‘tricaine’ and immersed in bleach.  
All procedures were performed on embryos less than 5.2 dpf which were therefore 
outside of the Animals (Scientific Procedures) Act, to standards set by the UK Home 
Office.  
2.3 Zebrafish anaesthesia 
In all experiments tricaine was used as an anaesthetic prior to experimental work. Larvae 
were anesthetised by immersion in 0.168 mg/mL tricaine in E3. For imaging, larvae were 
maintained in 0.168mg/mL tricaine in LMP agarose until the end of experiment. Where 
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required, larval recovery was completed through replacing medium with fresh E3 which 
did not contain tricaine. 
 Tail-fin transection 
To induce an inflammatory response, zebrafish larvae at 2 or 3dpf were anaesthetised in 
0.017% tricaine (3-amino benzoic acid ethyl ester) in E3 media and visualised under a 
dissecting microscope. Unless stated otherwise tail-fins were transected consistently 
using a scalpel blade (5mm depth, WPI) by slicing in the pigment gap at 3dpf and ensuring 
the circulatory loop isn’t damaged (Figure 2.1). When injuring larvae at 2dpf when the 
pigment gap was not developed, extra care was taken to transect the circulatory loop 
consistently proximal to the circulatory loop without damaging it. Following tail-fin 
transection larvae were placed in fresh E3 medium and left to recover at 28°c.  
 
 
Figure 2.1: Tail fin transection of zebrafish larvae 
Image to illustrate the region where tail fin transection of zebrafish larvae was 
performed at 3dpf to initiate an inflammatory response.  
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 Non-standard methods of tail-fin transection  
Where illustrated in figure legends, alternate methods were used to induce an 
inflammatory response. Figure 2.2 illustrates the injury severity types. A mild 
inflammatory response is induced by slicing the caudal tail-fin in the dorsal to ventral 
section to nick the tissue without damaging the notochord or circulation (A).  A mild 
inflammatory response can also be induced by at the end of the caudal tail-fin without 
transecting the notochord or circulation (B). A severe inflammatory response is induced 
by cutting the whole length of the tissue at the end of the caudal tail-fin and transecting 
both the notochord and circulatory loop (C).    
 
 Microinjection of embryos  
For injection of RNA or DNA embryos at the one cell stage, adults were placed in pair 
mating tanks and dividers removed at 8am to coincide with aquarium light cycles. 
Embryos were collected 20 minutes later and positioned against a glass cover slip inside 
a petri dish (Menzel-Gläser, Germany). Injections were performed using non-filament 
glass capillary needles (Kwik-FilTM Borosilicate Glass Capillaries, World Precision 
Instruments (WPI), Herts, UK) pulled using a Flaming Brown micropipette puller (Sutter 
Instrument Co., Novato, USA). RNA and DNA were prepared in sterile Eppendorf tubes 
and phenol red was added to allow for visualisation of injections. A graticule was used to 
measure 0.5nl droplet sizes to allow for consistency of injections. Injections were 
performed under a dissecting microscope attached to a microinjection rig (WPI). For 
DNA injections, the needle was aimed at the developing cell (Figure 2.3A). For RNA 
injections the needle was aimed at any point in the embryo including the yolk to enable 
faster injections (Figure 2.3B). Following microinjection embryos were transferred to 
clean E3 media and left to recover at 28°c. 
 
Figure 2.2: Non-standard methods of tail fin transection 
An inflammatory response of varying severity can be induced by performing tail fin 




 Microinjection of larvae 
For microinjection of compounds into the duct of cuvier, 2dpf larvae were anaesthetised 
and placed onto plates consisting of agarose dissolved in E3. Larvae were positioned 
using a fine hair taped into the end of a pipette tip, which allowed for gentle manipulation 
without causing damage to larvae. Injections were performed as described for 
microinjection of embryos, however the needle was aimed at the circulatory loop in the 
duct of cuvier. 1nl of compound was injected into the duct of cuvier and phenol red was 
added to compounds to visualise successful injections as it can be seen to circulate in 
the blood stream over the yolk sac. Following microinjection larvae were transferred to 
clean E3 media and left to recover at 28°c.  
 Equation to determine dose of compounds for microinjection 
To work out the dilution factor for stock solutions of compounds, an equation to 
determine the concentration of compound required in a 1nl injection to reach a desired 
body concentration in larvae was used by considering the total body volume of larvae 
(Figure 2.4).  
 
Figure 2.3: Microinjection of DNA and RNA into embryos at the one 
cell stage 
Image of a zebrafish embryo at the one cell stage adapted from ZFIN. DNA injections 
were aimed at the developing cell to increase the chance of integration into the 





 Compound incubation 
Chemical compounds were dissolved in DMSO unless otherwise indicated. For 
compound treatment by incubation larvae were incubated in 6 or 24 well plates (SLS), 
containing no more than 12 larvae in 400µl of E3 for 24 well plates, or 20 larvae in 1900µl 
E3 for 6 well plates. Compounds were prepared in Eppendorf tubes suspended in 100µl 
E3 media which was added to wells to give a total volume of 500µl or 2000µl for 24 and 
6 well plates respectively. For reverse migration assays AMD3100 was added directly to 
a 1% LMP agarose solution at 38°c to reduce the time between compound administration 
and imaging.  
 Mounting of larvae for microscopy 
Prior to imaging, larvae were anaesthetised in tricaine and transferred to a mounting 
dish. For high power microscopy mounting dishes consisted of a 0.1mm cover slip  (#0, 
SLS) placed into a circular receptacle secured using high vacuum grease (Dow Corning, 
Seneffe, Belgium) and for lower power imaging a 4x4 chamber mounting dish was used. 
Excess E3 was removed from larvae once placed in the mounting dish and covered in a 
low melting point (LMP) agarose (Sigma Aldrich) dissolved in clear E3 containing 4.2% 
tricaine. Unless stated otherwise LMP agarose solutions were made up to 1%. When 
necessary, appropriate volumes of compounds were also dissolved into the agarose 
solution for time lapse imaging. For long periods of imaging, a solution of clear E3 with 
4.2% tricaine was added on top of the solidified agarose solution to prevent dehydration 
of larvae.    
 
Figure 2.4: Equation used to work out injection concentrations 
When determining the dilution factors of stock solutions for injection into larvae, the 
above equation was used to work out the concentration required in tube to achieve 




2.4 Neutrophil behavioural assays 
 Neutrophil recruitment assays 
To observe the effect of compounds on the recruitment of neutrophils to the wound site, 
compounds were administered to larvae at 2 or 3dpf for 1 hour prior to injury. For 
administration to larvae at 2dpf, embryos were dechorionated and compounds were 
injected into the duct of Cuvier. For administration to larvae at 3dpf, compounds were 
dissolved in E3 media for 1 hour prior to injury which were left to recover in fresh medium 
containing the same dose of compounds. For injection assays larvae were injected and 
left to recover in E3 for 1 hour prior to injury. Neutrophils recruited to the wound site 
were counted at times indicated in figure legends.  
 Inflammation resolution assays 
To study the resolution of inflammation, neutrophils were counted at the wound site at 
intervals during the resolution phase from 8-24 hours post injury in 2 or 3dpf mpx:GFP 
larvae as indicated in figure legends. Larvae were dechorionated (for 2dpf) and 
anaesthetised prior to injury by tail-fin transection and left to recover at 28°c in fresh E3 
media. Larvae were screened for good neutrophil recruitment (around 20 neutrophils at 
the wound site) at 3-4hpi. Compounds were administered to larvae through injection 
into the duct of Cuvier in 2dpf larvae, or by incubation in the E3 media for 3dpf larvae at 
times indicated in figure legends. Neutrophils at the wound site were counted at 6hpi at 
the peak of recruitment to confirm that compound treatment did not alter the 
recruitment of neutrophils before counting during the resolution of inflammation.  
 Percentage resolution calculation 
To determine the percentage resolution of larvae, neutrophils were counted at the peak 
of recruitment at 6hpi, and at time points during the resolution phase indicated in figure 








 Analysis of total body neutrophil count 
Whole body neutrophil counts were measured in larvae at time points indicated in 
figures. Larvae were mounted in 1% agarose with tricaine and a single slice image was 
taken using a 4x NA objective lens on an Eclipse TE2000 U inverted compound 
fluorescence microscope (Nikon UK Ltd., Kingston upon Thames, UK). A GFP-filter was 
used at excitation of 488nm. Two images were taken per larvae, one of the head region 
and one of the tail region. Neutrophils were counted manually from both images and 
combined to give a total body neutrophil count.  
 Reverse migration assay 
Reverse migration assays were performed using larvae expressing the photoconvertible 
protein kaede under the neutrophil specific mpx promoter; 
Tg(mpx:GAL4;UAS:Kaede)i222 line (referred to as mpx:kaede thus forth). At 2 or 3dpf as 
specified in figure legends, larvae were anaesthetised and injured by tail-fin transection 
and left to recover at 28°c. Larvae were screened for good neutrophil recruitment at 
3.5hpi. AMD3100 was administered at 4hpi by injection into the duct of Cuvier of 2dpf, or 
by incubation in LMP agarose at 5hpi in 3dpf larvae. Photoconverstion of kaede labelled 
neutrophils at the wound site was performed using an UltraVIEWPhotoKinesisTM  device 
(Perkin Elmer and Analytical Sciences) on an UltraVIEWVoX spinning disc confocal laser 
imaging system (Perkin Elmer).  
The photokinesis device was calibrated using a coverslip covered in photobleachable 
substrate (Stabilo BossTM, Berks UK). Photoconverstion was perfomed using a 405nm 
laser at 40% using 120 cycles, 250 pk cyles and 100ms as previously published (Elks et al., 
2011). Following calibration a region of interest was drawn at the wound site between the 
edge of the circulatory loop and encapsulating the entirety of the wound edge. Successful 
photoconversion was detected through loss of emission detected following excitation at 
488nm, and gain of emission following 561nm excitation. Larvae were then transferred to 
an Eclipse TE2000-U inverted compound fluorescence microscope with 10x NA  objective 
lense to acquire images using an andor zyla 5 camera (Nikon). Time lapse imaging of 
neutrophil reverse migration was performed for 5 hours using 2.5 minute intervals using 
GFP and mCherry filters with 488 and 561 nm excitation respectively.  
For analysis of reverse migration, NIS elements software was used to compress z-slices 
into maximum intensity projections. A region of interest was drawn around the region 
away from the wound site, as illustrated in figure 2.6. For quantification of neutrophils 
moving away from the wound site, a threshold was applied to detect mCherry 
neutrophils from background noise and NIS elements software calculated the number of 




 Fixation of larvae 
Larvae were fixed prior to whole mount in situ hybridisation. Larvae were anaesthetised 
in tricaine at time points indicated in the figure legends. No more than 20 larvae were 
transferred to 1ml Eppendorf tubes and excess liquid was removed without damaging 
larvae. 1ml of paraformaldehyde (PFA) at 4°c was added to Eppendorf tubes for the 
fixation step. Larvae were stored at -20°c for at least 24 hours prior to use.  
 Whole mount in situ hybridisation 
WISH was performed to examine the spatial expression of CXCL12a mRNA at the wound 
site in injured larvae. After 24 hours in PFA, fixed nacre larvae were transferred through 
a methanol series increasing in concentration and stored in 100% methanol at -20°c until 
use.  
Larvae were rehydrated by transferring them through a reverse methanol series 
containing increasing concentrations of phosphate buffered saline plus tween 20 (Sigma-
Aldrich) (PBT). Larvae were digested in proteinase K (Thermo Fisher) at 10µg/ml for 40 
minutes and washed in PBT. Digested larvae were then fixed in 4% PFA at room 
temperature for 20 minutes followed by another PBT wash. 
Pre-hybridisation buffer (PreHyb) was heated to 70°c in a water bath and larvae were 
incubated in PreHyb for 3 hours at 70°c. Probe-hybridisation buffer was heated to 70°c 
and PreHyb was replaced with ProbeHyb in which larvae were incubated overnight at 
70°c. Buffers and wash solutions were prepared as described (Chitramuthu and Bennett, 
2013).  
 
Figure 2.6 Quantification of neutrophil reverse migration 
Neutrophil reverse migration was quantified using mpx:kaede larvae. Photoconverted 
neutrophils were quantified as they migrated away from the wound site using an 
automated assay to detect objects within a region of interest (yellow).  
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The ProbeHyb was gradually removed by a series of washes containing decreasing 
concentrations of ProbeHyb and increasing concentrations of a HybWash:2x SSC 
solution at 70°c. Larvae were then washed in a 2x SSC solution at 70°c before being 
transferred through a reverse series of 2x SSC containing decreasing concentrations of 
2x SSC and increasing concentrations of PBT. Finally larvae were washed in a PBT 
solution.  
Following the wash stages a larvae were gently rocked in a blocking solution for 2 hours 
at room temperature. An anti-DIG-AP antibody (Roche, UK) was incubated in the blocking 
solution at a dilution of 1:5000 overnight at 4°c with gentle rocking.  
The antibody was removed the next day and larvae were washed in PBT at room 
temperature followed by a series of washing in staining wash. Larvae were then 
transferred to a 24 well plate for incubation in staining solution until staining developed. 
The 24 well plate was wrapped in tin foil. Staining was terminated using 1mM EDTA and 
larvae were washed in PBT. Larvae were fixed in 4% PFA at room temperature for 20 
minutes and then transferred through a methanol series to be stored in 100% methanol 
until imaging.  
For imaging larvae were transferred through a reverse methanol series containing 
increasing concentrations of glycerol. Imaging was performed by placing larvae in an 80% 
glycerol solution onto a glass cover slip (SLS) and adjusting their position gently using a 
human hair. Imaging was performed using a fluorescent dissecting microscope with a 
Leica DFC310 camera and NIS elements software (Version 4.3).  
 Propidium iodide staining of larvae  
To study the plasma membrane integrity of neutrophils, 3dpf mpx:GFP larvae were 
incubated in propidium iodide (1µg/ml) unless otherwise stated for 30 minutes prior to 
tail-fin transection. Larvae were mounted in a 1% agarose containing 1µg/ml PI 
immediately following injury. Images of the wound site were taken using a 20x objective 
on an UltraVIEWVoX spinning disc confocal laser imaging system (Perkin Elmer) using 
GFP and mCherry specific excitation filters. 
2.5 Microcscopy 
 Timelapse imaging of neutrophil recruitment  
For neutrophil swarming experiments, 3dpf mpx:GFP larvae were mounted in a 1% low 
melting point agarose solution (Sigma-Aldrich) containing 4.2% tricaine for imaging 
immediately after tail transection. Agarose was covered with 500µl of a clear E3 solution 
containing 4.2% tricaine to prevent dehydration. Time lapse imaging was performed from 
0.5-5 hours post injury with acquisition every 30 seconds using an Eclipse TE2000-U 
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fluorescence microscope with a 1394 ORCA-ERA camera (Hamamatsu Photonics Inc). 10 
z-planes were captured per larvae over a focal range of 100µm using a GFP specific filter 
with excitation at 488nm. Maximum intensity projections were generated by NIS 
elements to visualise all 10 z-planes. 
 Imaging of the caudal hematopoietic tissue in mpx:GFP larvae 
3dpf mpx:GFP embryos were mounted in a 1% low melting point agarose solution (Sigma-
Aldrich) containing 4.2% tricaine. A single time point was captured using an 10x objective 
on an Eclipse TE2000-U fluorescence microscope with a 1394 ORCA-ERA camera 
(Hamamatsu Photonics Inc). 10 z-planes were captured per larvae over a focal range of 
100µm using a GFP specific filter with excitation at 488nm. Maximum intensity 
projections were generated by NIS elements to visualise all 10 z-planes. 
 Application of binary layers to time courses 
Binary layers were used to detect neutrophils in time lapses during their recruitment to 
the wound site. NIS elements software is able to accurately detect individual objects, 
using a combination of thresholding based on fluorescence intensity, circularity and size. 
These features can be refined by cleaning and smoothing binary layers, as well as turning 
on the object separation function which enables the software to separate touching 
objects. Binary layers were added to time courses by applying a threshold based on 
fluorescence intensity of neutrophils to exclude background noise. The accuracy of 
binary layers was improved by smoothing, cleaning and separating objects. A size 
restriction was applied where necessary to exclude small and large objects which did not 
correspond to individual neutrophils.  
 Automated assay to detect object area  
To detect neutrophil swarms at a wound site, the object size measurement feature on 
NIS Elements software was used. To measure the area of neutrophils in the time courses 
a binary layer was applied and accuracy was confirmed by checking multiple time points 
in the time courses. Binary layers were smoothed and cleaned, however object 
separation and size restrictions were not applied for this assay to ensure large objects 
were included in the binary layer. The measurements feature on NIS Elements (Version 
4.3) was used to calculate the area of every object detected in each time frame. A region 
of interest was drawn at the wound site and the area of objects detected in this area was 
calculated.  
 Tracking of neutrophils during recruitment to wound sites 
Tracking of GFP labelled cells was performed using NIS Elements (Version 4.3) with an 
additional NIS elements tracking module. A binary layer was added to time courses as 
previously described.  
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Binary layers were tracked based on algorithms generated by NIS elements software. A 
probability ellipse is calculated by the software following the input of information based 
on the movement of neutrophils. Parameters such as neutrophil speed, motion, 
fluorescence intensity and distance travelled were used to generate accurate neutrophil 
tracks. Post-tracking modifications were performed to remove short or inaccurate 
tracks, as well as to join gaps between tracks.  
Object features including position, heading, speed, displacement, area and circularity 
index are recorded by the tracking software to provide numbers parameters to study 
neutrophil migration.   
 Fluoresence resonance energy transfer (FRET) imaging 
To visualise apoptotic events in the context of neutrophil swarming, 3dpf 
Tg(mpx:FRET)sh237 were injured and mounted in a 1% agarose with tricaine solution. 
Agarose was covered with 500µl of a clear E3 solution containing 4.2% tricaine to prevent 
dehydration. FRET imaging was performed from 30 minutes post injury using a 20x 
objective lens on an UltraVIEWVoX spinning disc confocal laser imaging system (Perkin 
Elmer) with acquisition every 2 minutes. 10 z-planes were captured per larvae over a focal 
range of 100µ using the following filters: a donor CFP channel (440nm for excitation, 
485nm for detection), an acceptor YFP channel (514nm for excitation and 587nm for 
detection), and a FRET channel (440nm for excitation and 587nm for detection). An 
Ultraview dichroic mirror passes 405,440,515,640 was used to increase imaging speed 
using these filter blocks.  
Volocity™ software was used to calculate normalised FRET values (NFRET). To 
compensate for the bleed through of the CFP and YFP fluorophores into the FRET 
channel, FRET bleed through constants were calculated. Control samples containing 
HeLa cells transfected with CFP alone or YFP alone were imaged using the same settings 
used for data acquisition of the mpx:FRET zebrafish reporter line. ROIs were drawn 
around a population of cells in the frame and VolocityTM software calculated FRET bleed 
through values as the mean intensity of the recipient channel (FRET) divided by the mean 
intensity of the source (CFP or YFP).  
These FRET constants were then used by VolocityTM to calculate a normalised FRET value 
to generate a FRET value which reflects only the emission of acceptor YFP following 
excitation from the donor CFP considering the FRET bleed through and the background 
fluorescence emissions from each channel. Neutrophil apoptosis was observed by 
overlaying the YFP and NFRET channels. 
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 Ratiometric Imaging of HyPer  
To measure hydrogen peroxide concentration in neutrophils, fluorescence imaging of 
neutrophils expressing HyPer were acquired using an UltraVIEWVoX spinning disc 
confocal laser imaging system (Perkin Elmer). Fluorescence for HyPer420 was acquired 
using an excitation wavelength of 440nm and emission was detected at 587nm. 
Fluorescence for HyPer500 was acquired using an excitation wavelength of 514nm and 
emission was detected at 587nm as previously described for zebrafish (Niethammer et 
al., 2009a). 10 z-planes were captured per larvae over a focal range of 100µm. Data was 
collected for both channels on each z-plane before moving through the focal range to 
reduce the time between HyPer420 and HyPer500 excitation as recommended (Pase et al., 
2012).  
VolocityTM software was used to calculate HyPer ratios. Images were thresholded and 
backgrounds were subtracted. The ratio channel was generated by dividing HyPer500 by 
HyPer420 (Hyper500/HyPer420). A rainbow LUT was applied to the HyPer ratio channel with 
an R minimum of 0 and an R maximum of 3.  
 Confocal imaging of red and green fluorescence  
For imaging the lyz:histone2a.mCherry transgenic line, Cxcr4b.GFPx lyz:mCherry 
reporter line  and mpx:GFP larvae for propidium iodide experiments, confocal imaging 
of red and green fluorophores was performed. Larvae were mounted in a 1% low 
melting point agarose solution (Sigma-Aldrich) containing 4.2% tricaine for imaging 
immediately after tail transection. Agarose was covered with 500µl of a clear E3 
solution containing 4.2% tricaine to prevent dehydration. Propidium iodide was added 
to agarose at a final concentration of 1µg/ml where described in figure legend. Imaging 
was performed from 30 minutes post injury using a 10, 20x or 40x objective as 
described in figure legends on an UltraVIEWVoX spinning disc confocal laser imaging 
system (Perkin Elmer). Fluorescence for GFP was acquired using an excitation 
wavelength of 488nm and emission was detected at 510nm. Fluorescence for mCherry 
or propidium iodide was acquired using an excitation wavelength of 525nm and 
emission was detected at 640nm.  
2.6 Molecular Biology 
 Whole mount in situ hybridisation (WISH) probe synthesis  
WISH antisense RNA probe for cxcl12a was synthesised from linearised plasmid DNA 
obtained from a plasmid vector containing the zebrafish cxcl12a coding sequence, 
provided as a kind gift from Dr. Anne Robertson (University of Sheffield). RNA was 
transcribed using an SP6 RNA digoxigen labelling kit (Roche). 1µg of linearised DNA was 
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incubated in a final volume of 20µl containing transcription reagents described in table 









Following the transcription reaction, the DNA template was removed by adding 4µl 
DNAse for 20 minutes at 37°c. Lithium chloride was used for RNA precipitation. 1 µl EDTA 
(0.5M, ph8) was added with 2.5 µl LiCl (4M) and 75 µl 100% ethanol, which was stored at 
-80°c for 30 minutes followed by a centrifugation step at 14000rpm in 4°c for 30 minutes. 
Supernatent was removed and the pellet was resuspended in 75 µl 70% ethanol. 
Resuspended RNA was centrifuged for a further 10 minutes at 14000rpm in 4°c centrifuge, 
supernatant was removed and pellet was air dried for 5 minutes before being 
resuspended in 20 µl sterile water. 1 µl was loaded into a 1% agarose gel and gel 
electrophoresis was performed to confirm the presence of RNA. 80 µl formamide was 
added to RNA following confirmation of its presence and stored at -80°c.  
 Transformation 
Plasmid DNA was transformed using Top10 competent cells (Invitrogen, Paisley, UK). 1µl 
of plasmid indicated was added to 25µl of Top10 cells, mixed and incubated on ice to 
permeabilise cells for 30 minutes. Permeabilised cells were heat shocked for 45 seconds 
at 45°c and placed back on ice for 10 minutes. 150µl SOC media (Invitrogen) was then 
incubated with cells for a 1 hour vigorous shaking period of 200rpm at 37°c. Cells were 
plated on dry antibiotic selection plates specific to the antibiotic resistance cassette in 
the plasmid and cultured at 37°c overnight. Selection plates were made using autoclaved 
LB agar and 50µg/ml of the relevant antibiotic.  










Polymerase  1 
dH20 13 
 
Table 1: List of reagents used for transcription reactions 
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 DNA purification 
Following transformation, single colonies were selected from plates and grown over 
night by shaking rigorously at 37°c in 50µl autoclaved LB broth containing 50µg/ml of the 
relevant antibiotic.  
A HiSpeed Plasmid Midi Kit (QIAGEN, Manchester, UK) was used to purify DNA followed 
by an additional purification step using a MinElute PCR Purification Kit (QIAGEN) as 
described by the manufacturers’ instructions. The DNA concentration was determined 
by NanodropTM spectrophotometer (Thermo Scientific, Hemel Hempstead, UK).  
2.7 Analysis of RNA expression in zebrafish neutrophils 
Cxcr4 and Cxcl12 expression was analysed using RNA sequencing data shared with our 
group by our collaborator Anne-Marie Meijer (accession code: GSE78954). Briefly, RNA 
sequencing of FACS-sorted neutrophils was performed to detect expression of genes 
by neutrophils in zebrafish larvae at 5dpf, as described (Rougeot et al., 2014). From this 
data the fpkm values for both isoforms of cxcr4 and cxcl12 in neutrophils was extracted.  
2.8 Development of transgenic lines 
Plasmid DNA containing the construct was injected with Tol2 mRNA into mpx:GAL4 larvae 
at the one cell stage. At 3dpf, F0 larvae with visible expression of the construct of interest 
in the caudal hematopoietic tissue were selected for raising to adulthood. Founders were 
identified by outcrossing these F0 larvae to wildtype larvae and seeing positive 
expression in the CHT in offspring of these crosses. A founder was identified and 
outcrossed to a wildtype adult fish and offspring of this pairing were raised to produce a 
heterozygous population of F1 fish. For the Tg(mpx:GAL4)i222;Tg(UAS:cxcr4b.GFP)sh503 
line, experiments were performed on the offspring of these F1 larvae by incrossing or 
outcrossing. For experiments using the Tg(lyz:mcherry.histone2a,)sh503  experiments 
were performed on the offspring of F1 larvae by incrossing.  
2.9 Software  
1- Graph pad Prism software (version 7.03) was used for all data entry as well as statistical 
analysis, as described in individual figure legends.  
2- NIS elements (version 4.3) was used where described for analysis and visualisation of 
experiments performed using the Nikon wide field microscope.  
3- VolocityTM software (version 6.3) was used where described to analyse experiments 
performed using the UltraVIEW VoX spinning disk confocal microscope (Perkin Elmer, 
Cambridge, UK).   
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2.10 Statistical analysis 
GraphPad Prism® software was used for all statistical analysis. For comparisons between 
2 groups an unpaired two-tailed t-test was used. Where comparisons were made 
between 2 groups from the same paired data, a paired t-test was used. For 2 or more 
comparisons a one-way anova was used with Dunnett’s or Bonferroni’s correction. For 
reverse migration assays linear regression analysis was used to compare the difference 




3 Pioneer neutrophils initiate the swarming response to 
tissue injury in zebrafish larvae  
3.1 Introduction and aims 
As the most abundant of the circulating immune cells, neutrophils are one of the body’s 
first line of defence against infection.  Neutrophils are recruited to an inflammatory site 
within minutes of trauma where their major role is to eliminate pathogens using anti-
microbial functions including phagocytosis of pathogens, generation of the oxidative 
burst,  degranulation and formation of extracellular traps (Wright et al., 2010). The non-
specific microbicidal effects of the neutrophil, whilst preventing pathogens from 
establishing a niche within the host, are detrimental to host tissues when their activity 
becomes unregulated (Headland and Norling, 2015). 
Neutrophil recruitment to inflammatory sites has been extensively studied and the highly 
regulated cascade of events leading to the extravasation of neutrophils through vascular 
endothelial cells into the inflamed tissue has been well defined (Ley et al., 2007)(Kelly et 
al., 2007). It is currently understood that following egress from the blood stream, 
neutrophils are guided by a range of chemoattractant molecules released from 
pathogens or damaged cells at the inflammatory site, although the precise signalling 
pathways involved in coordinating neutrophil dynamics beyond the vasculature are not 
fully understood.  
Recent advances in intravital imaging of the inflammatory response have provided a new 
prospective on neutrophil responses within inflamed tissue (Lämmermann et al., 2013; 
Wang et al., 2017). Neutrophils are able to coordinate their migration within inflamed 
tissue such that following highly coordinated chemotaxis, neutrophils accumulate in 
clusters at inflammatory sites. This newly identified directed migration or ‘neutrophil 
swarming’ is reminiscent of the swarming behaviours observed in insects and birds 
(Lämmermann, 2015).  
The molecular controllers of the swarming response at the single-cell and whole 
population levels are currently being dissected (Reátegui et al., 2017). It is clear that 
neutrophil tissue navigation and clustering at injury sites follow multistep attraction 
cascades, whose exact molecular sequence and outcome is dependent on tissue context.  
Neutrophil swarming is now recognised as an important process during the neutrophilic 
inflammatory response. Whilst the precise physiological role for neutrophil swarming at 
inflammatory sites is not fully understood, arguments are currently being made for both 
host-protective and host-damaging outcomes (Kienle and Lämmermann, 2016).  
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The development of high resolution imaging of mouse tissue have allowed the 
mechanisms governing the swarming response at its later stages to begin to be dissected 
(Lämmermann et al., 2013). However, little is known about the early initiation of the 
swarming response where our current understanding is based on preliminary or 
unpublished findings (Lämmermann, 2015). 
In order to gain further insight into the neutrophil swarming response, high resolution in 
vivo imaging is required alongside genetically tractable models to dissect the 
mechanisms of this phenomenon at a single-cell stage. Zebrafish larvae provide an 
excellent model to study the behaviour of neutrophils at sites of injury or infection due 
to their thin tissue depth and optical transparency which allows the tracking of 
neutrophil behaviour in vivo in real time in high resolution (Renshaw and Loynes, 2006). 
The zebrafish is a model which can be used to overcome the limitations associated with 
in vivo imaging in mice as well as providing a truly physiological model to study the 
endogenous neutrophil swarming response.  
The aims of this chapter are to characterise the neutrophil swarming response to tissue 
injury in zebrafish larvae and investigate the initiation stages of neutrophil swarming on 
a single-cell level. 
3.2 Neutrophil swarming is observed in response to tail-fin 
transection in zebrafish larvae 
No reports currently exist to describe neutrophil swarming in response to tail-fin 
transection in zebrafish larvae, although swarming has been observed at sites of 
infection. I hypothesised that neutrophil swarming could be observed at the wound site 
during the recruitment phase of inflammation in zebrafish larvae. 
To determine the dynamics of the inflammatory response following tail-fin transection, 
the number of neutrophils present at the wound site were counted at regular intervals 
during the first 24 hours following injury (Figure 3.1). Recruitment of neutrophils was 
observed for the first 6 hours post injury, followed by a resolution phase which began 
from 8 hours post injury when the number of neutrophils at the wound began to 
decrease until returning to almost base line levels by 24 hours post injury. From these 
experiments I determined that the dynamics of neutrophil recruitment to tail-fin injury 
could be studied within the first 6 hours following injury.  
To investigate the migratory behaviours of neutrophils during recruitment to wound 
sites in zebrafish larvae, tail-fin transection of 3dpf mpx:GFP larvae was performed 
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followed by time lapse imaging from 30 minutes post injury for 5 hours, as described in 
methods.  
Neutrophil recruitment to the tail-fin was observed during the first 5 hours following tail-
fin transection. Neutrophil aggregates were observed which were reminiscent of those 
seen in mice. In larvae where aggregates were observed, the recruitment of the first 
neutrophils to the wound site was followed by the highly directed migration of a 
population of neutrophils which, instead of scouting the wound site, organised 
themselves to form a cluster (Figure 3.2). I hypothesised that the aggregates I observed 
in zebrafish tissue could be examples of neutrophil swarming, so I set out to characterise 








Figure 3.1: Dynamics of the neutrophilic response to tissue injury 
 
Tail fin transection was performed on 3dpf mpx:GFP larvae. The number of 
neutrophils at the site of injury were counted at 2, 4, 6, 8, 12 and 24 hours post injury. 
Neutrophil recruitment to the wound site was observed for up to 6 hours following 
injury. Inflammation resolution was observed from 8-24 hours post injury when the 
number of neutrophils at the wound site decreased over time (Data are shown as 




3.3 An unbiased assay to detect neutrophil swarming 
Before characterising any of the behaviours leading to neutrophil swarm formation at the 
wound site, I developed an unbiased assay to detect swarms within a population of larvae. 
This is important as there currently exists no definition of neutrophil swarming, 
something which is required for consistency between studies. The area of aggregating 
neutrophils is visibly larger than the area of individual neutrophils at the wound site, so I 
hypothesised that overlapping neutrophils such as those in the clusters would be 
detected as one large object. I developed an assay using the application of binary layers 
to the images which enabled the detection of all objects at the wound site in every time 
point during the imaging period.  
The area of neutrophils at the wound site was measured automatically in every point 
from time courses taken following tail-fin transection of 3dpf mpx:GFP larvae as 
described in methods. The area of the majority of neutrophils detected at the wound site 
was consistently clustered around the 100µm2 mark. In larvae where aggregates were 
seen at the wound site, the presence of an outlier object with an area exceeding 1000µm2 
was observed in the data (Figure 3.3A). This larger outlier was not seen in larvae where 
aggregates were not observed (Figure 3.3B). Of the positive hits from this assay where 
the area of an outlier population with an area closer to 1000µm2 was observed, 100% of 
the data corresponded to a neutrophil cluster.  
From these experiments I determined that neutrophil aggregates could be detected 
within a population of larvae by measuring the area of objects detected at the wound site. 
This unbiased assay provides a robust method to identify neutrophil clusters within a 







Figure 3.2: Neutrophil clusters are observed at the wound site 
Tail fin transection of 3dpf mpx:GFP larvae was performed followed by 
time lapse imaging from 30 minutes post injury for 5 hours. Figure shows 
neutrophil cluster formation at the wound site (red arrows) at time 
points indicated during the recruitment of neutrophils to the wound site 
in 3 representative larvae.  Time stamps shown in red (hh:mm:ss) are 








Figure 3.3: An automated assay to detect neutrophil clusters at the 
wound site 
Time lapse imaging of neutrophil recruitment was performed on 3dpf mpx:GFP larvae 
following tail fin transection from 30 minutes post injury for 5 hours. A binary layer was 
applied to each time course and the binary area of individual objects detected in an 
ROI drawn at the wound site was measured for each time point where swarms were 
detected as one large object (white arrow, A). Figure shows representative examples 
of binary object detection in larvae with a swarm at the wound site where objects with 
an area of up to 10000 µm2 were detected (red arrow, B) and larvae with no swarms 




3.4 Multiple neutrophil swarms can form at the wound site and 
neutrophils can move between competing swarms  
Interestingly during these initial observations the formation of multiple neutrophil 
aggregates at the wound site in larvae was seen. The outcome of neutrophil recruitment 
to and organisation at the wound site in larvae varied between larvae, where the 
formation of up to 3 individual neutrophil clusters at the wound site was observed (Figure 
3.4A-D). It was apparent that the most common phenotype observed was either no 
swarming behaviour or one individual swarm at the wound site, either of these 
phenotypes were observed in 38% of larvae. Multiple swarms were seen at the wound 
site less frequently, with 2 swarms being detected in 21%, and 3 swarms being detected 
in 3% of larvae (Figure 3.4E).   
Neutrophils have been observed to move between competing swarms in mice 
(Lämmermann, 2015). Where multiple swarms were observed at the wound site in 
zebrafish larvae, the movement of neutrophils between competing clusters was 
observed whereby a pioneer neutrophil initiated a first neutrophil swarm, which 
dissipated following the migration of neutrophils to a second pioneer neutrophil in close 
tissue proximity (Figure 3.5). These observations provide evidence that the neutrophil 
clustering observed in the zebrafish model shares characteristics with that seen in mice.  
3.5 Neutrophil swarming occurs in response to a range of 
inflammatory stimuli 
In mice one of the factors proposed to modulate the swarming response is the size of 
the initiating tissue damage (Kienle and Lämmermann, 2016). To determine whether 
neutrophil swarming occurred in response to a range of tissue injuries of a varying 
degree of severity, I changed the size of the inflammatory insult administered to larvae. 
Tail-fin transection of different severity was performed on 3dpf mpx:GFP larvae as 
described in methods. Neutrophil swarms were detected at the wound using the 
automated assay to detect large objects (Figure 3.6), indicating that neutrophil swarming 





Figure 3.4: Multiple neutrophils swarms can form at the wound site 
Time courses of neutrophil recruitment to tail fin transection in 3dpf mpx:GFP larvae 
were studied within the first 5.5 hours following injury. Neutrophil migration and 
swarming dynamics at the wound site varied between larvae where no swarms (A), 1 
swarm (B), 2 swarms (C) and up to 3 swarms (D) were observed. The frequency with 
which these phenotypes were observed was quantified (E) (n=29 larvae from 7 
experimental repeats). Time stamps shown in white (hh:mm:ss) are relative to the 







Figure 3.5: Neutrophils migrate between competing swarms 
Neutrophil migratory behaviour at the wound site was studied using time courses 
taken following injury of 3dpf mpx:GFP larvae. In some instances where neutrophil 
swarming behaviour was observed at the wound site, the migration of neutrophils 
from an initial cluster (red circle) towards a second pioneer neutrophil in close 
proximity (white circle) was observed. Figure shows representative example of the 
migration of neutrophils between two swarms. Time stamps shown in white (mm:ss) 






Figure 3.6: Neutrophil swarms form following a range of inflammatory 
stimuli 
Tail fin transection of varying severity was performed on 3dpf mpx:GFP larvae followed by 
time lapse imaging from 30 minutes post injury for 5 hours. Neutrophil swarms were 
observed (red arrow) at the wound site following a minor nick of the ventral side of the tail 
fin (A), a linear wound dissecting the tissue at the end of the caudal tail fin (B) and a severe 
linear wound dissecting the notochord and circulatory loop at the caudal tail fin (C). Time 





3.6 Dynamics of neutrophil swarming in zebrafish larvae  
In mice, neutrophils close to the wound site respond to the tissue insult within minutes. 
This is followed by a substantial chemotactic response by neutrophils distal to the wound 
site which exhibit highly directed migration to the wound where they aggregate with early 
pioneer neutrophils to form substantial neutrophil clusters (Lämmermann, 2015).  
After observing the formation of large neutrophil clusters at the wound site in zebrafish 
larvae in response to a range of inflammatory stimuli, I next sought to characterise the 
dynamics of the swarming response to determine the similarities and differences of 
endogenous zebrafish neutrophil swarming.  
Although there was variation from fish-to-fish in timing, all swarms formed following this 
same sequence of events, with kinetics similar to those observed in swarming 
neutrophils in mice models. This sequence of events can be divided into three distinct 
phases consisting of neutrophil scouting, swarm initiation and swarm aggregation (Figure 
3.7). The neutrophil scouting phase was observed in larvae regardless of swarming 
behaviour at the wound whereas the initiation and aggregation phases were specific to 
larvae where swarm formation occurred.  
 Phase 1: Scouting 
Within minutes following tail-fin transection, the recruitment of neutrophils proximal to 
the wound site began in all larvae (Figure 3.8, Movie 3.1-3.3). This initial ‘scouting’ phase 
was observed in all larvae regardless of whether a swarm formed at the wound site and 
was reminiscent of the scouting phase reported in mice following the release of 
chemoattractant by damaged tissue (Lämmermann et al., 2013).  
 Phase 2: Initiation 
Traditionally it was believed that neutrophil migration to inflammatory sites was 
governed by signalling through pattern recognition receptors in response to damaged 
cells and pathogens at the wound site (Kolaczkowska and Kubes, 2013). The identification 
of neutrophil swarming and the ability of neutrophils to modulate their own recruitment 
through intracellular relay signalling has changed the way neutrophil recruitment is 
perceived. It is currently unknown why neutrophils swarm at inflammatory sites in some 
contexts and not others, although it is clear that a specific tissue context is required 
(Lämmermann, 2015).  
I hypothesised that in larvae where swarms form at the wound site, a sub population of 
neutrophils were able to respond to additional chemoattractant cues which induce 






Figure 3.7: Dynamics of neutrophil swarming in zebrafish 
Tail fin transection was performed on 3dpf mpx:GFP larvae followed by time lapse 
imaging of neutrophil recruitment to the wound site from 30 minutes post injury for 
5 hours. Time courses where neutrophil swarming was observed at the wound site 
were selected and neutrophils were tracked during their recruitment to the wound. 
Figure shows the dynamics of neutrophil swarm formation in one representative 
example larvae. Neutrophil tracks are colour coded by time with red tracks 
corresponding to early recruited neutrophils and yellow tracks corresponding to 
neutrophils migrating later. The recruitment of neutrophils proximal to the wound 
site or ‘scouting phase’ was observed within minutes following tail fin transection (A). 
This is followed by a swarm ‘initiation’ phase in which one swarm-initiating neutrophil 
becomes chemotactic to other neutrophils at the wound site (B). The directed 
migration of neutrophils towards this chemotactic neutrophil is then observed during 
the ‘aggregation’ phase (C) .Time stamps shown in white (hh:mm:ss) are relative to 






Figure 3.8: Neutrophil scouting occurs within minutes following tail fin 
transection 
Time courses of neutrophil recruitment to tail fin transection in 3dpf mpx:GFP larvae 
were selected for study based on the observation of neutrophil swarming behaviour 
at the wound site. The region of the tail fin where imaging was performed is illustrated 
(A). Within minutes following tail fin transection the recruitment of neutrophils 
proximal to the wound site was observed. Figure shows the neutrophil tracks from 3 
representative larvae (B). Time stamps shown in white (hh:mm:ss) are relative to the 




To investigate this hypothesis the timecourses in which neutrophil aggregates were 
identified in larvae were studied. The frames immediately preceding swarm formation 
could be visualised in high resolution and the initiation of endogenous neutrophil 
swarming could be seen in vivo in real time. The most striking feature of swarm initiation 
was that the focal point of neutrophil migration was an individual round and immotile 
neutrophil; a pioneer (Figure 3.9, Movie 3.4-3.6). 
To study the recruitment of neutrophils to this immotile neutrophil, time courses were 
tracked in reverse, such that the migration of the swarm-initiating neutrophils to the 
wound site could be observed. Following the recruitment of the first neutrophils to the 
wound site during the scouting phase, a phenotypic change was observed in the swarm-
initiating neutrophil, and subsequently the  directed migration of neutrophils towards 
this neutrophil to form a cluster was observed (Figure 3.10-3.12, Movie 3.7-3.9). Swarm 
initiating neutrophils are referred to as pioneer neutrophils in the literature, so I have 
used this term to describe the neutrophil which initiates a swarm in zebrafish larvae. 
The time period from the change in phenotype of the pioneer neutrophil at the wound 
site, until it is joined by the first migrating neutrophil to form a neutrophil cluster has 
been termed the ‘initiation’ phase. During the initiation phase it would appear that 
pioneer neutrophils release a chemical which provides an additional chemotactic cue for 
neutrophils, resulting in a change in polarisation of a population of neutrophils which 
subsequently migrate to form a neutrophil swarm, rather than traditional patrolling of 
the wound site. I propose that the phenotypic change in pioneer neutrophils at the 
wound is induced by a specific tissue context. This could be a physical or mechanical 
barrier, alteration in chemical concentration/chemotactic cues, or the presence of a 
dead cells or pathogens.   
The phenotypic change in pioneer neutrophils can be illustrated by tracking the pioneer 
neutrophil during its recruitment to, and duration at, the wound site prior to swarm 
formation. Behavioural and morphological parameters such as neutrophil speed and 
circularity index were measured initially as proof of principle to illustrate the loss of 
motility and rounded morphology observed in pioneer neutrophils. Pioneer neutrophils 
were tracked during the scouting and initiation phases, during which time a striking 
change in pioneer neutrophil speed (Figure 3.13 A,C and E) and circularity index was 
observed (Figure 3.13 B, D and F). These data confirm the existence of a neutrophil 





Figure 3.9: Neutrophils direct their migration towards a pioneer 
neutrophil to initiate the swarming response 
Neutrophil swarms were identified in time courses of neutrophil recruitment to tail 
fin transection in 3dpf mpx:GFP larvae during the first 5 hours following injury.  
Neutrophils were tracked during the initiation and aggregation phases. Figure shows 
a representative example of the presence of one swarm-initiating pioneer neutrophil 
at the wound site which was the focal point of directed neutrophil migration leading 
to swarm formation (A).  Tracking of neutrophils illustrates the directed migration 
towards the pioneer neutrophil (B). Red dashed line represents wound edge. Time 







Figure 3.10: Pioneer neutrophils change phenotype at the wound site 
(example 1) 
The migration of swarm-initiating pioneer neutrophils was studied in time courses 
taken of neutrophil migration to tail fin transection in 3dpf mpx:GFP larvae. Pioneer 
neutrophils highlighted in red were tracked until the frame preceding the aggregation 
phase of swarming. Figure shows one example of pioneer neutrophil tracks (white) 
during migration to the wound site in the scouting phase (A).  Pioneer neutrophil 
tracks become stationary with a rounded morphology during the initiation phase (B). 
Dashed red line represents the wound edge. Time stamps shown in white (mm:ss) 







Figure 3.11: Pioneer neutrophils change phenotype at the wound 
(example 2) 
The migration of swarm-initiating pioneer neutrophils was studied in time courses 
taken of neutrophil migration to tail fin transection in 3dpf mpx:GFP larvae. Pioneer 
neutrophils highlighted in red were tracked until the frame preceding the aggregation 
phase of swarming. Figure shows one example of pioneer neutrophil tracks (white) 
during migration to the wound site in the scouting phase (A).  Pioneer neutrophil 
tracks become stationary with a rounded morphology during the initiation phase (B). 
Dashed red line represents the wound edge. Time stamps shown in white (mm:ss) are 






Figure 3.12: Pioneer neutrophils change phenotype at the wound site 
(example 3) 
The migration of swarm-initiating pioneer neutrophils was studied in time courses 
taken of neutrophil migration to tail fin transection in 3dpf mpx:GFP larvae. Pioneer 
neutrophils highlighted in red were tracked until the frame preceding the aggregation 
phase of swarming. Figure shows one example of pioneer neutrophil tracks (white) 
during migration to the wound site in the scouting phase (A).  Pioneer neutrophil 
tracks become stationary with a rounded morphology during the initiation phase (B). 
Dashed red line represents the wound edge. Time stamps shown in white (hh:mm:ss) 







Figure 3.13: Pioneer neutrophils change phenotype at the wound site; 
proof of principle 
The phenotypic changes observed in pioneer neutrophil behaviour at the wound site 
were confirmed by measuring the speed of neutrophil migration and the circularity 
index in the frames preceding neutrophil swarm formation. Figure shows the pioneer 
neutrophil track speed (A, C, E) and circularity index (B, D, F) from three 
representative larvae. A clear change in speed and circularity index is observed 




 Pioneer neutrophils undergo a morphological change at the wound site 
which is not seen in non-pioneer neutrophils 
After confirming that pioneer neutrophils changed their phenotype at the wound site 
throughout time, I next aimed to fully characterise the migratory behaviours of pioneer 
neutrophils and non-pioneer neutrophils during the scouting and initiation phases.  
Neutrophils were selected for tracking if they were equi-distant from or closer to the 
wound site than the pioneer neutrophil to ensure that selected neutrophils were 
migrating within a similar tissue-context during the time period measured. Neutrophil 
tracking was performed during the scouting and initiation phase on five time courses 
taken from four experimental repeats as described in methods, and pioneer neutrophil 
tracks were separated from non-pioneer tracks. Parameters which illustrate the 
migratory behaviour of neutrophils such as speed, displacement (linear distance 
between the start and end of the neutrophil track) and meandering index were used to 
study neutrophil migration during swarm initiation. The meandering index is calculated 
by dividing the displacement of each cell by the length of the path it has travelled, and 
provides a read out of how directly a cell has moved. A meandering index of 1 indicates 
movement in a direct line. A representative example of tracking during the scouting and 
initiation phases is illustrated in figure 3.14, where tracks extracted from the scouting 
phase are highlighted in cyan, and tracks taken from the initiation phase are highlighted 
in magenta.    
 Pioneer neutrophils migrate differently to non-pioneer neutrophils during 
the initiation phase 
I aimed to compare the migratory behaviour of pioneer neutrophils to that of non-
pioneer neutrophils during the initiation phase. I hypothesised that during initiation, the 
migratory behaviours of pioneer neutrophils would be different to that of non-pioneer 
neutrophils.  
The speed, displacement and meandering index was measured from pioneer and 
non-pioneer neutrophil tracks extracted from the initiation phase. Circularity 
index was also measured as a parameter to describe the roundness of the 
neutrophils where a value of 1 is completely round. These data demonstrate that pioneer 
neutrophil speed and displacement was significantly lower than non-pioneer neutrophils 
(Figure 3.15 A and B), whilst there was no difference in meandering index (Figure 3.15C). 
Furthermore the circularity index of pioneer neutrophils is significantly higher than non-
pioneer neutrophils at the wound site (Figure 3.15D). 
These data confirm the observation that pioneer neutrophils adopt a non-motile, 








Figure 3.14: Tracking neutrophil migration during the scouting and 
swarm initiation phases 
Tail fin transection was performed on 3dpf mpx:GFP larvae followed by time lapse 
imaging of neutrophil recruitment to the wound site from 30 minutes post injury for 
5 hours. Time courses in which pioneer neutrophil recruitment to the wound site was 
observed prior to swarm formation were selected for analysis. Tracking of pioneer 
neutrophils and non-pioneer neutrophils equi-distant from or closer-to the wound 
site was performed during the scouting (A) and initiation (B) phases. Figure shows a 
representative example of the neutrophils tracked in one larvae during the scouting 
phase (blue) and the initiation phase (pink). Time stamps shown in white (mm:ss) are 






Figure 3.15: Migratory behaviours of pioneer neutrophils are different 
to non-pioneer neutrophils during the swarm initiation phase 
Neutrophils proximal to the wound site were tracked in time courses of neutrophil 
recruitment to wound sites in 3dpf mpx:GFP larvae. Neutrophil migration was 
measured during the swarm initiation phase using track speed, track displacement 
and meandering index. Circularity index was used to measure neutrophil circularity.  
Dots represent individual neutrophils, where experiments were performed on five 
larvae. Pioneer neutrophils had significantly lower speeds (A) and displacement (B) 
compared to non-pioneer neutrophils, whilst meandering index was not statistically 
different (C). The circularity index of pioneer neutrophils was significantly higher than 
non-pioneer neutrophils during swarm initiation (D). (Data are shown as mean +/- 
sem. Unpaired t-test, n=5 *p<0.05 **p<0.01). 
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 Neutrophil migratory behaviour during the scouting phase is the same 
between pioneer and non-pioneer neutrophils  
There currently exists evidence of heterogeneous neutrophil populations which have 
distinct functions during inflammatory and pathologic conditions. It is currently unclear 
if these are neutrophil sub-populations or whether local tissue cues alter the activation 
or polarisation state of these neutrophils (Deniset and Kubes, 2018).  
I hypothesised that if pioneer neutrophils were a sub-population with a distinct pre-
programmed, their migratory behaviour may be different to non-pioneer neutrophils 
during their scouting to the wound site. 
To investigate this hypothesis, pioneer and non-pioneer neutrophil tracks were 
extracted from the scouting phase data and the speed, displacement and meandering 
index was recorded. These data demonstrate that pioneer neutrophils recruit towards 
the wound site at the same speed as non-pioneer neutrophils (Figure 3.16A). The 
displacement of pioneer neutrophils was significantly higher in pioneer neutrophils than 
non-pioneer neutrophils, indicating that during these experiments, pioneer neutrophils 
have migrated a larger distance to the wound site (Figure 3.16B). The meandering index 
was not significantly different between pioneer and non-pioneer neutrophils (Figure 
3.16C).  
Together these data suggest that pioneer and non-pioneer neutrophils migrate with 
similar kinetics to the wound site. The increased displacement observed in pioneer 
neutrophils reflects the selection of neutrophils closer to or equal-distance from the 
wound site for comparisons in these experiments.  
 Migratory behavioural changes between the scouting and initiation phases 
are observed in pioneer neutrophils but not non-pioneer neutrophils 
I next aimed to investigate the behavioural change in pioneer neutrophils between the 
scouting and initiation phase. I hypothesised that the phenotypic switch I have previously 
reported could be detected by comparing migratory behaviours between the two 
phases. As proof of concept I have previously shown that by tracking the speed and 
circularity index of the pioneer neutrophil throughout the scouting and initiation phase, 
a clear phenotypic change can be observed (Figure 3.13).  
I compared the pioneer neutrophil tracks taken from the scouting phase to those taken 
from the initiation phase. As anticipated I found that the migratory behaviours of pioneer 
neutrophils was significantly different in the initiation phase, which is highlighted by the 
significant reduction in speed, displacement and meandering index observed between 





Figure 3.16: Migratory behaviour during the scouting phase is not 
different between pioneer and non-pioneer neutrophils 
Neutrophils proximal to the wound site were tracked in time courses of neutrophil 
recruitment to wound sites in 3dpf mpx:GFP larvae. Neutrophil migration was 
measured during the scouting phase using track speed, track displacement and 
meandering index. Dots represent individual neutrophils, where experiments were 
performed on five larvae. There was no difference in the speed of migration to the 
wound site between pioneer and non-pioneer neutrophils (A). Pioneer neutrophil 
displacement was significantly higher than non-pioneer neutrophils (B) whilst there 
was no difference observed in meandering index (C). (Data are shown as mean +/- 






Figure 3.17: Migratory behaviour of pioneer neutrophils is reduced 
during the swarm initiation phase 
Pioneer neutrophils were tracked in time courses of neutrophil recruitment to 
wound sites in 3dpf mpx:GFP larvae. Pioneer neutrophil migration was measured 
during the scouting and initiation phase using track speed, track displacement and 
meandering index. Dots represent individual neutrophils, where experiments were 
performed on five larvae. A significant reduction in pioneer neutrophil speed (A), 
displacement (B) and meandering index (C) was observed during the swarm initiation 




Finally, to determine whether the phenotypic change observed was specific to swarm-
initiating pioneer neutrophils, I also studied the tracks of neutrophils which did not start 
swarms during the scouting and initiation phases from the same 5 larvae.  
The migratory behaviours of non-pioneer neutrophils did not differ between the scouting 
and initiation phases, which is demonstrated by the non-significant difference observed 
when measuring the neutrophil speed, displacement and meandering index (Figure 
3.18A-C) 
Together these data suggest that the migratory behaviours of pioneer neutrophils during 
the scouting phase are the same. Interestingly pioneer neutrophils arrive at the wound 
site and, unlike other neutrophils, undergo a phenotypic switch in behaviour which is 
specific to these swarm initiating neutrophils. This highlights that the tissue 
microenvironment at the wound site potentially induces the behavioural change of 







Figure 3.18: Migratory behaviours of non-pioneer neutrophils are 
unchanged during the scouting and initiation phases 
Non-pioneer neutrophils were tracked in time courses of neutrophil recruitment to 
wound sites in 3dpf mpx:GFP larvae. Non-pioneer neutrophil migration was measured 
during the scouting and initiation phase using track speed, track displacement and 
meandering index. Dots represent individual neutrophils, where experiments were 
performed on five larvae. There was no significant difference observed in neutrophil 
track speeds (A), displacement (B) and meandering index (C) between the scouting 




 Phase 3: Swarm aggregation 
The third stage of swarm formation observed in zebrafish larvae was the coordinated 
migration of a population of neutrophils at the wound site to form neutrophil clusters. 
Following the phenotypic switch of the pioneer neutrophil during the initiation phase, the 
directed migration of neutrophils towards the pioneer was observed, resulting in cluster 
formation at the wound site (Figure 3.19, Movie 3.10-3.12). During the aggregation phase, 
2 swarm phenotypes were observed. Large neutrophil swarms were observed which, 
following initiation continued to grow in size, persisting at the wound site for up to 6 
hours post injury (Figure 3.20). A second type of swarm was observed which, following 
the recruitment of neutrophils to the pioneer, persisted transiently before dissipating 
and re-forming, often multiple times throughout the time courses (Figure 3.21). 
From the time courses recorded for 5 hours following tail-fin transection of 3dpf 
mpx:GFP larvae, persistent swarms were identified using the automated assay previously 
described, in 6/14, and a further swarm was identified visually in one larva such that 7/14 
larvae had a persistent swarm at the wound site. The automated object area assay was 
not sensitive enough to detect smaller transient swarms, which were instead identified 
visually by observing the directed migration of neutrophils to form small clusters at the 
wound site. From these experiments transient swarming was observed in 2/14 larvae 
(Figure 3.22).  
Neutrophil swarming is a dynamic process which requires high speed imaging at regular 
intervals to observe. Time lapse imaging limits the number of larvae which can be used 
per experiment due to photo toxicity from lasers and the time taken to image each larva, 
resulting in low n numbers from each experiment. To overcome these limitations I next 
aimed to determine whether neutrophil swarming could be observed at the tail-fin in 
larvae at a static time point without time lapse imaging. 3dpf mpx:GFP larvae were injured 
as described in methods and neutrophil swarms were detected at 3hpi using a stereo 
microscope with a GFP emission filter. Neutrophil swarms were identified by the 
presence of an obvious neutrophil cluster at the wound site (Figure 3.23A) which were 
not detected in larvae with no swarms (Figure 3.23B). From these experiments, 
neutrophil swarms at the wound site were detected at 3hpi in just 16% of larvae (Figure 
3.23C). As the nature of neutrophil swarming is dynamic, I was unable to identify smaller 
transient swarms using this assay. These data indicate that whilst many more larvae can 
be used per experiment using this assay, neutrophil swarming is detected in far fewer 






Figure 3.19: The neutrophil swarm aggregation phase 
Time course imaging was performed on 3dpf mpx:GFP larvae following tail fin 
transection from 30 minutes post injury for 5 hours. Following the initiation of the 
swarming response by pioneer neutrophils, phases of directed migration of 
neutrophils were observed for the remainder of the time courses, resulting in the 
formation of large neutrophil aggregates at the wound site. Region of imaging is 
highlighted in (A). Figures shows the aggregation of neutrophils to form swarms 
around a pioneer neutrophil after the initiation phase in three representative larvae 
(B). Time stamps shown in white (mm:ss) are relative to the start of imaging at 30 






Figure 3.20: Neutrophil swarms can be persistent during the 
aggregation phase 
Neutrophil swarming was observed during the aggregation phase in time courses 
recorded of neutrophil recruitment to tail fin transection in mpx:GFP larvae at 3dpf. A 
phenotype of neutrophil swarming whereby neutrophils continued to aggregate in 
clusters at the wound site throughout the duration of the time courses was observed. 
Figure shows a representative example of a persistent neutrophil swarm at the wound 
site during neutrophil recruitment. Time stamps shown in white (hh:mm:ss) are 






Figure 3.21: Neutrophil swarms can be transient during the aggregation 
phase 
Neutrophil swarming was observed during the aggregation phase in time courses 
recorded of neutrophil recruitment to tail fin transection in mpx:GFP larvae at 3dpf. A 
phenotype of neutrophil swarming was observed whereby neutrophils formed a 
cluster around a pioneer neutrophil, which resolved and re-formed multiple times 
throughout the time course. Figure shows a representative example of a transient 
neutrophil swarm (red arrow) in which neutrophils aggregate and resolve around a 
pioneer neutrophil. Time stamps shown in white (hh:mm:ss) are relative to the start 







Figure 3.22: Exploring the frequency of persistent and transient 
swarming 
Time courses were studied of neutrophil recruitment to injury sites in 3dpf mpx:GFP 
larvae. Larvae with clusters at the wound site were identified and of these clusters 
50% were persistent and 14% were transient. Larvae with no neutrophil swarming 







Figure 3.23: Observing neutrophil swarming at a static time point 
Tail fin transection was performed on 3dpf mpx:GFP larvae and neutrophil 
recruitment to the wound site was observed at 3hpi. Neutrophli swarming was 
identified by the presence of obvious neutrophil clusters at the wound site (red 
arrows, A) which were not present in larvae where swarming wasn’t observed at 3hpi 
(B). The number of larvae with obvious clusters at the wound site was quantified (C). 
16% of larvae had neutrophil swarms at the wound site, whilst 84% did not. (n=293 




3.7 Quantification of aggregation phase phenotype 
Parameters used to quantify neutrophil swarming in vitro include swarm area and 
neutrophil counts in the swarm. To quantify the swarming phenotypes observed during 
the aggregation phase, the number of neutrophils recruited to swarms were counted at 
hourly intervals for the first 5 hours following tail-fin transection in individual larvae with 
swarms (Figure 3.24A and C respectively). From these experiments I found that the 
average number of neutrophils recruited to persistent swarms continued to increase 
until reaching their peak at the end of the time course at 5hpi (Figure 3.24B), whilst the 
average number of neutrophils recruited to transient swarms peaked earlier at 2hpi 
(Figure 3.24D). The average number of neutrophils recruited to persistent swarms at 
their peak (at 5hpi) was higher than the average number of neutrophils recruited to 
transient swarms at their peak recruitment (at 2hpi), although this difference was not 
significant (unpaired t-test with Welch’s correction, p=0.076) (Figure 3.25E).   
These findings are recapitulated when measuring the area of neutrophil swarms at 
hourly intervals in individual larvae with persistent and transient swarms (Figure 3.25A 
and C respectively). The average area of persistent neutrophil swarms was highest at 
4hpi, after which point a small but not significant decrease was observed at 5hpi, 
suggesting that these swarms remain stable at least until the end of the time course when 
they begin to decrease in size (Figure 3.25B). The average area of transient neutrophil 
swarms peaked at 2 hours post injury and continued to decrease and completely 
dissipate by the end of the time course (Figure 3.25D). The average area of persistent 
swarms at their peak size was significantly higher than that of transient swarms (Figure 
3.25E), further demonstrating that persistent swarms are larger than transient swarms.  
These data demonstrate that persistent neutrophil swarms are larger than transient 
swarms as highlighted by their larger area and higher number of recruited neutrophils. 
From these experiments I found that differences in neutrophil swarming phenotypes 
during the aggregation phase can be quantified by measuring parameters such as swarm 










Figure 3.24: Evaluation of neutrophil counts in persistent and transient 
swarms 
Time course imaging was performed on 3dpf mpx:GFP larvae following tail fin 
transection from 30 minutes post injury for 5 hours and those with persistent and 
transient neutrophil swarms at the wound site were selected for analysis. Neutrophils 
were counted manually in individual swarms at hourly intervals in persistent and 
transient swarms (A,C). Neutrophil counts were pooled for persistent and transient 
swarms (B-D). The maximum number of neutrophils recruited to persistent and 
transient swarms was compared. There was no significant difference in the maximum 
number of neutrophils recruited to persistent or transient swarms peak (E). (Data are 








Figure 3.25: Evaluation of neutrophil swarm area in persistent and 
transient swarms 
Time course imaging was performed on 3dpf mpx:GFP larvae following tail fin 
transection from 30 minutes post injury for 5 hours and those with persistent and 
transient neutrophil swarms at the wound site were selected for analysis. The area of 
individual neutrophil swarms was measured at hourly intervals throughout the time 
courses in persistent and transient swarms (A,C). Swarm area was pooled for 
persistent and transient swarm phenotypes (B,D). The maximum area of neutrophil 
swarms compared between persistent and transient swarms, identifying that 
persistent swarms had significantly larger area than transient swarms. (Data are 
shown as mean +/- sem. n= 7 persistent and 2 transient swarms from 5 experimental 
repeats. Unpaired t-test *P<0.01) 
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3.8 Investigating the spatio-temporal dynamics of the swarming 
response 
After identifying three phases of migration leading to neutrophil swarming, I next 
characterised the temporal component of these phases to provide insight into the time 
point when the swarming response takes place, as well as to determine the fish-to-fish 
variation in these phases.  
Persistent swarms were selected from time courses recorded for 5 hours following tail-
fin transection of 3dpf mpx:GFP larvae, and the time frame in which the initiation and 
aggregation phases began was recorded. To recap, the scouting phase was the initial 
recruitment of neutrophils to the wound site, the initiation phase was defined as the first 
time frame in which a phenotypic change was observed in the pioneer neutrophil, and 
the aggregation phase was defined as the time frame in which the first neutrophil is 
recruited to the pioneer. Neutrophil scouting was observed from the start of the time 
course at 0.5 hours post injury, although it is likely that this begins within minutes of the 
tail-fin transection. In these experiments the initiation phase began within 1hpi in the 
majority of larvae, although interestingly in a minority of larvae the initiation phase began 
much later at around 4 hours post injury, indicating that later onset neutrophil swarming 
is also observed. The aggregation phase began within 2hpi in most larvae, however again 
there was a later onset population of swarms which began between 2.5-4.5hpi (Figure 
3.26A).  
The duration of each phase of swarm formation was also recorded to determine the 
average time of each phase. From these experiments, the mean duration of the scouting, 
initiation and aggregation phases was 88.18+/- 23.63 minutes, 36.45+/- 7.40 minutes, and 
183+/- 25.52 minutes respectively (Figure 3.26B). To determine the entire duration of the 
aggregation phase longer time lapses are required as swarms were still aggregating at 
the end of the time courses.  
These data show that on average the scouting phase occurs during the first one hour 
following tail-fin transection. The initiation phase is the shortest of the three phases and 
usually occurs for around half an hour. Swarm formation usually begins within 180 
minutes post injury and persists at least until 5.5 hours post injury.  
From these initial observations I have identified three distinct and consistent stages of 






Figure 3.26: Characterisation of the temporal component of neutrophil 
swarming 
Time course imaging was performed on 3dpf mpx:GFP larvae following tail fin 
transection from 30 minutes post injury for 5 hours. The time in which the initiation 
and aggregation phases of neutrophil swarming began was recorded (A). The scouting 
phase begins within minutes following tail fin transection and is observed by time 
course imaging from 30 minutes post injury. The initiation phase of the majority of 
swarms begins approximately 1 hour post injury and the aggregation phase usually 
begins between 1 and 2 hours post injury. The duration of the scouting, initiation and 
aggregation phases was also measured (B). (Data are shown as mean +/- sem. n=11 




 I propose that the zebrafish could provide an excellent model to study the 
initiation phase of swarming due to the ability to observe pioneer neutrophils 
throughout the entirety of their recruitment to the wound site and initiation of 
swarms.  
 Pioneer neutrophils change morphology within 60µm of the wound edge 
I next investigated the hypothesis that the phenotype change in pioneer neutrophils was 
tissue context dependent. To do this I selected persistent swarms from time courses 
recorded for 5hpi following tail-fin transection of 3dpf mpx:GFP larvae. I hypothesised 
that if tissue context was important for inducing the pioneer neutrophil phenotype 
switch, there would be consistency in the position at the wound site where the 
phenotypic switch took place.  
The position at the wound site where pioneer neutrophils undergo their phenotypic 
switch was measured in order to gain insight into the tissue context required for swarm 
initiation. Time lapse sequences were studied from six experimental repeats and 15 
swarms were detected from 11 larvae (multiple swarms were detected in some larvae).  
The x and y position of pioneer neutrophils relative to the edge of the tail-fin and the 
ventral edge of larvae was recorded in the frame preceding the aggregation phase. To 
provide approximate spatial information regarding the position of swarms at the wound 
site, these data were superimposed on top of a representative tail-fin region as indicated 
by green circles superimposed (Figure 3.27A). By looking at the x position of pioneer 
neutrophils relative to the wound edge, I identified that all pioneer neutrophils initiated 
swarms within 60µm from the wound edge, with the average distance being 42.8+/- 
6.287µm (Figure 3.27B). The small standard deviation of points around the mean 
illustrates that neutrophil swarm formation at the wound site is consistently within 38-
50µm from the wound edge. When looking at the y position of pioneer neutrophils 
relative to the ventral edge of larvae, I found that swarms did not form within 132µm of 
the ventral edge of the larvae, and no swarms were detected above 362.5µm from the 
ventral edge (Figure 3.27C). These data demonstrate that on average swarms do not 
form within 132 µm of the ventral edge, and 82.5µm from the dorsal edge. The average 
position of swarm formation in the y dimension was 260.8+/-72.98µm. The large 
standard deviation of points from the mean identifies that the distribution of neutrophils 
in the y dimension at the wound site is large, I therefore concluded that neutrophil 
swarms form anywhere within an approximately 300µm range in the centre of the fish in 




Together these data demonstrate that the x position of swarm formation is highly 
conserved between larvae whilst the y position is variable, suggesting that the perhaps a 
tissue context exists within 60µm of the wound edge which induces a pioneer neutrophil 





Figure 3.27: Investigating the position of swarm formation at the 
wound site 
3dpf mpx:GFP larvae with persistent neutrophil swarms at the wound site following 
time lapse imaging were selected for analysis. The x and y coordinate of the position 
where pioneer neutrophils initiated swarm formation relative to the wound edge and 
the ventral fin edge was recorded. Green spots represent position of individual swarm 
formation (A). The x position of neutrophil swarm formation was within a 30µm niche 
within 60µm from the wound (B). The y position of swarm formation was within a 
400µm niche in the centre of the wound edge, with no swarms being observed within 
100µm of the dorsal or ventral edges of the larvae (C).  (Data are shown as mean +/- 




3.9 A zebrafish reporter line to investigate hydrogen peroxide 
concentration in pioneer neutrophils 
The proximity to the wound edge in which pioneer neutrophils adopt their change in 
morphology as well as the consistency between larvae suggests that these neutrophils 
encounter a tissue environment which initiates their change in phenotype. Following 
activation of the inflammatory response leukocytes are recruited from large distances 
within minutes. In zebrafish this is modulated in part by the release of reactive oxygen 
species such as hydrogen peroxide by cells at the wound margin. This hydrogen peroxide 
gradient diffuses up to 200µm into the tail-fin epithelium, peaking in concentration at 
around 20 minutes post injury and persisting for over 99 minutes post injury 
(Niethammer et al., 2009a). Hydrogen peroxide induces programmed cell death in 
eosinophils (Reis et al., 2015) as well as programmed and necrotic cell death in human 
retinal pigment epithelial cell lines (Kim et al., 2003) and is therefore a candidate to 
investigate swarm induction.  
I hypothesised that high levels of hydrogen peroxide at the wound site may induce the 
pioneer cell death resulting in the morphological changes observed in pioneer 
neutrophils and cell death signalling to induce neutrophil swarming. To investigate this 
hypothesis I used a genetically encoded biosensor expressed specifically in neutrophils 
under the lyz promoter.  
HyPer consists of a circularly permuted YFP (cpYFP) conjugated to the bacterial 
hydrogen peroxide sensitive OxyR transcription factor.  OxyR undergoes a 
conformational change following cysteine oxidation by hydrogen peroxide, such that the 
spectral emission properties of the cpYFP are altered. At higher concentrations of 
hydrogen peroxide, emission of the cpYFP increases following excitation at 500nm, and 
a decrease in emission is observed when excited at 420nm. Generating a HyPer ratio 
signal (YFP500/YFP420) provides a spatiotemporal read-out of hydrogen peroxide 
concentration in individual neutrophils at the wound site.  
3.10 Exogenous hydrogen peroxide increases HyPer ratio 
The Tg(lyz:HyPer)sh274 reporter line was made in collaboration by Katherine Henry and 
Graham Lieschke using gateway cloning (Renshaw lab unpublished). I first aimed to 
confirm that this reporter line accurately provides a read out of hydrogen peroxide 
concentration in neutrophils. I hypothesised that following the addition of exogenous 
H2O2, the OxyR domain of HyPer would detect an increase in H2O2 in the neutrophils and 
subsequently the HyPer ratio would increase.  
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To validate the function of the HyPer reporter line, 3dpf lyz:HyPer larvae were mounted 
in a 1% agarose solution and ratiometric imaging was performed as described in 
methods, focusing on the CHT region of larvae using a 40x lens (Figure 3.28A). Exogenous 
hydrogen peroxide was poured on to the top of the agarose and allowed to diffuse into 
the agarose for 5 minutes when imaging was performed again (Figure 3.28B). A 
YFP500/YFP420 ratio channel was generated and a rainbow lookup table was applied to the 
pre and post H2O2 images as described in methods. ROIs were drawn around individual 
neutrophils in the CHT and the mean intensity of the ratio channel was recorded. 
Although this experiment was only performed once, the HyPer ratio of neutrophils in the 
CHT increased following the addition of exogenous H2O2 (Figure 3.29C), demonstrating 
that the reporter is able to successfully provide a read out of H2O2 concentration in 
neutrophils.  
Due to time constraints preliminary experiments were performed to determine whether 
neutrophil swarming could be observed in lyz:HyPer larave before investigating hydrogen 
peroxide production in pioneer neutrophils. 3dpf lyz:HyPer larvae were injured by tail-fin 
transection as described in methods. HyPer imaging was performed from 30 minutes 
post injury for 4 hours. A ratio channel was generated by dividing the HyPer500 channel 
by the HyPer420 channel as described in methods. From the first experimental repeat 
neutrophil swarming was observed in one larvae. The pioneer neutrophil could be 
visualised within the first few frames of the time course (red arrow, Figure 3.29). This 
demonstrates that pioneer neutrophils can be visualised prior to swarm formation and 
that hydrogen peroxide production can be measured in these neutrophils. This tool is 
now ready for the evaluation of H2O2 concentration in neutrophils and its relationship to 








Figure 3.28: Exogenous hydrogen peroxide increases HyPer ratio 
Ratiometric imaging of the CHT region of 3dpf lyz:HyPer larvae was performed and a 
ratio channel was generated (A). Exogenous hydrogen peroxide was administered to 
larvae by incubation and left to diffuse for 5 minutes. Ratiometric imaging of the same 
region of the CHT was performed post hydrogen peroxide addition (B). The HyPer 
ratio was calculated for individual neutrophils in the CHT, which increased following 
exogenous hydrogen peroxide administration (C). (Data are shown as mean +/- sem. 








Figure 3.29: Pioneer neutrophil hydrogen peroxide concentration can 
be measured during swarm initiation 
3dpf lyz:HyPer larvae were injured ratiometric imaging was performed from 30 
minutes post injury for 4 hours and a HyPer ratio channel was generated for each time 
point. Figure shows a representative example of a pioneer neutrophil which can be 
studied during the initiation phase to determine hydrogen peroxide concentration 




3.11 Investigating pioneer cell death as a mechanism for neutrophil 
swarm initiation 
The early stages of neutrophil swarm initiation are not fully understood largely due to 
limitations in in vivo imaging and challenges in measuring intracellular molecular 
signalling. Currently the accepted paradigm is that cell death signalling by propidium 
iodide positive pioneer neutrophils initiates the first amplification stage of neutrophil 
swarming  (Kienle and Lämmermann, 2016; Lämmermann, 2015; Lämmermann et al., 2013; 
Reátegui et al., 2017). The appearance of propidium iodide positive neutrophils correlates 
with the accelerated recruitment of neutrophils to form a swarm in mice, suggesting that 
cell death by necrosis is important in swarm initiation (Lämmermann et al., 2013). 
Cell death presents with macroscopic morphological alterations which historically were 
employed to classify cell death into 3 different forms. Type 1 cell death or apoptosis is 
characterised by cytoplasmic shrinkage, chromatin condensation, nuclear 
fragmentation, and plasma membrane blebbing. Type 2 cell death or autophagy is 
characterised by extensive cytoplasmic vacuolization. Type 3 cell death or necrosis does 
not present the morphological features observed in type 1 and 2. The outcome of type 1 
and 2 cell death is phagocytic uptake and lysosomal degradation whilst the cell corpses 
following necrosis are deposited into the tissue without evidence of phagocytic removal 
(Galluzzi et al., 2007). Since 2005 the Nomenclature Committee on Cell Death (NCDD) 
have frequently updated the classification of cell death modalities based on a mixture of 
genetic, pharmacological, biochemical and functional features of cell death, rather than 
morphological features, to ensure more accurate detection of cell death (Galluzzi et al., 
2018). It is important to employ multiple, methodologically unrelated assays to quantify 
dying and dead cells, where guidelines exist to quantify and interpret cell death-related 
parameters (Galluzzi et al., 2009).  
The rounded morphology and loss of motility I have observed in swarm initiating pioneer 
neutrophils suggests that cell death may be an initiating factor of swarm formation in the 
zebrafish model.  I therefore hypothesised that a tissue context encountered by pioneer 
neutrophils at the wound site induced their death, and that cell death signals causes the 
initiation of swarm formation.  This section of work aims to use available tools to dissect 
the behaviour of pioneer neutrophils during the initiation phase of swarm formation in 
zebrafish larvae.  
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3.12 Pioneer neutrophils do not become propidium iodide positive 
during swarm initiation 
I hypothesised that pioneer neutrophils become necrotic prior to swarm formation in 
zebrafish larvae. To test this hypothesis I used the DNA intercalating agent propidium 
iodide. Propidium iodide labels intracellular RNA or DNA by intercalating between the 
bases and as a cell impermeable compound, it can only access the DNA and RNA in the 
nucleus if the plasma membrane is compromised.  
 Determining a dose of propidium iodide for live imaging 
Propidium iodide (PI) has been used to label nucleotides in fixed zebrafish tissues but no 
reports of live imaging currently exist (Okuthe, 2013; Zampolla et al., 2008). Live imaging 
of plant tissues incubated with PI has been performed for short time periods (Jones et 
al., 2016).   
To determine an appropriate dose of PI which was able to label nucleotides in zebrafish 
larvae without toxicity, a dose-response assay was performed using three concentrations 
of propidium iodide. 3dpf mpx:GFP larvae were pre-incubated with PI at concentrations 
of 1, 5 and 50 µg/ml for 30 minutes followed by tail-fin transection. Whole body images of 
larvae were taken at 6hpi to observe any obvious features of toxicity. Larvae incubated in 
1 µg/ml  PI showed no visible signs of toxicity whilst those incubated in 5 and 50µg/ml 
showed clear signs of toxicity as indicated by the appearance of propidium iodide 
positive lesions in the brain as well as dark regions of tissue (Figure 3.30). From these 
observations I was able to determine that doses of PI above 5 µg/ml were toxic to larvae 







Figure 3.30: Determining a non-toxic dose of propidium iodide for live 
imaging 
3dpf mpx:GFP larvae were pre-incubated in propidium iodide at concentrations of 1, 
5 and 50 µg/ml for 30 minutes prior to tail fin transection. Whole body images were 
taken of larvae following a 6 hour incubation in propidium iodide following tail fin 
transection. Larvae incubated in doses of 5 and 50 µg/ml showed obvious signs of 
toxicity as indicated by propidium iodide positive lesions present in the brain. This 




I next observed the ability of propidium iodide at a non-toxic dose to label cells at the 
wound site following tail-fin transection. 3dpf mpx:GFP larvae were pre incubated in 
propidium iodide (1 µg/ml) before tail-fin transection and images were taken at 30 
minutes post injury as described in methods. From these initial experiments a population 
of cells at the wound site stained positive for PI (Figure 3.31A). This is demonstrated by 
measuring the intensity through a line drawn at the wound site (Figure 3.31B), suggesting 
that propidium iodide is able to intercalate into the DNA of a population of cells at the 
wound edge which have lost their plasma membrane integrity.   
After determining a non-toxic dose of propidium iodide which was able to label a 
population of cells at the wound edge, I next aimed to observe the viability of pioneer 
neutrophils during the initiation phase.  
3dpf mpx:GFP larvae were pre-incubated in 1µg/ml PI for 20 minutes prior to injury. 
Larvae were mounted in a 1% agarose solution containing 1µg/ml PI and time lapse 
imaging was performed from 30 minutes following injury for 4 hours. Larvae with 
neutrophil swarms at the wound site were selected for further analysis. Single slice 
image analysis of the pioneer neutrophil in the initiation phase in the frame prior 
aggregation determined that there was no colocalisation of propidium iodide and GFP 
signal from the pioneer, indicating that the pioneer is not PI positive prior to swarm 
formation (Figure 3.32A-B). Single slice analysis of neutrophil swarms during the 
aggregation phase was also performed and no colocalisation was observed between GFP 
and propidium iodide (Figure 3.32C).  
These data illustrate that pioneer neutrophils have intact plasma membranes during the 
initiation phase of neutrophil swarming, suggesting that primary or secondary necrosis 






Figure 3.31: Propidium iodide labels a population of cells at the wound 
site 
3dpf mpx:GFP larvae were pre-incubated in propidium iodide at 1 µg/ml for 30 
minutes prior to tail fin transection. Images were taken of the wound site at 30 
minutes post injury. Figure shows a representative example of the population of cells 
labelled with propidium iodide observed at the wound edge (A). The red fluorescence 
intensity through a line was measured to demonstrate the intensity of propidium 






Figure 3.32: Pioneer neutrophils are not propidium iodide positive prior 
to swarm formation 
3dpf mpx:GFP larvae were pre-incubated in propidium iodide (PI) at 1 µg/ml for 30 
minutes prior to tail fin transection. Time lapse imaging was performed from 30 
minutes post injury for 4 hours and larvae with neutrophil swarms at the wound site 
were identified. Pioneer neutrophil is highlighted by white ROI during the initiation 
phase. (A). Fluorescence signals from GFP and PI in pioneer neutrophils (white ROI) 
were analysed on single z-planes to determine any overlap between fluorescence (B). 
An intensity line profile was measured through pioneer neutrophils in the frame prior 
to swarm aggregation (yellow line, B). There was no overlap in intensity from the PI 
signal (red) and the GFP pioneer neutrophil signal (green) (C). Figure shows 




3.13 Pioneer neutrophils are not undergoing caspase-3 mediated 
apoptosis prior to swarming 
After determining that in zebrafish larvae, pioneer neutrophils are not propidium iodide 
positive, I next aimed to investigate other modes of cell death which could initiate 
swarming through cell death signalling. The rounded morphology of pioneer neutrophils 
observed on average for half an hour suggests that pioneer neutrophils could be 
undergoing a programmed cell death. Caspase-3 mediated neutrophil apoptosis can be 
observed using our Tg(mpx:FRET)sh237 zebrafish line (Robertson et al., 2016). This 
zebrafish line expresses a genetically encoded FRET biosensor consisting of a caspase-3 
cleavable DEVD sequence flanked by a CFP YFP pair, under the neutrophil specific mpx 
promoter. Förster resonance energy transfer (FRET) is a distance-dependent transfer 
of energy from an excited donor fluorophore to a neighbouring acceptor fluorophore. 
Emission from the acceptor fluorophore can be detected following excitation of the 
donor fluorophore, only when the pair are within the Förster radius (Förster, 1965). The 
proximity of the CFP and YFP when flanking an intact DEVD sequence is within the Förster 
radius such that FRET occurs following excitation of the donor CFP fluorophore. Cleavage 
of the DEVD sequence by caspase-3 during apoptosis results in the proximity of the CFP 
YFP pair falling outside of the Förster radius, and a subsequent loss of FRET, providing a 
read out of caspase-3 mediated apoptosis in neutrophils. Of the numerous methods of 
performing FRET, a sensitised emission of acceptor FRET (NFRET) method was used to 
detect apoptosis in neutrophils (Xia and Liu, 2001). 
To observe neutrophil apoptosis in the context of pioneer cells initiating swarming, 3dpf 
mpx:FRET larvae were injured and FRET imaging was performed as described in 
methods. Normalised FRET (NFRET) values were calculated for each time point to 
account for bleed through and fluorophore cross talk as described in methods.  
Following the data acquisition period and generation of an NFRET channel, larvae with 
neutrophil swarms at the wound site were selected from the population for further 
investigation. Pioneer neutrophils were identified and visualised during the scouting and 
initiation phases. During these experiments, an NFRET signal was detected in all pioneer 
neutrophils during both the scouting and initiation phases (Figure 3.33).  Conversely, 
neutrophils which lost their NFRET signal did not initiate swarm formation at least in the 
observed time window (Figure 3.34).  
Together these observations demonstrate that pioneer neutrophils are not undergoing 





Figure 3.33: Pioneer neutrophils are not undergoing caspase-3 
mediated apoptosis 
3dpf mpx:FRET larvae were injured and time lapse imaging was performed from 30 
minutes post injury for 5 hours. Time courses containing neutrophil swarms were 
selected for analysis and a normalised FRET (NFRET) channel was created for every 
time point. Figure shows a representative example of a pioneer neutrophil during the 
scouting and initiation phases (white arrow) with its NFRET signal intact. This was 
observed in 100% of neutrophil swarm initiation events. Figure shows representative 






Figure 3.34: Neutrophils which lose their NFRET signal do not initiate 
swarming 
3dpf mpx:FRET larvae were injured and time lapse imaging was performed from 30 
minutes post injury for 5 hours. Time courses containing neutrophil swarms were 
selected for analysis and a normalised FRET (NFRET) channel was created for every 
time point. Figure shows a representative example of a neutrophil at the wound site 
losing its NFRET signal at 4hpi. No directed migration to this neutrophil was observed 
following loss of NFRET, at least in the time period observed Figure shows 







3.14 A neutrophil specific histone2a reporter to visualise neutrophil 
extracellular trap formation  
Recently neutrophil extracellular trap formation has been implicated in neutrophil 
swarming in response to aluminium hydroxide injection (Stephen et al., 2017).  I 
hypothesised that cell death by NETosis could provide the chemoattractant signals 
required to initiate neutrophil swarming. In vivo imaging of NETs has not been performed 
extensively, so to test this hypothesis I generated a reporter of NETosis.  
To observe extracellular trap formation by neutrophils, I have generated a transgenic line 
expressing an mCherry tagged histone 2a construct (made by Dr. Katherine Henry using 
gateway cloning) under the neutrophil specific lyz promoter. The construct was 
prepared by transformation from plasmid DNA followed by DNA purification steps as 
described in methods, prior to injection into larvae. I injected the construct into the 
mpx:GFP background and raised larvae to adulthood from the F2 generation to  produce 
a stable line in a neutrophil reporter background as described in methods.  
The stable line is currently growing up for experiments on the F2 generation in the future. 
Preliminary observations of larvae from the F1 generation were performed. 3dpf 
lyz:histone2a.mCherry larvae from the F1 generation were imaged in the CHT region as 
described in methods. The histone2a.mCherry transgene was found within neutrophils 
in the CHT of larvae, (Figure 3.35). Tail-fin transection of 3dpf F1 lyz:histone2a.mCherry 
larvae was performed and recruitment of double labelled neutrophils to the tail-fin was 
observed in all larvae imaged (Figure 3.36, Movie 3.13). These initial observations suggest 
that the Tg(lyz:histone2a.mCherry) line will be useful for visualising NETosis in vivo in real 
time, where the histone localisation in pioneer neutrophils will be studied during the 








Figure 3.35: A histone2a.mCherry constructs labels the nucleus of 
neutrophils 
A histone2a.mcherry construct was injected into mpx:GFP embryos at the 1 cell stage. 
Larvae were screened for double positive expression of both transgenes in the CHT 
at 3dpf. F0 larvae were grown to adulthood and founders which transmitted the 
transgene to their gametes were identified by the presence of offspring with double 
labelling in the CHT. These F1 offspring are being raised to adulthood. Figure shows a 
representative image taken of the CHT region in 3dpf larvae from the F1 generation. 






Figure 3.36: Histone.mCherry labelled neutrophls recruit to 
inflammatory sites 
A histone2a.mcherry construct was injected into mpx:GFP embryos at the 1 cell stage. 
Larvae were screened for double positive expression of both transgenes in the CHT 
at 3dpf. F0 larvae were grown to adulthood and founders which transmitted the 
transgene to their gametes were identified by the presence of offspring with double 
labelling in the CHT. These F1 offspring are being raised to adulthood. Preliminary 
investigations were performed on F1 offspring, which were injured at 3dpf. Neutrophil 
recruitment to the wound site was observed at 2hpi in all larvae (n=4 larvae from one 
experimental repeat).  
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3.15 Conclusions and chapter discussion 
In this chapter I have described a novel neutrophil behaviour which has not been 
previously reported in response to tissue injury in zebrafish. By studying the migratory 
behaviours of neutrophils at sites of inflammation, I have characterised the neutrophil 
swarming response. Here, I demonstrate that neutrophil swarming in zebrafish shares 
characteristic features with the swarming response reported in human and murine 
neutrophils. I have identified that neutrophil swarming in zebrafish is initiated by an 
individual ‘pioneer’ neutrophil which exhibits non-characteristic behaviour at the wound 
site. My work has begun to dissect the cell death signalling mechanisms previously 
reported to initiate the swarming response. I have identified that, contrary to evidence 
in murine models, neutrophil swarming in zebrafish is not initiated by propidium iodide 
positive cells. I have investigated alternative cell death pathways which could be involved 
in neutrophil swarm initiation and have collaboratively generated a new tool to visualise 
NETosis in vivo in real-time. I have provided the first evidence of neutrophil swarming in 
an endogenous and physiologically relevant model, where neutrophils are attracted to 
chemoattractants released at the wound site but migrate towards additional 
chemoattractants to form swarms at the wound site. Most notably the zebrafish provides 
a new and exciting platform to study the initiation of the swarming response which thus 





 Neutrophil swarming is observed at the wound site in zebrafish larvae 
The swarming response has been studied in only a handful of reports thus far. Early 
reports of neutrophil cluster formation identified a multi-phase response leading to the 
aggregation of neutrophils at sites of infection (Chtanova et al., 2008; Peters et al., 2008), 
focal tissue injury (Lämmermann et al., 2013), and in vitro around zymosan coated beads 
(Reátegui et al., 2017). These studies identify that neutrophil swarming is a recognised 
phenomenon which is conserved between species. Neutrophil swarming can be studied 
using many systems and models, however more physiologically relevant models are 
required to characterise all aspects of this novel neutrophil behaviour.  
The zebrafish immune system shares many features with the mammalian immune 
system, and the response of neutrophils to tissue injury induced by tail-fin transection of 
larvae has similar kinetics to that reported in mammalian inflammatory response 
(Renshaw and Loynes, 2006). Analysis of neutrophil number at the wound site has been 
used as an assay to study inflammation by many research groups and accurately provides 
a read-out of the neutrophilic component of the inflammatory response to tissue injury 
(de Oliveira et al., 2013; Renshaw and Loynes, 2006; Tauzin et al., 2014). This inflammatory 
response can be manipulated pharmacologically and genetically to dissect the 
mechanisms governing neutrophil migration to and removal  from the wound site (Elks 
et al., 2011; Powell et al., 2017; Robertson et al., 2014). Tail-fin wounding of zebrafish larvae 
using scalpel blades has been used as a method to induce an inflammatory response by 
many research groups within the zebrafish community (de Oliveira et al., 2013; Elks et al., 
2011; Renshaw and Loynes, 2006). Performing a time course to quantify the neutrophilic 
inflammatory response to tail-fin transection identified that the response induced in my 
assays is consistent to published reports from our group (Renshaw and Loynes, 2006). 
These data demonstrate that, in keeping with published reports, neutrophil recruitment 
can be studied within the first 6 hours following tail-fin transection in zebrafish larvae.  
Neutrophil swarming, in response to non-sterile tissue injury, has not been reported in 
zebrafish larvae. This study provides the first evidence of endogenous neutrophil 
aggregates at the wound site during the recruitment phase, which were  reminiscent of 
those reported at site of focal tissue damage and infection in mice and zebrafish 
(Chtanova et al., 2008; Lämmermann et al., 2013). Caution was taken before referring to 
this behaviour as neutrophil swarming, since there currently exist no guidelines to 
accurately define neutrophil swarms. Neutrophil swarms are currently recognised by the 
field as the formation of large neutrophil aggregates which form following stages of highly 
directed neutrophil recruitment.  
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 Characterisation of the neutrophil swarming response in zebrafish larvae 
Initial attempts to characterise neutrophil swarming using quantifiable parameters 
identified that swarming is an incredibly dynamic process which varies between larvae. I 
developed an assay based on a feature common to all swarms.  I was able to identify 
larvae where neutrophil swarming behaviour occurred at the wound site from time 
courses, based on the area of neutrophils detected at the wound site. This work provides 
a non-biased read out of neutrophil swarming at the wound site and could be used in 
future experiments as a robust method to detect swarming behaviour within a 
population of larvae.   
 Multiple swarms can form at the wound site and neutrophils migrate 
between competing swarms 
Due to the limited number of studies of neutrophil swarming, there currently exists no 
evidence to describe the number of neutrophil swarms which can form at an injury site. 
The experiments performed in this chapter identify that, whilst swarming is not seen in 
all larvae, in those where it does occur, swarms can be observed in multiple regions of 
the tail-fin at one time. My data provides insight into the migratory behaviours of 
neutrophils which participate in individual swarms in specific tissue contexts within one 
wound site, and illustrates that the tissue context required to initiate a swarm can occur 
at multiple locations in one tail-fin.  
There currently exists no primary in vivo evidence of neutrophils migrating between 
competing neutrophil swarms, however it is suggested that this is a commonly observed 
phenomenon based on unpublished findings (Lämmermann, 2015). In vitro human 
neutrophils migrate between competing swarms when they occur within close enough 
proximity (Reátegui et al., 2017). The observation that neutrophils migrate between 
competing swarms at the tail-fin region in zebrafish larvae provides the first primary in 
vivo evidence that neutrophils migrate between competing gradients generated by 
neutrophil swarms. This is interesting because it illustrates that these neutrophils are 
able to detect and prioritise additional gradients from a new source. I propose that for 
this to happen the signalling pathways which maintain neutrophils in their initial clusters 
must become interrupted. This could be due to cell desensitisation by chemokine 
receptor downregulation, a reduction in the production of the attractants maintaining 
neutrophils in clusters, or downregulation of integrin receptor expression. On the 
contrary neutrophil migration between swarms could occur as a result of random 
neutrophil migration.  These observations also suggest that the swarming response I 
observed in zebrafish shared features of that observed in mice. The conservation of 
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these neutrophil migratory behaviours between different species and models suggests a 
degree of conservation across species and evolution.  
 Swarms form at different tail-fin injuries 
This size of the initial tissue damage is proposed to be a factor which shapes the 
neutrophil swarming response although this has not been experimentally confirmed 
(Kienle and Lämmermann, 2016). I demonstrated using a variety of tail-fin transection 
methods, that neutrophil swarms form at all inflammatory sites regardless of the 
initiating stimulus. Unfortunately, due to time constraints I did not manage to quantify 
the frequency with which neutrophil swarms were observed in response to these 
different tissue injuries. This would be interesting to do in future to determine whether 
the size of the inflammatory stimulus contributes to the frequency with which swarms 
are observed within a population, or the phenotype of the swarming response.  
 Dynamics of neutrophil swarming in zebrafish larvae  
The studies that have addressed the sequential stages of neutrophil swarming at sites of 
sterile tissue injury have identified a common multistep attraction cascade. First is the 
initial chemotaxis of neutrophils close to the damage (scouting), followed by the 
amplified chemotaxis of neutrophils distal to the wound site (amplification), leading to 
neutrophil clustering (stabilisation) (Ng et al., 2011). More recently, this has been adapted 
to the five-stage model currently accepted in the field, which describes the initiation of 
swarming through, 1st tissue injury, and 2nd, signal amplification by cell death. This is 
followed by a 3rd stage of amplification through intercellular LTB4 relay signalling between 
neutrophils. The remodelling of tissue underlying the aggregating swarm occurs during 
the 4th phase, and the 5th stage describes swarm resolution (Lämmermann et al., 2013). 
These sequential phases describe neutrophil swarming in intravenous/ intradermal 
neutrophil transfer models, however these assays circumvent the recruitment of 
endogenous neutrophils from the circulation and do not demonstrate the neutrophil 
swarming response in a truly physiological setting. Endogenous neutrophil recruitment 
to swarms has been observed in mice, however the precise phases of this response have 
not been described (Ng et al., 2011). Further studies are required to study the sequential 
phases of the endogenous neutrophil swarming response in more physiological settings. 
By imaging neutrophil recruitment to tail-fin transection in zebrafish larvae I identified 
the migration of endogenous neutrophils to the wound site resulting, in some cases, in 
the formation of neutrophil clusters.   
Neutrophil migration to the wound site occurred in distinct stages, which appear to be 
comparable in some respects to the phases described in mouse models (Ng et al., 2011). 
I observed the initial recruitment of few neutrophils from the hematopoietic niche which 
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I termed the scouting phase, based on the migration of a few neutrophils proximal to the 
wound site which switch from random motility to chemotactic movement towards the 
wound within minutes (Lämmermann, 2015; Ng et al., 2011). The initiation of swarms by 
pioneer neutrophils is a novel finding which is perhaps similar in function to the first wave 
of amplification by cell death reported in the mouse model (Lämmermann, 2015). During 
this stage the migratory behaviours of the neutrophil population as a whole may not 
change, but the behaviour of the swarm initiating pioneer neutrophil is markedly altered 
at the wound site. I propose that the initiation stage is a key component of the swarming 
response and the zebrafish is a good model to study this stage because it can be 
visualised in its entirety in high resolution. I next observed the migration of neutrophils 
to form neutrophil clusters which I termed the aggregation phase, due to the presence 
of aggregating neutrophils and the similarities of this phase to the aggregation phase 
reported in mice. The aggregation phase in zebrafish encapsulates the amplified 
recruitment of neutrophils to the wound site as well as their aggregation in clusters. 
These stages are summarised in Figure 3.37, where I have speculated on the potential 







Figure 3.37 Graphical schematic of the neutrophil swarming response 
in zebrafish 
Proposed schematic of the swarming response based on the migratory behaviours of 
neutrophils observed in response to tail fin transection. Following tail fin transection 
neutrophils proximal to the wound site migrate towards wound-derived 
chemoattractants. Swarms are initiated by ‘pioneer’ neutrophils which change 
behaviour at the wound site. These pioneer neutrophils release additional gradients 
which attract neutrophils, resulting in the directed migration of a population of 
neutrophils to the pioneer neutrophil. These neutrophils aggregate at the wound site 




In the zebrafish, it is not clear whether these stages can be distinguished as I have thus 
far not identified measurable parameters. In mice the amplification phase is 
distinguished by a second ‘wave’ of neutrophil migration which can be clearly identified 
when looking at the neutrophil tracks (Lämmermann et al., 2013). Tracking of the 
migration of the whole population of neutrophils in the tail-fin may be useful to determine 
whether a similar migratory signature could be identified within the aggregation phase.  
In terms of the molecular signals which govern neutrophil swarming in zebrafish, I have 
not yet investigated the role of LTB4 in relay signaling during the aggregation phase. The 
limitations of studying the endogenous neutrophil swarming response mean that 
inhibition of signaling molecules involved in the early recruitment of neutrophils is not 
possible using this model. Attempts during this study to inhibit the LTB4 receptors were 
performed (data not shown), however the global effect of LTB4 inhibition using BLT1 and 
2 inhibitors was the reduction in neutrophil recruitment to the wound site in general, 
such that the scouting phase was affected and the initiation and aggregation phases could 
not be studied. This problem is circumvented in the mouse model where neutrophils are 
directly injected into the ear pinna of mice, such that neutrophil extravasation and early 
recruitment are bypassed. In future the role for LTB4 relay signaling in modulating the 
swarming response in zebrafish should be investigated. Administration of BLT1 and BLT2 
inhibitors to larvae where a swarming response has already been established should be 
performed, and using the assays to quantify swarm phenotype or tracking of the whole 
neutrophil population in the tail-fin, determine if inhibition of LTB4 signaling could affect 
the aggregation phase. 
I propose that if I had visualised neutrophil swarming during the resolution phase of 
inflammation, swarm resolution could be studied. This would be interesting to for future 
experiments to elucidate some of the mechanisms which govern neutrophil stability in 
clusters, some of which have been suggested based on in vitro findings (Reátegui et al., 
2017).  CRISPRi technology would be useful to dissect some of the mechanisms of swarm 
resolution by knocking out receptors of interest specifically in neutrophils.  
I took advantage of the resolution available when imaging neutrophil recruitment to tail-
fin injury, to track the behaviour of swarm-initiating-pioneer-neutrophils and compare 
their behaviour to neutrophils migrating within the same tissue microenvironment 
during the same period. These data demonstrate that swarm-initiating pioneer 
neutrophils at the wound site have reduced motility and a rounded morphology 
compared to the neutrophils which do not initiate swarms. I confirmed that this was a 
phenotype specific to swarm initiating neutrophils, which migrate to the wound site with 
similar behaviour to non-pioneer neutrophils. The limitations of these experiments are 
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the low number of pioneer neutrophils observed which make statistical analysis 
challenging. I propose that the difference in pioneer neutrophil migratory behaviours is 
striking, such that the few examples I have are statistically significant. 
I performed power calculations for each set of tracking experiments to determine if the 
data I generated has statistical power (summarised in table 3.1).  
For experiments in figure 3.18 where the difference between neutrophil behaviours is 
very small, the number of repeats required to see a significant difference is not 
biologically plausible. I therefore propose that the difference is small and not different. 
For figure 3.16 I propose that my experiments are underpowered and that it will be worth 
repeating these experiments up get n numbers to around 15, which would be enough for 
80% confidence. For experiments in figures 3.17 where the difference is large, an n of 5 
is enough to be 90% confident for speed and displacement, although to see significance 
in meandering index I could repeat the experiment a few more times. I conclude that 
repeating the experiments so that I have 10 pioneer neutrophils would enable to me to 
be 90% confident whilst being plausible in terms of repeating experiments. 
Experiment Parameters N number 





Figure 3.15  
Meandering index 36 49 
Speed 17 23 
Displacement 7 10 
Circularity index 9 12 
Figure 3.16 
Meandering index 12 16 
Speed 15 20 
Displacement 155 212 
Figure 3.17 
Meandering index 6 9 
Speed 3 4 
Displacement 2 3 
Figure 3.18 
Meandering index 271 371 
Speed 54 73 
Displacement 77 105 
Table 3.1 Power calculations for tracking experiments.  
The equation n= 2 x  k x (d2/sd2) where n= number of experiments, d= 
difference and sd=  standard deviation was used to calculate the  number  





Together my work investigating the dynamics of neutrophil swarming in the zebrafish 
model has identified that swarming occurs in a multi-step cascade which is similar in 
parts to that described in other models. I have identified that the zebrafish can be used 
as a model to study the early initiation of neutrophil swarming, which has thus far not 
been possible due to limitations in the mouse models used to study swarming. This is 
promising for determining the factors which govern neutrophil swarm initiation using 
the zebrafish model. 
 How often do neutrophils swarm at the wound site? 
The most recent review of neutrophil swarming: “Neutrophil swarming: an essential 
process of the tissue response” implies that the swarming response is an essential 
requisite of the neutrophil response to tissue injury (Kienle and Lämmermann, 2016). I 
propose that making this claim based on few studies of the swarming response in models 
with severe limitations is a good example of ‘the problem of extrapolation in basic 
research’ (Baetu, 2016). It is assumed from the published studies that neutrophil swarms 
are observed in 100% of tissue injuries or infections, although the data do not exist to 
confirm otherwise. The models used to study the swarming response share a common 
feature: the inflammatory stimuli (focal tissue damage, zymosan bead, pathogen for 
example) generates chemotactic gradients from a focal point. Chemoattractants 
released from these focal points diverge outwards from a common centre, producing a 
gradient which diffuses outwards radially from the source. In these models the 
secondary gradients produced by neutrophils diffuse with the same spatial dynamics as 
primary gradients released at the inflammatory source. Perhaps, in these models, the 
release of a combination of gradients from the same focal centre may promote the 
formation of neutrophil swarms. Whilst there are some physiological settings in which 
chemotactic gradients would diverge from a focal point (insect bite, pathogenic 
infection) the need to study swarming in a model where neutrophils encounter 
chemotactic gradients from multiple sources is required. The experiments I performed 
have provided the first study into the frequency with which endogenous neutrophil 
swarming is observed at a linear wound where chemotactic gradients diffuse into the 
tissue along the length of the entire wound edge. Interestingly, neutrophil swarms were 
only observed in a proportion of larvae. I propose that the swarming response is only 
observed in a proportion of larvae due to the competing gradients released along the 
linear wound edge. These assays are not performed in sterile conditions so the intrusion 
of pathogens into the tissue at the wound site is also a possibility, where pathogen 
derived chemoattractant gradients could induce the swarming response. Perhaps the 
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precise tissue context required for neutrophils to swarm depends on spatial distribution 
of the complex array of primary and secondary chemotactic gradients produced at the 
wound site.  Here, I provide evidence that endogenous neutrophil swarming in a 
physiological setting is only observed in a population of larvae, suggesting that contrary 
to current claims, the neutrophil swarming response is a dispensable component of the 
inflammatory response.  
 Quantification of swarm phenotypes  
Large dense neutrophil clusters consisting of hundreds to thousands of neutrophils have 
been observed at a site of focal tissue injury (Lämmermann et al., 2013), whilst smaller 
clusters persisting for less time have been reported at sites of pathogenic infection 
(Chtanova et al., 2008; Lämmermann et al., 2013; Peters et al., 2008). It is proposed based 
on these observations that large persistent neutrophil swarms form at sites of tissue 
damage whereas smaller more transient neutrophil swarms form in response to diffuse 
pathogens distributed in tissues (Kienle and Lämmermann, 2016). Arguably, it is difficult 
from the evidence provided to determine whether this is correct. The differences in 
experimental settings and models these swarm phenotypes have been observed in mean 
that this hypothesis has not been tested under experimentally controlled conditions. 
Whilst this is the case, the hypothesis that transient swarms form at sites of diffuse 
pathogens in tissues and persistent swarms form at sites of large tissue damage is 
sensible. My experiments provide examples of both persistent and transient swarming 
phenotypes using the same experimental conditions. Whilst I observed both persistent 
and swarm phenotypes during my experiments, the frequency with which transient 
swarms occurred was incredibly low, suggesting that perhaps sites of injury are more 
likely to induce persisting neutrophil swarms. The experiments in this study were not 
performed under sterile conditions, so I propose that the transient swarms observed at 
the wound site could be induced by pathogens which have infiltrated the tissue, whilst 
persistent swarms could be induced by local host generated gradients at the wound site, 
in keeping with the suggestions from the literature. Further studies to increase the 
number of larvae imaged and the number of transient swarms observed would be useful 
to gain more insight into the frequency with which the two phenotypes occurred within 
a larger population. I propose that the zebrafish could be a tractable model to study 
neutrophil swarming in a dual model of injury and infection to investigate the swarm 
phenotypes observed in response to infection and tissue injury in the same experimental 
conditions (Ellett et al., 2015).  
Assays to measure the area of neutrophil swarms and the number of neutrophils in a 
swarm have been used as measurable parameters to study swarm phenotype (Ng et al., 
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2011; Reátegui et al., 2017). I propose that the zebrafish may provide an excellent tool to 
elucidate the mechanisms governing the aggregation and resolution of swarms in future. 
These studies require an assay to quantify swarming phenotype during the aggregation 
phase, so I attempted to measure the parameters measured in vitro in the zebrafish 
model. The phenotype of the swarms observed in my experiments were comparable to 
those reported in vitro (Reátegui et al., 2017). These assays provide some of the first 
examples of methods to measure the endogenous swarming response in vivo. In terms 
of future work, I propose that of these methods to quantify swarm phenotypes, swarm 
area could be an accurate assay for use in experiments to study factors which may 
regulate the aggregation and resolution phases of swarming.  
 Investigating the spatio-temporal dynamics of the swarming response 
The spatio-temporal dynamics of neutrophil swarming  in mouse models are not 
representative of a physiological swarming response, as these assays circumvent the 
initial recruitment of endogenous neutrophils from the blood stream (Lämmermann et 
al., 2013). I investigated the temporal component of neutrophil swarming to determine 
how long following tissue injury the swarming response occurs, providing one of the first 
reports of the temporal dynamics of swarming in vivo. My data show that swarming is 
variable in timings between larvae, although the majority of swarms form within the first 
2 hours following injury. These findings suggest that the tissue context required to induce 
swarms in the majority of cases occurs relatively rapidly following injury. From these 
experiments I proposed that tissue factors released at the beginning of the inflammatory 
response were responsible for initiating swarms. The identification that neutrophils 
could initiate a swarm later on in the inflammatory response provides evidence that the 
tissue context required for swarming can occur later in the inflammatory response. In 
future I would like to study the aggregation phase to determine how long neutrophil 
swarms persist for at the wound site, something which was not possible to do from the 
experiments reported in this chapter due to the length of the time courses.  
Evidence from the literature as well as my own findings suggest that tissue context is a 
factor which determines whether neutrophils swarm at inflammatory sites (Kienle and 
Lämmermann, 2016). I sought to determine whether there was a common tissue location 
in which pioneer neutrophils underwent their phenotypic switch prior to the aggregation 
of neutrophils. My data demonstrates that neutrophil swarming is initiated within a small 
region close to the wound edge, providing evidence to suggest that the tissue 
environment within this region at the wound edge provides the context needed for 
swarm initiation. This is the first data to illustrate the spatial aspect of endogenous 
neutrophil swarming in relation to the wound edge and provides the first description of 
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the position where neutrophil swarms form. Together these investigations provide 
spatio-temporal information about the swarming response and suggest that a tissue 
context within 50µm of the wound edge, which is generated within 2 hours following 
injury, is important in swarm initiation. Based on this spatio-temporal evidence, I propose 
pioneer neutrophils encounter an unfavourable environment at the wound site which 
induces a cell death programme. Cell death signalling could then amplify the recruitment 
of the first neutrophils to form a swarm followed by the rapid influx of many more 
neutrophils. 
The recruitment of immune cells to inflammatory sites in zebrafish is modulated by the 
establishment of a variety of signal gradients by cells at the wound site (Medzhitov, 
2008).  Following tail-fin transection in zebrafish larvae a hydrogen peroxide gradient is 
produced by epithelial cells at the wound site within minutes following injury. This 
gradient diffuses up to 200µm into the tail-fin epithelium, peaking in concentration at 
around 20 minutes post injury and persisting for over 99 minutes post injury 
(Niethammer et al., 2009a). Hydrogen peroxide induces programmed cell death in 
eosinophils (Reis et al., 2015) as well as programmed and necrotic cell death in human 
retinal pigment epithelial cell lines (Kim et al., 2003).  
Ratiometric imaging is used to measure H202 concentration at the wound edge using a 
genetically encoded biosensor, HyPer (Niethammer et al., 2009). Our group developed a 
transgenic zebrafish line using gateway cloning to drive HyPer under the lyz promoter, 
such that the expression was constrained to neutrophils (Renshaw group, unpublished). 
HyPer eliminates some of the issues associated with using chemically synthesised 
sensitive fluorescent dyes to measure hydrogen peroxide production (Pase et al., 2012). 
Using ratiometric imaging to measure H202 concentration provides an internally 
controlled parameter which is normalised to artefacts such as uneven protein 
concentrations in the cell, tissue thickness and cell movement. I demonstrated that the 
HyPer reporter line detected changes in hydrogen peroxide concentration. Due to time 
constraints, these experiments were performed only once as proof-of-principle, so in 
future I would like to repeat these experiments to generate sufficient data to perform 
statistical analysis. It would also be important to negatively control this experiment by 
inhibiting hydrogen peroxide production to determine if the HyPer ratio could also be 
reduced. The enzyme dual oxidase (duox) enzyme catalyses hydrogen peroxide 
production in zebrafish, so it would be interesting to repeat these experiments alongside 
a chemical inhibitor of duox, such as DPI (Niethammer et al., 2009b). Additional control 
experiments to determine that changes in HyPer ratio are attributed only to fluctuations 
in H202 concentration and not variation in light intensity from the source to the camera, 
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or induced by microscopy, will also be performed as recommended (Pase et al., 2012). I 
performed preliminary tail-fin transection experiments where I observed neutrophil 
swarms at the wound site, and generated a protocol for ratiometric imaging of HyPer in 
neutrophils.  The next step is to visualise the recruitment of pioneer and non-pioneer 
neutrophils in lyz:HyPer larvae.   
Hydrogen peroxide readily diffuses in tissues and can cross cell membranes, meaning 
that HyPer senses both intracellular production of H202 as well as extracellular H202 which 
has diffused into the neutrophil. This may make the source of hydrogen peroxide 
detected by HyPer difficult to determine. Perhaps it would be useful to combine data 
using the lyz:HyPer reporter with experiments using  ubiquitously expressed HyPer 
(Niethammer et al., 2009b) to observe the tissue scale gradient of hydrogen peroxide at 
the precise location at the wound site where pioneer neutrophils change their 
morphology. In future these experiments using HyPer will provide valuable insight into 
the role of hydrogen peroxide concentration in swarm initiation.  
3.16 Investigating cell death in the context of swarm initiation 
The functional dissection of the early signals which modulate early recruitment of 
neutrophils is technically challenging in mice models. Following tissue injury in the ear 
dermis of mice, neutrophils close to the injury site migrate towards chemotactic factors 
released at the wound site. The death of a few neutrophils at the damage site in mice 
correlates with the second wave of neutrophil recruitment, although other tissue events 
cannot be ruled out (Lämmermann et al., 2013). Based on this evidence, I hypothesised 
that pioneer neutrophils would become propidium iodide positive at the wound site 
prior to swarm formation.  
 Pioneer neutrophils are not propidium iodide positive  
There are no reports, to the author’s knowledge, where propidium iodide has been used 
in vivo for periods of live imaging. I developed a method for in vivo imaging of propidium 
iodide in zebrafish larvae, which is useful for the zebrafish research community. I 
determined an appropriate dose to use for time lapse imaging of zebrafish based on the 
concentration used for imaging of fixed tissue in zebrafish larvae (Okuthe, 2013). This 
dose labelled cells at the wound edge without inducing signs of toxicity after a 6 hours 
incubation. Based on the extensive work I performed observing neutrophil recruitment 
to the tail-fin in zebrafish larvae, recruitment to the wound site appeared to be reduced 
in larvae following propidium iodide incubation, although I did not confirm this 
observation experimentally. Consequently, I observed relatively few neutrophil swarms 
during these assays. Of the neutrophil swarms which I did observe, 100% of pioneer 
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neutrophils were not labelled with propidium iodide. I confirmed that propidium iodide 
was able to label cells in the tail-fin, as cells deeper into the tail-fin tissue were positively 
labelled with propidium iodide.  In future it would be useful to repeat these assays using 
a second cell-viability stain such as SYTO probes which may be more appropriate for live 
imaging of zebrafish larvae (Wlodkowic et al., 2009).   
This striking observation is potentially exciting as it challenges the current hypothesis 
that propidium iodide positive pioneer neutrophils induce the first amplification stage of 
the swarming response (Lämmermann et al., 2013). Further work to confirm these 
findings in other systems is required. It cannot be ruled out that neutrophil swarms in 
zebrafish are initiated by different tissue factors than those in mice, although I propose 
that the limitations associated with the mouse models of swarming mean that swarm 
initiation is not fully understood in any context. Perhaps the advantages of the zebrafish 
model could provide a novel insight into swarm initiation and identify the precise 
mechanisms which govern neutrophil swarming. 
 Pioneer neutrophils are not undergoing caspase-3 mediated apoptosis 
The morphological changes of pioneer neutrophils prior to neutrophil swarming suggest 
that a programmed cell death mechanism initiates the neutrophil swarming response. 
Apoptotic cells release soluble “find me” signals which attract phagocytes to the site of 
cell death within a tissue (Gregory, 2009). I hypothesised that caspase-3 mediated 
apoptosis could contribute to the morphological features observed in pioneer 
neutrophils, and the release of soluble mediators by these cells could provide the cell 
death signals which are proposed to initiate the swarming response.  
I utilised the tools available to study programmed cell death in zebrafish larvae. A 
transgenic zebrafish reporter to study caspase-3 mediated apoptosis has been 
developed for use in in vivo imaging of neutrophil apoptosis during the inflammatory 
response (Robertson et al., 2016). There are important factors to consider when using 
fluorescent proteins for FRET studies. The use of FRET pairs with spectrally overlapping 
properties has drawbacks including the reciprocal excitation of both donor and acceptor 
fluorophores by the excitation wavelength of the other fluorophore, as well as the bleed-
through of fluorescence emission between channels. There are multiple methods to 
obtain a true FRET signal. The NFRET method of FRET calculates a normalised FRET value 
by considering the contribution of fluorophore background and bleed through in FRET 
channel emission, as well as reciprocal cross talk of the fluorophores and local 
concentration of the fluorophore (Xia and Liu, 2001). Imaging of a HeLa cells transfected 
with CFP or YFP alone enabled the calculation of FRET constants which contributed to 
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the NFRET value to correct for bleed through and cross talk of the overlapping 
fluorophores. From my experiments it was clear that pioneer neutrophils did not lose 
their NFRET signal at any point prior to swarm aggregation. Furthermore, apoptotic 
neutrophils observed during these experiments did not initiate neutrophil swarming. 
Pioneer neutrophils may become apoptotic during the aggregation phase, however once 
neutrophils have begun to aggregate it is not possible to observe individual neutrophils 
within the swarm. The limitations associated with the imaging speed of larvae in these 
experiments due to the acquisition of all channels required for FRET, result in the imaging 
of only a handful of larvae per experimental repeat. Again, this results in a low number of 
neutrophil swarms observed per experimental repeat which means that I have only a few 
examples of pioneer neutrophils. In future I will repeat these experiments to increase the 
number of examples, as well as perhaps developing a quantitative assay to measure FRET 
signal in pioneer vs non-pioneer neutrophils during the swarm initiation phase. I would 
ideally like to confirm these observations using a second method. It is important to 
employ multiple, methodologically unrelated assays to quantify dying and dead cells, so 
in future I would like to confirm my observations using an Annexin V transgenic reporter 
line  which has been used for live imaging of apoptotic cells in zebrafish (van Ham et al., 
2010).  
3.17 Future work and conclusions 
This study provides one of the first examples of the swarming response of endogenous 
neutrophils in a physiological setting. The study of neutrophil migration at the wound site 
in zebrafish larvae has provided valuable insight into the characteristic features of the 
endogenous neutrophil swarming response. Perhaps the most important observation 
was that the signal amplification reported to initiate the swarming response originates 
from one individual ‘pioneer’ neutrophil. I identified that the zebrafish is a tractable 
model to study pioneer neutrophils in the context of swarm initiation and began 
investigations into the cell death signalling which could initiate the swarming response.  
Investigations into pioneer neutrophil behaviour from this study have thus far not 
identified a mechanism of cell death which induces neutrophil swarming. The assays 
performed during this study suggest that pioneer neutrophils are not propidium iodide 
positive, and still have intact caspase-3 prior to swarm formation. This to some extent 
rules out caspase-3 mediated apoptosis and primary or secondary necrosis as initiators 
of swarming, although it would be useful to confirm these findings using further 
unrelated assays.  I will continue to investigate cell death as a mechanism of swarm 
induction. I have in collaboration with others, developed a transgenic zebrafish reporter 
line to study extracellular trap formation in neutrophils, to begin to address the 
145 
 
hypothesis that pioneer cell death by NETosis induces neutrophil swarm formation. This 
is exciting as live imaging of neutrophil ETosis has not been reported to date, so this is a 
promising tool which can be used by the zebrafish community to understand NET 
formation in vivo in the context of tissue injury or infection. In future the role of cell death 
subroutines including pyroptosis, necroptosis, autophagy and senescence should be 







4 Elucidating the mechanisms governing neutrophil 
reverse migration 
4.1 Introduction and aims 
Chronic inflammation plays a role in many of the leading causes of death worldwide 
(“WHO | The top 10 causes of death,” 2017). Of these diseases, the unregulated behaviour 
of neutrophils is a major contributor to disease pathogenesis (Wright et al., 2010). 
However there currently exists no therapies to target the neutrophilic component of 
chronic inflammatory diseases. 
Neutrophils are removed from inflammatory sites by caspase-dependent neutrophil 
apoptosis followed by efferocytosis by macrophages. Through extensive studies, 
methods to both accelerate and delay apoptosis have been identified (Fox et al., 2010; 
Renshaw and Loynes, 2006). More recently reverse migration has been identified in 
multiple models as a mechanism by which neutrophils redistribute into the tissue 
surrounding the inflammatory site, a process which is thought to disperse the 
inflammatory burden to promote tissue healing (Nourshargh et al., 2016). Further 
understanding of the mechanisms which modulate neutrophil reverse migration may 
identify novel targets to treat chronic inflammatory diseases.  
This work in this chapter is focussed on understanding the mechanisms which modulate 
neutrophil reverse migration using the zebrafish as a model to study neutrophil removal 
form wound sites. During this chapter I will investigate the hypothesis that neutrophil 
retention signals generated through G protein coupled receptor signalling are 
responsible for retaining neutrophils at inflammatory sites, and that desensitisation of 
neutrophils to these retention signals results in their reverse migration. Of the GPCRs 
receptors expressed on the surface of neutrophils, I will investigate the candidate 
receptor CXCR4 and its ligand CXCL12  and the role of this signalling axis in modulating 
neutrophil retention at wound sites. 
The  CXCR4 receptor (also known as LESTR/fusin/ cd184) and its ligand CXCL12 (also 
known as stromal derived factor  SDF-1 or pre B cell stimulating factor/ PBSF) were first 
identified through the discovery that CXCR4 was a co-receptor for entry of X4 trophic 
strains of HIV entry into T-cells (Deng et al., 1996). CXCR4 is expressed developmentally 
in a broad range of cells of the immune and central nervous system, and mediates the 
migration of leukocytes and haematopoietic progenitors in response to its ligand, 
CXCL12 (Zou et al., 1998).  
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CXCL12 is a small cytokine belonging to the α-chemokine family, which mediates the 
migration of cells expressing high levels of CXCR4 including hematopoietic progenitors 
in bone marrow, B cells and primordial germ cells (PGCs). Signalling through the 
CXCR4/CXCL12 axis therefore regulates the function of many processes including stem 
cell trafficking (Aiuti et al., 1997), B-cell development and compartmentalisation (Nie et 
al., 2004)  and primordial germ cell migration (Doitsidou et al., 2002). CXCL12 also binds 
to the CXCR7 receptor, which lacks the intracellular DRYLAIV motif essential for G 
protein binding and activation of downstream pathways. CXCR7 is thought to be a  
scavenger receptor which functions to sequester CXCL12, reducing its availability 
outside of the cell for binding to CXCR4 (McGinn et al., 2013).  
There exists growing evidence to support a role for CXCR4/CXCL12 in neutrophil 
retention signalling. A specific role for the CXCR4/CXCL12 signalling axis in neutrophil 
retention at wounds has recently been suggested in zebrafish (Paredes-Zúñiga et al., 
2017). Expression of the chemokine CXCL12 provides a retention signal to neutrophils in 
the bone marrow through activation of its receptor CXCR4 (Suratt et al., 2004). 
Furthermore, CXCR4 and CXCL12 are known HIF targets and their promoters contain 
HIF responsive elements (Schioppa et al., 2003; Wang et al., 2008).  
In terms of chronic inflammation, tissue infiltrated neutrophils from patients with 
chronic inflammatory lung diseases and rheumatoid arthritis have increased CXCR4 
surface expression (Hartl et al., 2008). Neutrophil surface expression of CXCR4 is 
increased after extravasation into injured lungs in mice (Yamada et al., 2011) and in 
human tissue samples, where pulmonary CXCL12 expression increases during acute 
lung injury (Petty et al., 2007). Additionally, the inhibition of CXCL12 using blocking 
antibodies prevented the accumulation of neutrophils in the lung during the late stages 
of this LPS induced lung injury  (Yamada et al., 2011). 
Gain of function CXCR4 mutations are found in patients with WHIM syndrome, who 
present with neutropenia and increased susceptibility to infections (Kawai and Malech, 
2009). CXCR4 is highly expressed on neutrophils, which are inappropriately retained in 
the bone marrow because of the gain of function mutation in WHIM syndrome. Similarly, 
CXCR4 knockout mice show a marked increase in neutrophil release from the bone 
marrow (Gilchrist et al., 2015). Likewise, CXCR4 antagonist AMD3100 is used to mobilise 
stem cells from the bone marrow in humans (Broxmeyer et al., 2005). Together these 
findings highlight the role of signalling through the CXCR4/CXCL12 axis in neutrophil 
retention in mammalian and non-mammalian systems. 
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The CXCR4/CXCL12 signalling axis is one of the best characterised of all chemokine 
signalling in the zebrafish. Following the identification of this signalling axis  in directing 
the migration of the posterior lateral line in zebrafish larvae, extensive work has found 
many roles for CXCR4/CXCL12 in regulating the migration of cells including neural cells 
(Gilmour et al., 2004), endodermal progenitors (Nair and Schilling, 2008) and 
neutrophils (Walters et al., 2010).   
Zebrafish have two paralogues for CXCR4 and CXCL12 following a genome duplication 
event in teleost evolution. Mapping of the Cxcr4 genes in zebrafish demonstrates that 
Cxcr4 is expressed in most cell lineages known to express Cxcr4 in mammals. The 
developmental roles of Cxcr4 seem to be divided between the two isoforms of the gene, 
and expression of cxcr4a and cxcr4b in most cell lineages is mutually exclusive (Chong et 
al., 2001).  Cxcr4a predominantly binds Cxcl12b, whilst Cxcr4b predominantly binds 
Cxcl12a. Cxcl12a is produced in regions including the head, pronephric duct and CHT of 
zebrafish larvae at 2dpf, which are regions of neutrophil development or accumulation 
(Walters et al., 2010). CXCR4b is broadly expressed on immune cells such as neutrophils 
and macrophages, but also cells including mesodermal cells and motor neurons in the 
zebrafish (Chong et al., 2001). More recently the a role for the CXCR7 scavenger receptor 
in modulating cell responsiveness to CXCL12 gradients has been identified (Donà et al., 
2013), suggesting that monogamous signalling of CXCL12 through the CXCR4 receptor is 
an oversimplified model that needs to be revisited (Sánchez-Martín et al., 2013).  
AMD3100 is a non-peptide bicyclam which is able to specifically antagonize the CXCR4 
receptor at three main interaction residues located around the main ligand binding 
pocket of CXCR4 in transmembrane domains IV, VI and VII.  Binding of AMD3100 
competitively inhibits binding of CXCL12 and prevents subsequent downstream signalling  
(Fricker et al., 2006). AMD3100 is also an allosteric agonist of the low-affinity CXCR7 
receptor (Kalatskaya et al., 2009). AMD3100 is used in combination with G-CSF as a 
mobiliser of stem cells from bone marrow into the blood through its ability to inhibit the 
CXCR4/CXCL12 signal which retains haematopoietic stem cells in the bone marrow (Liles 
et al., 2003). AMD3100 is administered to humans and mice via intravenous injection 
(Liles et al., 2003), and to zebrafish larvae through incubation of the compound at  
concentrations ranging from 10-30M in the E3 medium of larvae (Tamplin et al., 2015).  
During this chapter I will determine whether the molecular components required to 
generate a retention signal are present at inflammatory sites in zebrafish larvae, and 
specifically in neutrophils. I will investigate the inhibition of CXCR4 using the antagonist 
AMD3100. I aim to inhibit the CXCR4 receptor using chemical manipulation to study its 
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function in the context of neutrophil recruitment to inflammatory sites. Finally, I will use 
assays to study the effect of CXCR4 inhibition on driving inflammation resolution and 
more specifically neutrophil reverse migration.  
4.2 Cxcr4b and Cxcl12a are strong candidates for retention 
signalling 
 CXCR4 and CXCL12 are conserved between humans and zebrafish 
Protein sequence alignment was performed to determine the similarity between human 
and zebrafish genes. Protein sequences were extracted from the ncbi database and 
clustal omega was used to align the sequences of the human genes with zebrafish 
homologues for both CXCR4 and CXCL12 (Figure 4.1a and 4.2a respectively). Interestingly 
this protein sequence alignment has been recently published by another group (Tulotta 
et al., 2016). The percentage identity between human and both zebrafish homologue 
protein sequences for CXCR4 and CXCL12 was determined, as well as the percentage 
identity between the two zebrafish homologues (Figure 4.1b and Figure 4.2b). 
 Neutrophil expression of Cxcl12 and Cxcr4  
To determine which of the CXCR4 homologues are expressed by neutrophils, RNA 
sequencing data from neutrophils extracted from wildtype larvae at 5dpf, provided 
kindly by our collaborator Anne-Marie Meijer, was studied. The fragments per kilobase 
of transcript per million mapped reads (fpkm) values for both Cxcr4 and Cxcl12 isoforms 
were extracted from the dataset to determine the expression level of both isoforms in 
zebrafish neutrophils. From this data it was apparent that cxcr4b is the predominantly 
expressed isoform in neutrophils, as the fpkm value for cxcr4b was over 100-fold higher 
than the fpkm value for cxcr4a (Figure 4.3). The expression of both Cxcl12 isoforms was 
relatively similar, however fpkm values were much lower than that of Cxcr4b (Figure 4.4).  
These data demonstrate that CXCR4 and CXCL12 are highly conserved between humans 
and zebrafish, and that zebrafish neutrophils predominantly express the cxcr4b isoform. 
I therefore decided to study the Cxcr4b receptor and its ligand Cxcl12a throughout the 





Figure 4.1: Protein sequence alignment of human and zebrafish CXCR4 
Protein sequences were extracted from the Ensembl database. Human CXCR4 was 
aligned to the zebrafish homologs using Clustal Omega software (A). Asterisks (*) 
represent fully conserved residues; colons (:) represent strong similarity between 
residues, and periods (.) indicate weak similarity between residues. The percentage 
identify between human (h) and zebrafish (z) CXCR4a and b homologs was calculated 





Figure 4.2: Protein sequence alignment of human and zebrafish CXCL12 
Protein sequences were extracted from the Ensembl database. Human CXCL12 was 
aligned to the zebrafish homologs using Clustal Omega software (A). Asterisks (*) 
represent fully conserved residues; colons (:) represent strong similarity between 
residues, and periods (.) indicate weak similarity between residues. The percentage 
identify between human (h) and zebrafish (z) CXCL12a and b homologs was calculated 







Figure 4.3: Expression of cxcr4 in zebrafish neutrophils during early 
development 
RNA sequencing of wildtype zebrafish neutrophils at 5 days post fertilisation was 
performed by a collaborator. Relative expression of transcript in fragments per 
kilobase of transcript per million mapped reads (fpkm) for both cxcr4a and cxcr4b 
was extracted from the database of genes provided from 3 independent repeats. 
Expression of cxcr4b was high, and is the predominantly expressed of the two CXCR4 






Figure 4.4 Expression of cxcl12 in zebrafish neutrophils during early 
development 
RNA sequencing of wildtype zebrafish neutrophils at 5 days post fertilisation was 
performed by a collaborator. Relative expression of transcript in fragments per 
kilobase of transcript per million mapped reads (fpkm) for both cxcl12a and cxcl12b 
was extracted from the database of genes provided from 3 independent repeats. 






 Cxcl12a is expressed at the wound site in zebrafish larvae 
I hypothesised that in order for Cxcl12a to generate a neutrophil retention signal, Cxcl12a 
must be expressed at the wound site to signal through the Cxcr4b receptor on 
neutrophils. To assess the expression of the chemokine Cxcl12a in zebrafish larvae, a 
combination of zebrafish reporter lines and whole mount in situ hybridisation (WISH) 
was used.  
A cxcl12a reporter zebrafish line Tg(cxcl12a:eGFP)sh479 was generated at the University 
of Sheffield by Dr. Robert Wilkinson using a short promoter region (Lund et al., 2014). 
This line was leant to me on a collaborative basis and will be referred to as cxcl12a:GFP 
thus fourth. To determine the expression profile of cxcl12a at 3dpf in the transgenic 
reporter larvae, imaging of uninjured 3dpf cxcl12a:GFP larvae was performed as 
described in methods. Expression of the cxcl12a:GFP transgene was seen in anatomical 
locations reported in the literature at similar developmental stages such as the disk-
shaped somite external cells along the horizontal myoseptum (Svetic et al., 2007), head 
region (Astin et al., 2014) and lateral mesoderm (Torregroza et al., 2012) (Figure 4.5a). 
Imaging of these larvae at higher power identified that cxcl12a is highly expressed by 
many cells in the tail-fin of uninjured larvae (Figure 4.5b and c). 
To investigate the expression of cxcl12a at the wound site in vivo in real time, tail-fin 
transection of 3dpf cxcl12a:GFP larvae was performed as described in methods. Imaging 
of the tail-fin region of these larvae was performed at 6hpi. Representative images of 
injured larvae at 40x magnification in five representative larvae (Figure 4.6a) alongside 
age matched uninjured control larvae (Figure 4.6b) demonstrate that there is no 
detectable increase in fluorescence in injured larvae compared to controls. The high 
levels of cxcl12a expression by cells in the tail-fin make it difficult to determine whether 
cxcl12a expression at the wound site is generated in response to tail-fin injury or whether 
the expression observed is constitutive.  
I therefore could not make any conclusions about the up-regulation of Cxcl12a at the 
wound site from these experiments.  
 The cxcl12a:GFP transgene is not expressed by neutrophils in detectable 
levels 
I next investigated the production of Cxcl12a by neutrophils at the wound site. 
Neutrophils are able to generate gradients to modulate their recruitment to wound sites 
so I hypothesised that neutrophils might produce Cxcl12a at the wound site.  
To investigate this hypothesis, I out crossed the cxcl12a:GFP reporter line to our 
Tg(lyz:mCherry)sh260 neutrophil reporter line. Offspring from this outcross were 
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selected for double positive expression of both transgenes and tail-fins were transected. 
Imaging of neutrophils at the wound site was performed at 5hpi as described in methods.  
Figure 4.7a shows a maximum intensity projection of lyz:mCherry neutrophils at the 
wound site at 4hpi at 40x magnification. I observed expression of both transgenes in 
single z-slices to determine if there was any level of colocalisation of mCherry with GFP 
signal. Figure 4.7b shows a representative example of a single slice of the lyz:mCherry x 
CXCL12:GFP larvae after observing expression in at least 30 larvae from 3 experimental 
repeats. Yellow outline highlights the area in which neutrophils are located, showing that 
there is no GFP expression where neutrophils are found. Line profiles were drawn 
through the centre of three neutrophils at the wound site in three fish taken from three 
experimental repeats, from which colocalisation of mCherry and GFP was seen in zero 
neutrophils. Figure 4.7c shows a representative example of the intensity measured 
through a line drawn through the centre of neutrophils corresponding to neutrophils 1, 
2 and 3. This data demonstrated that no GFP expression was observed to colocalise with 
mCherry.  
From these experiments I can conclude that neutrophils do not express cxcl12a at the 






Figure 4.5: Expression profile of Cxcl12a in a transgenic reporter line 
A Cxcl12a reporter line was made by a collaborator using a short promoter region to 
drive the expression of eGFP under the Cxcl12a promoter. Expression of the 
transgene was observed in 3dpf Tg(cxcl12a:GFP)sh479 larvae at 2x (A), 20x (B) and 
40x (C) magnification. Expression can be seen in the brain, skin and most notably at 






Figure 4.6: Investigating Cxcl12a expression in injured larvae 
Tail fin transection of cxcl12a:eGFP larvae was performed at 3dpf. Expression of the 
Cxcl12a transgene at the wound site was visualised at 6hpi. Figure shows 4 the injured 
tail fins of 4 example larvae where the wound edge is indicated by a dotted white line 
(A). Imaging of injured larvae was performed alongside uninjured age-matched 






Figure 4.7: Cxcl12a:eGFP is not expressed by neutrophils 
3dpf double transgenic Tg(cxcl12a:eGFP);Tg(lyz:mCherry) larvae were injured at 3dpf 
and neutrophils at the wound site were imaged at 5hpi. A representative maximum 
intensity projection (A) shows neutrophils recruited to the wound site at 5hpi. By 
studying each z-slice of images it was apparent that neutrophils did not express the 
Cxcl12a:eGFP transgene at detectable levels (B). Intensity profiles were plotted for 3 
neutrophils at the wound site as indicated by yellow dashed lines (B). Representative 
intensity plots of mCherry eGFP expression further illustrate that no co-localisation is 





 CXCL12a mRNA is detected at the wound site in injured larvae 
It was difficult to draw conclusions about cxcl12a expression from experiments 
performed using the cxcl12a:GFP reporter line. I next decided to use whole mount in situ 
hybridisation as a more sensitive method to visualise cxcl12a mRNA at the wound site.  
WISH was performed as described in methods using an antisense RNA probe made 
from a plasmid vector containing the zebrafish cxcl12a coding sequence. The antisense 
RNA probe was prepared from linearised plasmid DNA which I received as a kind gift 
from Dr. Anne Robertson (University of Sheffield) as described in methods. Figure 4.8 
shows representative examples of cxcl12a mRNA expression in larvae at 4, 8 and 24 hpi. 
The left panel shows mRNA expression in non-injured age matched control larvae, 
whilst the middle and right panels show whole body expression and tail-fin expression 
of injured larvae respectively. Expression of cxcl12a mRNA was found in anatomical 
locations reported in the literature at similar developmental stages such as the disk-
shaped somite external cells along the horizontal myoseptum (Svetic et al., 2007), head 
region (Astin et al., 2014) and lateral mesoderm (Torregroza et al., 2012). Expression in 
injured larvae at 4hpi was not markedly different to that observed in uninjured control 
larvae. At 8 and 24hpi the expression of cxcl12a was visually higher in injured larvae 
compared to uninjured controls.   
Taken together these experiments suggest that cxcl12a is expressed by cells at the 
wound site and is therefore a good candidate for retention signalling.  
 Generation of a Cxcr4b transgenic reporter line using the GAL4 UAS 
system 
Measuring Cxcr4 receptor turnover at the cell surface has been used as a tool to 
calculate Cxcl12 concentration outside of cells in zebrafish larvae (Donà et al., 2013).  I 
next aimed to visualise the spatial distribution of the Cxcr4b receptor in neutrophils to 
investigate Cxcl12a concentration at the wound site during the inflammatory response. 
Using the Gal4:UAS system (Scheer and Campos-Ortega, 1999) I drove the expression of 
a UAS conjugated Cxcr4b GFP fusion protein (Cxcr4b-GFP) in neutrophils expressing 






Figure 4.8: Whole mount in situ hybridisation to assess cxcl12a 
expression at the wound site 
Tail fin transection of 3dpf nacre larvae was performed and larvae were fixed in 
paraformaldehyde at 4, 8 and 24hpi along with non-injured age matched controls. 
Whole mount in situ hybridisation was performed using an antisense probe for 
Cxcl12a. The expression of Cxcl12a in uninjured larvae is shown in the left panel, injured 
larvae in the centre panel and a higher magnification of the tail fin region of injured 
larvae in the right panel. Images are representative of experiments performed over 3 




A construct consisting of a GFP tagged Cxcr4b conjugated to UAS (UAS:Cxcr4b-GFP) 
flanked by Tol2 arms was received as a kind gift from Professor Darren Gilmour 
(University of Zurich). The construct was prepared by transformation from plasmid DNA 
followed by DNA purification steps as described in methods prior to injection into larvae. 
The construct was injected into the Tg(mpx:GAL4)i222 zebrafish reporter line expressing 
the GAL4 transcriptional activator in neutrophils specifically. Embryos in the mpx:GAL4 
background were injected with the construct at the one cell stage. Larvae expressing the 
construct were selected for raising and a stable line of F1 generation larvae was produced 
as described in methods.  Experiments were performed on F2 generation larvae.  
Expression of UAS:cxcr4b-GFP was observed in the caudal hematopoietic tissue of 3dpf 
Tg(mpx:GAL4)i222x(UAS:cxcr4b-GFP)sh503 larvae, which will be referred to as 
cxcr4b:GFP for simplicity (Figure 4.9). I aimed to confirm that the expression of the 
construct in the stable line was neutrophil specific. To do this I outcrossed cxcr4b:GFP 
zebrafish adults to Tg(lyz:mCherry)sh260 in which the neutrophil specific lyz promoter 
drives mCherry. Larvae were screened at 3dpf for double positive expression of GFP and 
mCherry in the CHT and mounted for imaging as described in methods.  
Figure 4.10 shows a representative example of cxcr4b:GFP expression in mCherry 
expressing neutrophils which was observed in at least 20 larvae from 3 experimental 
repeats. The cxcr4b:GFP transgene was only observed in a proportion of neutrophils in 
the CHT. I next aimed to study Cxcr4b in neutrophils at the inflammatory site throughout 
the recruitment and resolution of inflammation. I hypothesised that a difference in 
Cxcr4b dynamics would be observed in neutrophils in the resolution phase compared to 
the recruitment phase.  
Initially I aimed to determine the dynamics of the neutrophilic inflammatory response in 
the cxcr4b:GFP line. F1 cxcr4b:GFP adults were crossed to produce offspring and 
offspring with the brightest neutrophil expression were selected for experiments at 3dpf. 
Tail-fin transection was performed as described in methods prior to mounting and 
imaging which began at 1 hour post injury for 10 hours. Interestingly recruitment of 
neutrophils expressing the cxcr4b:GFP transgene to the wound site was not observed in 
these 10 hour time courses. Representative images of the wound site from three larvae 
at 6hpi are illustrated in Figure 4.11.  
I hypothesised that the impaired recruitment of neutrophils to the wound site was due 
to the over-expression of Cxcr4b in neutrophils by the GAL4 transcriptional activator, 
similar to the phenotype observed in WHIM zebrafish with over-active Cxcr4b signalling 






Figure 4.9: Expression of the Cxcr4b.GFP construct in the CHT of larvae 
Tg(mpx:GAL4)i222;Tg(,UAS:cxcr4b-GFP)sh503 larvae were mounted for imaging at 
3dpf. Images of the CHT of larvae were taken at 20x magnification (A) and 40x 
magnification (B). Figure shows a representative example of expression of the cxcr4b-






Figure 4.10: Expression of the cxcr4b-GFP transgene is neutrophil 
specific 
Tg(mpx:GAL4)i222;Tg(UAS:cxcr4b.GFP)sh503 adults were out crossed to 
Tg(lyz:mCherry)sh260 adults and double positive offspring were mounted for imaging 
at 3dpf. Images of the CHT region of larvae were taken at 40x magnification. Figure 
shows a representative example of expression of the cxcr4b-GFP transgene (green) 







Figure 4.11: A WHIM phenotype is recapitulated in neutrophils 
expressing the cxcr4b-GFP transgene 
Tg(mpx:GAL4)i222;Tg(UAS:cxcr4b.GFP)sh503 larvae were injured at 3dpf and time 
lapse imaging of neutrophil recruitment to the wound site was performed from 1hpi 
for 5 hours. No neutrophil recruitment to the wound site was observed in larvae 
during the first 6 hours following injury. Figure shows 3 representative wound sites at 
6hpi where no recruitment of neutrophils expressing the Cxcr4b.GFP was observed 




To test this hypothesis I studied the recruitment capacity of transgenic neutrophils to 
wildtype neutrophils in the same larvae. Adult fish from the cxcr4b:GFP background were 
outcrossed to lyz:mCherry adults and tail-fins of the double-positive offspring from this 
cross were transected at 3dpf. The number of neutrophils at the wound site was counted 
at 5hpi (Figure 4.12). Interestingly, these experiments identified that mCherry expressing 
neutrophils recruited to the wound site, whilst a significant reduction in neutrophils 
expressing cxcr4b-GFP was observed, despite the CHT of every larvae in the experiment 
containing cxcr4b-GFP labelled neutrophils (n=19 larvae from 2 experimental repeats). 
These data suggest that in neutrophils over expressing Cxcr4b, recruitment to the wound 
site is impaired whilst neutrophils not expressing the construct can recruit to the wound 
site.  
These experiments highlight that over expression of CXCR4b in neutrophils caused the 
same phenotype observed in other zebrafish models of enhanced Cxcr4b signalling such 
as WHIM syndrome. Therefore, I was unable to use this line using these experiments to 
study Cxcr4b behaviour at the wound site due to the lack of recruitment of Cxcr4b-GFP 





Figure 4.12: Neutrophils which don’t express the cxcr4b-GFP transgene 
are recruited to the wound site 
Tg(mpx:GAL4)i222;Tg(UAS:cxcr4b.GFP)sh503 adults were out crossed to 
Tg(lyz:mCherry)sh260 adults and tail fin transection was performed on double 
positive offspring. Imaging of neutrophils recruited to the wound site was performed 
at 5hpi. Figure shows neutrophils at the wound site in three representative larvae 
where neutrophils expressing both transgenes are highlighted by white arrows (A). 
The number of mCherry positive and Cxcr4b.GFP positive neutrophils at the wound 
site was counted, identifying that single positive lyz:mCherry expressing neutrophils 
were recruited to the wound site whilst neutrophils expressing the Cxcr4b.GFP 
transgene were not (B). (n=20 larvae from 2 experimental repeats. Unpaired t-test 





4.3 Using the compound AMD3100 to inhibit the CXCR4/CXCL12 
signalling axis 
 Inhibition of CXCR4/CXCL12 signalling does not affect haematopoiesis 
during early development 
Before using AMD3100 to investigate the role of CXCR4/CXCL12 signalling in neutrophil 
retention at wound sites, I first aimed to determine that the inhibition of CXCR4/CXCL12 
signalling did not affect whole body neutrophil counts in larvae. AMD3100 was 
administered to larvae via incubation or injection as described in methods, and whole 
body counts were performed 5 and 24 hours post administration (Figure 4.13).  
Inhibition of CXCR4/CXCL12 signalling caused no significant difference in the whole body 
counts of larvae either injected or incubated with AMD3100 at 2 or 3 dpf, at both 5 and 
24 hours post administration. These data demonstrate that AMD3100 does not change 
the number of neutrophils in the larvae such that any change in neutrophil number 
observed when investigating neutrophil recruitment to or removal from the wound site 
should not be attributed to a difference in whole body neutrophil number.  
 Inhibition of CXCR4/CXCL12 signalling does not affect neutrophil 
colonisation of the caudal hematopoietic tissue  
Neutrophil colonisation of the caudal hematopoietic tissue of zebrafish occurs between 
48 and 72hpf. This process is CXCR4/CXCL12 dependent and it has been shown in 
zebrafish that AMD3100 treatment can reduce the amount of HSPC markers runx1 and 
cmyb in the CHT following treatment during this window  (Tamplin et al., 2015).  
To determine if inhibition of CXCR4/CXCL12 signalling affected the colonisation of 
neutrophils specifically in the CHT, mpx:GFP larvae were incubated in AMD3100 at 
concentrations indicated in Figure legend from  48-72hpf.  
Neutrophils were counted in the CHT region illustrated in Figure 4.14A. In these 
experiments AMD3100 did not significantly affect neutrophil numbers in the CHT region 
following incubation (Figure 4.14B) or injection (Figure 4.14C) of the compound (n=27 







Figure 4.13: Inhibition of CXCR4/CXCL12 signalling does not affect 
haematopoiesis during early development 
AMD3100 was administered to larvae at 48 or 72 hours post fertilisation by 
microinjection into the Duct of Cuvier or by incubation in E3 media respectively.  
Assessment of whole body neutrophil counts was performed at 5 and 24 hours post 
administration. Injection of AMD3100 into 2dpf larvae had no effect on whole body 
neutrophil counts at 5 and 24 hours post administration (A,C). Similarly incubation of 
AMD3100 in the media of 3dpf larvae did not change whole body neutrophil counts 
(B,D). (n=27 larvae from 3 experimental repeats. Unpaired t-test where p>0.05 Data 









Figure 4.14: Inhibition of CXCR4/CXCL12 signalling does not affect 
neutrophil colonisation to the CHT 
AMD3100 was administered to larvae at 48hpf by microinjection into the Duct of 
Cuvier or by incubation in E3 media and the CHT of larvae was imaged at 72hpf (A). 
No significant difference in neutrophil counts in the CHT was observed following 
AMD3100 injection (B) or incubation in E3 media (C). (n=25-30 larvae per group from 
3 experimental repeats. Unpaired t-test was performed where p>0.05 (B).  Data are 





 Inhibition of CXCR4/CXCL12 signalling does not affect neutrophil 
retention in the CHT 
Following colonisation of the CHT neutrophils are retained in this tissue, a process which 
is modulated by CXCR4/CXCL12 signalling. It has been shown in a zebrafish model for 
WHIM syndrome in which C-terminal truncating mutations prevent the internalisation of 
the CXCR4b receptor from the surface, that neutrophils are inappropriately retained in 
the CHT. 
To test the hypothesis that CXCR4 inhibition using AMD3100 could release neutrophils 
from the CHT following their colonisation, 3dpf mpx:GFP larvae were treated with 
AMD3100 by incubation in the E3 media. The CHT region was imaged 5 hours post 
administration as described in methods. To quantify neutrophil retention in the CHT, 
neutrophil numbers inside and outside of the CHT were counted (Figure 4.15A). In these 
experiments, AMD3100 administration by incubation (Figure 4.15B), did not alter the 
number of neutrophils inside nor outside of the CHT (n=26-29 larvae per experimental 






Figure 4.15: Inhibition of CXCR4/CXCL12 signalling does not affect 
neutrophil retention in the CHT 
AMD3100 was administered to 3dpf mpx:GFP larvae by incubation in the E3 media. The 
CHT of larvae was imaged at 5 hours post incubation and the number of neutrophils 
inside the CHT as indicated by the white region of interest (A) and outside of the CHT 
were counted (B). No difference in the number of neutrophils inside or outside of the 
CHT was observed between treatment groups (n=29 larvae from 3 experimental 
repeats. Chi squared contingency test with Fishers test where p=0.4376. Data are 




 Inhibition of CXCR4/CXCL12 signalling increases neutrophil recruitment 
to the wound site 
The recruitment of neutrophils to inflammatory sites is increased in Cxcr4b mutant 
zebrafish larvae, where it is proposed that loss-of-function Cxcr4b mutations reduce 
neutrophil retention signalling in the CHT and thus increase neutrophil responsiveness 
to chemotactic cues released at the wound site (Paredes-Zúñiga et al., 2017).  
I therefore hypothesised that inhibition of CXCR4/CXCL12 signalling using AMD3100 
would increase the number of neutrophils recruited to the wound. To test this 
hypothesis AMD3100 was administered by injection or incubation to 2 or 3dpf mpx:GFP 
larvae respectively prior to tail-fin transection as described in methods section.     
Injection of AMD3100 significantly increased the number of neutrophils recruited to the 
wound site (Figure 4.16A, n=36-40 larvae per group from 4 experimental repeats). 
Incubation of AMD3100 however, had no effect on neutrophil recruitment to the wound 
site in these experiments (Figure 4.16B, n=29-30 larvae per experimental group from 3 
experimental repeats). These data suggest that neutrophils may be able to respond to 
directional cues released at the wound site more effectively when the CXCR4/CXCL12 
signalling axis is inhibited, and that administration of AMD3100 by injection into the 
circulation may be a more effective way to administer the compound.  
 Inhibition of CXCR4/CXCL12 signalling accelerates inflammation 
resolution 
To test the hypothesis that CXCR4/CXCL12 signalling generates a neutrophil retention 
signal, I performed inflammation resolution assays similar to those previously published 
by our group (Elks et al., 2011; Robertson et al., 2014). I hypothesised that administration 
of AMD3100 would reduce neutrophil counts at the wound site during the resolution 
phase of inflammation.   
Initial experiments were performed by administration of AMD3100 via injection into the 
duct of Cuvier at 4hpi at a final blood concentration of 20µM, as described in methods. 
Neutrophils at the wound site were counted at the peak of recruitment at 6hpi, and 
during the resolution phase at 8 and 24hpi (Figure 4.17). Neutrophil counts at the wound 
site at the peak of recruitment were not affected in these experiments (Figure 4.17A), 
whereas the number of neutrophils at the wound site in AMD3100 treated larvae was 







Figure 4.16: Inhibition of CXCR4/CXCL12 signalling increases neutrophil 
recruitment to the wound site 
AMD3100 was administered by microinjection into the Duct of Cuvier for 2dpf larvae, 
or incubation into the E3 media for 3dpf larvae. 2 and 3dpf mpx:GFP larvae were 
injured 1 hour prior to AMD3100 administration and neutrophils recruited to the 
wound site at 6hpi were counted. Injection of AMD3100 into 2dpf larvae significantly 
increased neutrophil counts at the wound site (A) (n=36-40 larvae from 4 
experimental repeats. Unpaired t-test where * represents p<0.05). There was no 
difference observed in neutrophil counts in larvae at the wound site following 
AMD3100 incubation at 3dpf (B) (n=28-30 larvae from 3 experimental repeats. 






Figure 4.17: Inhibition of CXCR4 signalling by injection of AMD3100 
accelerates inflammation resolution 
Tail fin transection of 2dpf mpx:GFP larvae was performed and larvae  with a good 
neutrophil response were selected for experiments. AMD3100 was injected into the 
Duct of Cuvier at 5hpi and neutrophils at the wound site were counted at 6 and 8 hpi. 
There was no difference in neutrophils recruited to the wound site at 6hpi between 
treatment groups (A), however AMD3100 injected larvae had significantly fewer 
neutrophils at the wound site at 8hpi (B). The percentage resolution measured 
between 6 and 8 hours was calculated for vehicle control and AMD3100 injected 
larvae. Percentage resolution was significantly higher in AMD3100 injected larvae (C) 
(n=55 larvae from 5 experimental repeats. Unpaired t-test where **p<0.01 and 




The percentage resolution was calculated from these data as described in methods, and 
shows that AMD3100 significantly increases percentage inflammation resolution (Figure 
4.17E). These data illustrate that AMD3100 treatment causes the more rapid removal of 
neutrophils from the wound site in a higher proportion of larvae than in controls.  
I next investigated whether incubation of AMD3100 in the E3 media of 3dpf mpx:GFP 
larvae could also accelerate inflammation resolution. AMD3100 was administered to 
larvae at 4hpi as described in methods. Neutrophils present at the wound site were 
counted at the peak of recruitment at 6hpi, and during the resolution period at 8, 12 and 
24 hours post injury.  
These experiments show that AMD3100 incubation causes no change in the number of 
neutrophils present at the wound site at the peak of recruitment however a significant 
decrease in the number of neutrophils present at the wound site during the resolution 
phase of inflammation was seen at 8 and 12hpi (Figure 4.18A). The rate of inflammation 
resolution was measured by calculating the percentage inflammation resolution of 
neutrophils from 6-8 hours and 6-12 hours post injury as described in methods (Figure 
4.18B and 4.18C respectively). There was no significant difference in percentage 
resolution between the two groups in these experiments, however there was a trend to 
increased % resolution in AMD3100 treated larvae.  
Together these data demonstrate that AMD3100 is able to accelerate the removal of 
neutrophils from the wound site in zebrafish larvae, supporting the hypothesis that the 
CXCR4/CXCL12 signalling axis generates a neutrophil retention signal at the wound site 
and further provide evidence to suggest that injection of the compound shows a greater 














Figure 4.18: Inhibition of CXCR4 signalling by incubation of AMD3100 
increases inflammation resolution 
3dpf mpx:GFP larvae were injured and larvae with a  good neutrophil response at the 
wound site were selected for experiments. AMD3100 or vehicle control was 
administered by incubation in the E3 media at 4 hours post injury. Neutrophils present 
at the wound site were counted at 6, 8, 12 and 24 hours post injury. Neutrophil counts 
were not significantly different at 6hpi between groups, however AMD3100 incubation 
significantly reduced neutrophil counts at the wound site at 8 and 12 hours post injury 
(A). The percentage resolution was calculated for both groups between 6-8 hours and 
6-12 hours post injury. (n=29-30 larvae per group from 3 experimental repeats. 




 Inhibition of CXCR4/CXCL12 signalling accelerates neutrophil reverse 
migration 
I have shown that inhibition of Cxcr4 using AMD3100 is able to accelerate inflammation 
resolution without reducing the ability of neutrophils to recruit the wound site or altering 
neutrophil counts in the zebrafish. Inflammation resolution can be achieved in part by 
the apoptosis of neutrophils and their efferocytosis by macrophages, or by the reverse 
migration of neutrophils away from the inflammatory site. I hypothesised that the 
acceleration in inflammation resolution I observed was due to an increase in neutrophil 
reverse migration. 
To investigate this hypothesis reverse migration assays were performed using 
Tg(mpx:kaede)i222 larvae at 2 or 3dpf for injection or incubation of AMD3100 
respectively, as described in methods.  
I first performed these assays by injecting the compound into the duct of Cuvier at 5hpi. 
In these experiments, I observed more neutrophils migrating away from the wound site 
in the AMD3100 injected larvae compared to the vehicle control group (Figure 4.19A). 
Linear regression analysis indicated that this difference was highly significant (n=16-18 
larvae per treatment group from 3 experimental repeats, p<0.005). The number of 
photoconverted neutrophils in the whole tail region of larvae at the first frame of the 
time lapse was counted and I found that there was no significant difference in the number 
of photoconverted neutrophils between the two groups (Figure 4.19B). This 
demonstrates that the increased number of neutrophils detected away from the wound 
site was not due to a difference in the number of photoconverted neutrophils.  
I next repeated these experiments by administering the AMD3100 by incubating the 
compound in the agarose of larvae throughout the duration of the experiment.  AMD3100 
was administered to larvae at 5hpi prior to photoconversion at 6hpi, as described in 
methods. The number of neutrophils which moved away from the wound site was 
significantly higher in larvae treated with AMD3100 (Figure 4.20A) (n=32-35 larvae from 
6 experimental repeats). Linear regression analysis indicated that this difference was 
highly significant (p<0.001). This difference was not due to a difference in the number of 
photoconverted neutrophils (Figure 4.20B).  
This data suggests that the acceleration of inflammation resolution observed in AMD3100 
treated larvae can be attributed at least in part, to the increased reverse migration of 







Figure 4.19: Inhibition of CXCR4 by AMD3100 injection accelerates 
neutrophil reverse migration at 2dpf 
Tail fin transection was performed on 2dpf mpx:kaede larvae. Those which mounted 
a good neutrophil response at 3.5hpi were selected for microinjection with AMD3100 
or vehicle control at 4hpi. Larvae were mounted in 1% agarose and neutrophils at the 
wound site were photoconverted at 5hpi from green to red fluorescence. Time lapse 
imaging was performed from 6-10hpi. Experimental schematic adapted from Ellett et 
al., 2015 is illustrated in (A). The number of neutrophils which moved away from the 
wound site into a defined region of interest was quantified throughout the time 
course. AMD3100 significantly increased the number of neutrophils which moved 
away from the wound site (B). This increase was not due to a difference in the number 
of photoconverted neutrophils between treatment groups which were quantified in 
the first frame of time courses (C). (n=16-18 larvae from 3 experimental repeats. 
Linear regression analysis where p<0.001 (A). Unpaired t-test where p>0.05 (B).  Data 






Figure 4.20: Inhibition of CXCR4 by AMD3100 incubation accelerates 
neutrophil reverse migration at 3dpf 
Tail fin transection was performed on 3dpf mpx:kaede larvae. Those which mounted 
a good neutrophil response at 4hpi were selected for experiments and mounted in a 
1% agarose containing AMD3100 or vehicle control at 5hpi. Neutrophils at the wound 
site were photoconverted at 5hpi from green to red fluorescence. Time lapse imaging 
was performed from 7-12hpi. Experimental schematic adapted from Ellett et al., 2015 
is illustrated in (A). The number of neutrophils which moved away from the wound 
site into a defined region of interest was quantified throughout the time course. 
AMD3100 significantly increased the number of neutrophils which moved away from 
the wound site (B). This increase was not due to a difference in the number of 
photoconverted neutrophils between treatment groups which were quantified in the 
first frame of time courses (C). (n=35 larvae from 6 experimental repeats. Linear 
regression analysis where p<0.001 (A). Unpaired t-test where p>0.05 (B).  Data are 




4.4 Chapter discussion  
In this chapter I have investigated the role of the CXCR4/CXCL12 signalling axis in 
modulating neutrophil retention at inflammatory sites in zebrafish larvae. I have 
generated evidence that the components required for a retention signal through 
CXCR4/CXCL12 are present at the wound site, with the receptor being expressed on 
zebrafish neutrophils and mRNA for the ligand expressed at the tail-fin in injured larvae. 
I attempted to disrupt known CXCR4/CXCL12 dependent processes in zebrafish and 
recapitulated the phenotype observed in Cxcr4b/Cxcl12a mutant larvae where 
neutrophil recruitment to the wound site is increased (Paredes-Zúñiga et al., 2017). 
Finally, I have begun to address the hypothesis that CXCR4 generates a neutrophil 
retention signal by demonstrating that inhibition of the CXCR4 receptor using AMD3100 
can accelerate inflammation resolution by driving neutrophil reverse migration.  
These experiments provide evidence that the CXCR4/CXCL12 signalling axis exists at the 
wound site in zebrafish larvae, where neutrophil reverse migration is accelerated in 
larvae following CXCR4 receptor inhibition. This is the first evidence that CXCR4/CXCL12 
signalling is important in neutrophil retention at inflammatory sites and suggests a novel 
signalling pathway is involved in neutrophil retention at sites of inflammation, however 
the downstream components of this pathway have yet to be elucidated.  
 Cxcr4b and Cxcl12a are strong candidates for retention signalling at the 
wound site  
Computational modelling data suggest that neutrophil reverse migration is the stochastic 
redistribution of neutrophils back into the tissue rather than their active migration away 
from the wound site (Holmes et al., 2012). These data imply that neutrophil 
desensitisation to gradients at the wound site rather their active migration away from 
chemorepulsive gradients (fugetaxis) is more likely to modulate reverse migration. 
Cellular desensitisation to external gradients is a characteristic feature of signalling 
through G protein coupled receptors, many of which are expressed on the surface of 
neutrophils (Magalhaes et al., 2012).  
The CXCR4/CXCL12 signalling axis modulates many processes in zebrafish (Donà et al., 
2013; Itou et al., 2012; Tamplin et al., 2015), and in terms of neutrophil function, has been 
shown to regulate the retention of neutrophils in the CHT (Paredes-Zúñiga et al., 2017; 
Walters et al., 2010).  Before investigating the CXCR4/CXCl12 signalling axis in modulating 
neutrophil retention at inflammatory sites, I first determined that cellular components 
required for signalling were present at the wound site in zebrafish larvae.  
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I compared the protein sequences for human and both zebrafish paralogues of CXCR4 
and CXCL12 and identified that there is a degree of conservation between the two 
species, which is useful to determine that the proteins may function similarly. The 
zebrafish has been used to study Cxcr4 function in many developmental processes so 
this investigation supports the notion that Cxcr4 is functionally similar to its mammalian 
counterpart (Donà et al., 2013; Valentin et al., 2007). RNA sequencing data from our 
collaborator Professor Annemarie Meijer (University of Leiden, NL) identified that cxcr4b 
is the predominantly expressed isoform in neutrophils during early development at 5dpf. 
This data provides information about Cxcr4b expression at 5dpf, however experiments 
in this study were performed on zebrafish at 2 and 3dpf.  There exists evidence that 
cxcr4b is expressed in a population of hematopoietic cells at 3dpf including neutrophils, 
which migrate towards tissues expressing  cxcl12a (Walters et al., 2010). It is reported 
that the cognate ligand for Cxcr4b is Cxcl12a, so this evidence along with the RNA 
sequencing data suggests that these are the two isoforms which should be investigated 
during this study. Cxcr4b/12a in zebrafish neutrophils may function similarly to its human 
counterpart as CXCR4/CXCL12 signalling acts to retain neutrophils in their niche in both 
organisms (Day and Link, 2012; Paredes-Zúñiga et al., 2017).  
 Cxcl12a is produced at the wound site in zebrafish larvae  
CXCL12 produced by stromal cells generates a neutrophil retention signal in human bone 
marrow niches as well as in zebrafish caudal hematopoietic tissue during development 
(Broxmeyer et al., 2005; Paredes-Zúñiga et al., 2017). Expression of  cxcl12a has been 
observed in zebrafish by WISH in the head region (Hess and Boehm, 2012), lateral 
mesoderm (Torregroza et al., 2012), trunk (Venero Galanternik et al., 2016) and posterior 
lateral line primordium (Venkiteswaran et al., 2013). Of the reports of cxcl12a expression 
at 3dpf, mRNA is detected by WISH in the ventral side of the head region, caudal 
hematopoietic tissue and pronephric duct (Walters et al., 2010). There currently exists 
no evidence of cxcl12a expression in the caudal tail-fin 3dpf, although at 2dpf reports 
show expression in a population of cells at the end of the notochord protrusion which 
likely correlate with the cells of the posterior lateral line primordium (Walters et al., 
2010). From my experiments using a cxcl12a:eGFP reporter line and whole mount in situ 
hybridisation, expression of Cxcl12a using both a transgenic reporter and WISH was 
observed in similar anatomical regions in the head, fins and trunk of larvae. Caudal tail-
fin expression of cxcl12a appeared higher in the transgenic reporter, although this is 
likely due to differences in the sensitivity of the imaging performed between the 
experiments, where high power confocal microscopy was used to visualise the 
transgenic line whilst low power wide field light microscopy was used to visualise mRNA 
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following WISH experiments. Taken together I propose that the cxcl12a:eGFP reporter 
recapitulates cxcl12a mRNA expression seen by in situ hybridisation.  
Experiments using a cxcl12a:eGFP transgenic reporter line were inconclusive due to the 
high constitutive levels of Cxcl12a expressed in the zebrafish tail-fin, which made 
distinguishing between constitutive and upregulated gene expression in injured larvae 
difficult. To improve assays to image the cxcl12a:eGFP transgenic line in the future, tail-
fin transection could be performed in an anatomical region of the tail-fin away from the 
intensely bright notochord protrusion. I hypothesise that expression of cxcl12a by cells 
at the wound site in a region where basal levels of GFP intensity are lower would enable 
the detection of the transgene when driven by weaker promoters. Recent advances in in 
vivo imaging microfluidics devices for zebrafish larvae will enable the tracking of cxcl12a 
expressing cells in individual larvae prior to injury and rapidly following tail-fin 
transection (Ellett and Irimia, 2017). These new imaging devices hold the head and trunk 
of larvae in silicon moulds with their caudal tail-fins extruding from the edge. Using these 
moulds a pre-injury image can be taken and tail-fins can be transected whilst the larvae 
remain anaesthetised. Imaging of larvae can then continue almost immediately with 
larvae maintained in the same position. Currently these experiments are not possible to 
perform due to the requirement to mount larvae in agarose for imaging. In future I hope 
these new moulds will enable the detection of cells at a wound edge further away from 
the notochord protrusion and comparisons of individual larvae can be made pre and post 
injury, so that conclusions can be made with regards to cxcl12a:eGFP expression using 
the transgenic reporter line.  
Evidence from WISH experiments illustrate that in uninjured larvae cxcl12a expression is 
detected at low levels at the end of the notochord protrusion, in correlation with the 
expression observed in the reporter line. The expression observed in uninjured larvae 
was comparable to that observed by other groups earlier in zebrafish development at 
2dpf (Walters et al., 2010). Staining for cxcl12a mRNA appeared to increase over time, in 
keeping with a significant body of evidence that illustrates a role for CXCL12 in tissue 
repair and regeneration (Bouzaffour et al., 2009; Itou et al., 2012). (Dufourcq and Vriz, 
2006; Itou et al., 2012)(Itou et al., 2012). Following tail-fin amputation expression of 
CXCL12a is observed by WISH from 1 day post amputation and persists during fin 
regeneration until 5 days post amputation when a rapid downregulation is observed 
(Dufourcq and Vriz, 2006).  It is proposed that CXCL12a is important in providing 
directional guidance cues to regulate endothelial cell migration during arterial 
morphogenesis in the regenerating fin (Xu et al., 2014). My data may support a 
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regenerative capacity for Cxcl12a following tail-fin amputation, as it looks like CXCL12a 
mRNA increases in expression in the tail-fin of larvae throughout the time course, 
although quantification of this observation by qPCR is required.  
These experiments provide information about the spatial expression of cxcl12a mRNA 
within zebrafish larvae, where it looks like cxcl12a mRNA is expressed at the wound site. 
The limitations of using WISH to observe gene expression are the tissue resolution 
achieved imaging fixed stained tissue is limited such that the precise cell types expressing 
the gene could not be identified. WISH provides spatial information about gene 
expression but quantification is subjective and there exist more robust methods to 
quantify mRNA levels such as qPCR which could be employed in future. Furthermore, it 
should be considered that RNA expression is a useful but certainly far from perfect 
predictor of protein expression, where multiple processes contribute to the synthesis of 
a protein from its RNA transcript (Liu et al., 2016).  
 Production of Cxcl12a:eGFP by neutrophils 
Neutrophils are the main producers of local CXCL12 in the trachea of influenza infected 
mice although the release of soluble CXCL12 from neutrophils was not detected (Lim et 
al., 2015). It was identified in mice that neutrophils migrating in infected lung tissue 
deposit CXCL12 enriched membrane particles (Lim et al., 2015). It has been proposed 
that this method of chemokine release provides a membrane tethered source of 
chemokine to act as a slow-release depot to induce T-cell migration, as opposed to the 
release of soluble CXCL12 which diffuses into the tissue or is degraded (Lim et al., 2015).  
There is relatively little known about the release means of CXCL12 by neutrophils, 
therefore the non-traditional CXCL12 deposition by neutrophils may be experimentally 
more complicated than anticipated (Lim et al., 2015). The RNA sequencing data suggests 
that zebrafish neutrophils at 5dpf express both cxcl12a and cxcl12b although the fpmk 
values for both genes are much lower than that of cxcr4b. The cxcl12a:eGFP transgene 
was not detectable in neutrophils in these experiments, which may be due to cxcl12a 
being switched on in neutrophils later than 3dpf. Potentially there are issues with 
detection of the transgene driven by the cxcl12a promoter, where the microscope 
settings used to visualise cxcl12a:eGFP expression in cells at the wound site may not 
enable the detection the transgene driven in cells weakly expressing the promoter. More 
conclusive data could be generated using FACS sorting to separate the lyz:mCherry 
neutrophil population from the rest of the cells in the zebrafish larvae (Rougeot et al., 
2014). Quantitative PCR could then be performed on these cells to provide quantitative 
information about the expression of cxcl12a in injured and non-injured larvae at multiple 
time points throughout the inflammatory response. There is a body of evidence to 
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suggest that tissue epithelial cells are the predominant producers of CXCL12 in some 
inflammatory disease settings (Dotan et al., 2010; Petty et al., 2007).  Perhaps damaged 
stromal cells at the wound site are the main producers of Cxcl12, as reported in injured 
lungs (Petty et al., 2007).  In future it would be interesting to determine the cell types 
which produce CXCL12 in zebrafish, as the development of CRISPRi technology could 
enable inhibition of Cxcl12 production in these cells specifically.  
 Generation of a Cxcr4b transgenic reporter line using the Gal4 UAS system 
The lack of tools available to study endogenous guidance signals in vivo has prevented 
the visualisation of physiological chemokine gradients. To circumvent these limitations, a 
novel system has been developed to provide a read out of chemokine activity by 
measuring receptor turnover at the cell surface. Cxcr4b receptor internalisation in 
response to Cxcl12a binding is a well characterised cellular response in zebrafish (Minina 
et al., 2007). A fluorescent timer approach has been used in zebrafish larvae to measure 
ligand-triggered Cxcr4b receptor turnover in the context  of self-generated Cxcl12a 
gradients by cells of the posterior lateral line primordium (Donà et al., 2013).  We 
proposed that adapting this system for visualisation of Cxcr4b in neutrophils would 
enable the visualisation of Cxcl12a gradients at the wound site in injured zebrafish larvae. 
A commonly used method of subcellular fluorescence labelling is using the Gal4-UAS 
two-component gene expression system  (Brand and Perrimon, 1993). Gal4 is a yeast 
transcriptional activator which binds to and activates its specific effector upstream 
activating sequences (UAS). When expressed under the control of a tissue-specific 
promoter, Gal4 activates the transcription of UAS located in an expression cassette close 
to a minimal promoter upstream of the target gene of interest, such that expression of 
UAS is largely silent in the absence of Gal4. This results in the transcriptional activation 
of target genes found downstream of the UAS in specific tissues  (del Valle Rodríguez et 
al., 2011).  
I developed a stable transgenic zebrafish line driving the expression of a UAS coupled 
CXCR4b.GFP fusion construct in neutrophils expressing the Gal4 transcriptional 
activator under the mpx promoter. However, when I out crossed this line to a neutrophil 
reporter, I found that there was relatively little overlap between expression of the 
transgenes. The mCherry and Cxcr4b.GFP transgenes in the neutrophils are driven by 
two separate promoters in this system, suggesting that promoter competition whereby 
the transcription of one transgene is preferential over the other, is unlikely. The 
hematopoietic cells in the CHT are immature progenitors to mature cells and could be 
precursors for different lineages (Tamplin et al., 2015). The CHT cells could be at 
different developmental stages where in some instances the lyz promoter is switched on 
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before the Gal4, and vice versa. A second explanation is that perhaps the transcriptional 
machinery required to drive the expression of the transgenes is utilised by the strong 
Gal4 promoter, such that in cells where the one of the promoters is switched on before 
the other, the expression of one of the transgenes occurs at the expense of the other. 
Regardless of the explanation, it is clear that not every cell in larvae is labelled with the 
Cxcr4b.GFP transgene.  
Initial experiments were performed using the tail-fin transection assay to visualise 
Cxcr4b.GFP localisation in neutrophils recruited to the wound site. Unfortunately, these 
experiments were not successful, as neutrophil recruitment to the wound site was 
severely impaired in the reporter line. Interestingly this phenotype is observed in a 
zebrafish model for WHIM syndrome in which neutrophils are inappropriately retained 
in the CHT due to over active CXCR4/CXCL12 signalling (Walters et al., 2010). WHIM 
zebrafish express a mutant allele of CXCR4b with a c-terminal truncation which renders 
the receptor unable to be internalised resulting in increased surface expression. 
Furthermore, Cxcr4b  loss of function mutant zebrafish larvae exhibit increased 
neutrophil recruitment to tail-fin injury, where it is proposed that inhibition of neutrophil 
retention infers increased sensitivity to chemokine gradients released at the wound site 
(Paredes-Zúñiga et al., 2017). I hypothesised that the expression of both endogenous 
CXCR4b and Gal4 driven CXCR4b.GFP in this reporter line could over activate the 
CXCR4/CXCL12 signalling axis, resulting in the inappropriate retention of neutrophils in 
the CHT and decreased sensitivity to chemoattractant gradients at the wound site. I 
tested this hypothesis by crossing the Cxcr4b.GFP reporter zebrafish line to the 
lyz:mCherry transgenic reporter line. I have demonstrated that these larvae have a 
population of neutrophils which express the Cxcr4b.GFP transgene in addition to 
endogenous cxcr4b, as well as a neutrophil population unlabelled with the transgene 
which express only endogenous Cxcr4b. I utilised these larvae containing both wildtype 
and transgenic neutrophils and demonstrated that wildtype neutrophils were recruited 
to tail-fin injury whilst neutrophils expressing the Cxcr4b.GFP transgene were not seen 
at the wound site. This illustrates that the Cxcr4b.GFP reporter line is functional, 
however renders this zebrafish line useless for the experiments I wished to perform.  In 
future it would be interesting to determine if preventing signalling through the 
Cxcr4b.GFP receptor could rescue the defect in neutrophil recruitment. Similarly 
interruption of endogenous CXCR4/CXCL12 signalling axis using chemical inhibitors or 
CRISPR may also rescue the recruitment defect of neutrophils over-expressing Cxcr4b. 
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4.5 Using AMD3100 to inhibit the CXCR4/CXCL12 signalling axis in 
zebrafish 
The role for the CXCR4/CXCL12 signalling axis in zebrafish developmental processes has 
been elucidated largely using genetic studies to knock down the genes encoding the 
CXCR4 and CXCL12 proteins (Donà et al., 2013; Haas and Gilmour, 2006; Valentin et al., 
2007). One of the advantages of using the zebrafish as a model to study inflammation is 
that chemical compounds can be used to manipulate signalling pathways, where several 
compounds which target neutrophils have been identified using this approach 
(Robertson et al., 2016, 2014). There are a broad range of chemical compounds used to 
inhibit CXCR4/CXCL12 signalling in humans, however few reports of the use of these 
inhibitors exist in zebrafish. AMD3100 has been used to inhibit the CXCR4/CXCL12 
signalling axis in a limited number of studies in zebrafish larvae, where concentrations 
ranging from 10-30M have been administered to larvae through incubation in fish water 
for up to 24 hours  (Tamplin et al., 2015). Experimental results using chemical inhibitors 
should be interpreted with care as compounds can target multiple receptors on different 
cell types. In particular AMD3100 can target Cxcr4a and b, as well as the scavenger 
receptor Cxcr7, all of which are expressed on multiple cell type in zebrafish (Donà et al., 
2013).  
 Transient inhibition of CXCR4/CXCL12 signalling does not affect 
haematopoiesis during early development 
When inhibiting signalling pathways which are important in developmental processes in 
a broad number of cell types, it is important to determine any off target or toxic side 
effects. The CXCR4/CXCL12 signalling axis regulates neutrophil mobilisation from the 
bone marrow to the circulation (Broxmeyer et al., 2005). Mice with a myeloid lineage 
CXCR4 deletion have increased numbers of circulating neutrophils (Eash et al., 2009). 
Zebrafish mutants lacking a functional Cxcl12a or Cxcr4b receptor show increased 
numbers of circulating neutrophils and disrupted granulopoiesis in the kidney at later 
stages of development, although this phenotype is not observed at 3dpf (Paredes-Zúñiga 
et al., 2017). Before performing experiments using AMD3100 to elucidate the role of the 
CXCR4/CXCL12 signalling axis in the regulation of inflammation resolution, I 
demonstrated that inhibition of CXCR4/CXCL12 signalling does not affect whole body 
neutrophil counts. No signs of toxicity were observed in larvae following administration 
of AMD3100 by either incubation or injection for up to 24 hours post administration. 
These data support similar findings that the number of neutrophils in the CHT and kidney 
at 3dpf are not changed in Cxcr4b or Cxcl12a mutant zebrafish larvae (Paredes-Zúñiga et 
al., 2017). These data demonstrate that early haematopoiesis is not affected by AMD3100 
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in these experiments, such that any phenotype observed in larvae following treatment 
with AMD3100 should not be attributed to a difference in whole body neutrophil counts.  
 Inhibition of CXCR4/CXCL12 signalling does not affect CHT colonisation 
by neutrophils 
I next aimed to demonstrate that AMD3100 could affect neutrophils specifically by 
attempting to interrupt CXCR4/CXCL12 processes involved in regulating neutrophils in 
larvae. In zebrafish, definitive hematopoietic stem and progenitor cells (HSPCs) give rise 
to all blood cells in the dorsal aorta where they are released into the circulation 
(Bertrand et al., 2010). HSPCs colonise the caudal hematopoietic tissue, an intermediate 
niche enriched in Cxcl12a where they differentiate into terminally differentiated blood 
cells including neutrophils, before colonising the adult marrow which in zebrafish is the 
kidney (Tamplin et al., 2015). A dose dependent reduction in HSPC markers rux1 and 
cmyb assessed by WISH was observed in larvae treated with AMD3100 from 48-72hpf 
(Tamplin et al., 2015). Based on this evidence, I hypothesised that AMD3100 may reduce 
the colonisation of neutrophils arising from HSPCs in the CHT, which would be useful to 
provide evidence of a neutrophil specific effect of AMD3100. The data from these 
experiments illustrates that CXCR4/CXCL12 inhibition using AMD3100 does not affect the 
neutrophil population in the CHT. Perhaps the cmyb runx1 positive progenitors which are 
reduced following AMD3100 treatment (Tamplin et al., 2015) may give rise to other blood 
cell populations. This could explain why CHT colonisation by neutrophils specifically was 
not effected in my experiments. I could not draw conclusions about the cell autonomous 
effects of AMD3100 from these experiments so I next aimed to study the retention of 
neutrophils in the CHT to demonstrate a cell autonomous effect of CXCR4/CXCL12 
inhibition using AMD3100.  
 Inhibition of CXCR4/CXCL12 does not affect neutrophil retention in the 
CHT 
As previously described, over-active CXCR4/CXCL12 signalling results in WHIM 
syndrome (Kawai and Malech, 2009). The retention of neutrophils in bone marrow niche 
is proposed to be a tug of war between neutrophil retention signalling through 
CXCR4/CXCL12 and chemoattractant gradients such as CXCL8 and G-CSF which 
mobilise neutrophils in to the bloodstream (Eash et al., 2010). AMD3100 is used clinically 
in combination with G-CSF as a mobiliser of stem cells from bone marrow into the 
circulation for use in transplantation in multiple melanoma patients (Liles et al., 2003).  
In zebrafish, neutrophil retention in the CHT is disrupted in Cxcr4b and Cxcl12a mutant 
larvae where the number of circulating neutrophils is increased in larvae between 5-13 
days post fertilisation (Paredes-Zúñiga et al., 2017). I hypothesised that inhibition of 
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CXCR4/CXCL12 signalling could mobilise neutrophils from the CHT to demonstrate a 
cell-autonomous effect of CXCR4 inhibition using AMD3100. These experiments 
identified that CXCR4 inhibition using AMD3100 did not release neutrophils from the 
CHT. Perhaps inhibition of the neutrophil retention signal alone without the presence of 
a mobilisation signal is insufficient to drive neutrophils out of the CHT. In future, inhibition 
of the CXCR4/CXCL12 signalling axis in combination with mobilisers of neutrophils such 
as exogenous CXCR2 or G-CSF, could be useful to determine if CXCR4 inhibition 
augments neutrophil release from the CHT. Similarly, performing tail-fin injury in 
combination with AMD3100 could provide endogenous mobilisation signals for 
neutrophils to determine if AMD3100 can augment the release of neutrophils from the 
CHT. It is possible that the dose of AMD3100 used to inhibit the CXCR4 receptor may not 
be sufficient to recapitulate findings observed in zebrafish mutants. This could be due to 
the surface expression of CXCR4 on neutrophils being too high for AMD3100 to prevent 
signalling at the concentration used, or due to problems with bioavailability of the 
compound associated with administration of compounds via incubation. In future it 
would be interesting to determine whether genetic manipulation of the CXCR4/CXCL12 
axis using CRISPR and CRISPRi technology could release neutrophils from the CHT.  
 Inhibition of CXCR4/CXCL12 signalling increases neutrophil recruitment 
to the wound site 
The recruitment of neutrophils to the wound site has been shown to increase in CXCR4b 
mutant larvae where it is suggested that this is due to loss of neutrophil retention 
signalling in the CHT, resulting in neutrophils being more able to respond to other 
chemotactic gradients (Paredes-Zúñiga et al., 2017). My data demonstrates that this 
effect can be recapitulated by chemically inhibiting CXCR4/CXCL12 signalling, although 
only when AMD3100 is administered by injection into the circulation. Experiments 
performed to administer AMD3100 by injection and incubation were performed at 
different developmental stages and are therefore not comparable. I propose that 
differential expression of Cxcr4b on neutrophils at 2 and 3dpf could confer the difference 
in neutrophil recruitment to the wound site observed between experiments. 
Furthermore, neutrophils could be more sensitive to CXCR4 inhibition at 2dpf due to 
differences in Cxcr4b receptor expression or Cxcl12a ligand production by stromal cells 
in the CHT. Alternatively, the differences in neutrophil recruitment observed between 
the two assays could be due to the bioavailability of the compound being higher in 
injected larvae compared to those incubated in the compound. These questions can be 
answered by administering AMD3100 by injection and incubation to larvae at 2dpf, to 
determine if the developmental stage of administration method is important. A further 
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consideration is that AMD3100 binds to the scavenger receptor Cxcr7 which modulates 
Cxcl12a concentration by acting as a sink receptor, the expression of which could be 
expressed differentially at these different stages of development (Donà et al., 2013).   
 Inhibition of CXCR4/CXCL12 signalling accelerates inflammation 
resolution by promoting reverse migration 
A large body of evidence now exists to suggest a role for the CXCR4/CXCL12 signalling 
axis in modulating neutrophil retention at inflammatory sites. Aside from this signalling 
axis generating a neutrophil retention signal in multiple physiological settings (Eash et al., 
2010; Suratt et al., 2004), neutrophils taken from patients with chronic inflammatory 
disease have increased CXCR4 expression, and CXCL12 is produced at sites of lung injury 
(Hartl et al., 2008; Yamada et al., 2011). A specific role for the CXCR4/CXCL12 signalling 
axis in modulating inflammation resolution has recently been suggested following the 
study of neutrophil behaviour at wound sites in zebrafish Cxcr4b and Cxcl12a mutant 
larvae (Paredes-Zúñiga et al., 2017). To begin to address the key questions of this work, I 
assessed the effects of CXCR4/CXCL12 inhibition using AMD3100 on the resolution of 
neutrophilic inflammation using a transgenic reporter lines (Elks et al., 2011; Renshaw and 
Loynes, 2006). Inflammation resolution assays using pharmacological compounds have 
been performed in zebrafish larvae where it has been shown that compounds can 
regulate inflammation resolution by both delaying and accelerating neutrophil removal 
from the  wound site (Elks et al., 2011; Robertson et al., 2014). I hypothesised that if a 
neutrophil retention signal generated through CXCR4/CXCL12 signalling exists at the 
wound site, interruption of this signal using AMD3100 to inhibit the CXCR4 receptor 
would accelerate neutrophil removal from the wound site.  
Inhibition of CXCR4/CXCL12 signalling in these assays did not affect neutrophil 
recruitment to the wound site. AMD3100 was administered to larvae at 4hpi when the 
majority of neutrophil recruitment had occurred, such that the increased recruitment 
seen previously was not recapitulated in these experiments. Screening for good 
responders at 4hpi prior to AMD3100 administration reduced the noise produced by fish-
to-fish variation within the assay such that only larvae with similar number of neutrophils 
at the wound site were selected for experiments. Inhibition of CXCR4/CXCL12 signalling 
by administration of AMD3100 via injection and incubation reduced the number of 
neutrophils at the wound site during the resolution phase of inflammation.  
The resolution of inflammation in zebrafish is the result of the contribution of neutrophil 
apoptosis and removal by macrophages, and the reverse migration of neutrophils away 
from the wound site. I next aimed to assess the contribution of neutrophil reverse 
migration to driving the resolution of inflammation in this system, a phenomenon which 
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has been observed by multiple research groups in zebrafish, as well as in mammalian 
systems (Buckley et al., 2006; Elks et al., 2011; Robertson et al., 2014; Wang et al., 2017). 
Transendothelial migration of neutrophils has recently been observed in mice, providing 
some of the first in vivo evidence that neutrophils are able to re-enter the circulation 
following their role at an inflammatory site (Wang et al., 2017). Neutrophils in zebrafish 
tissue appear to migrate preferentially back through the tissue of the tail-fin rather than 
back into the vasculature (Holmes et al., 2012). We propose that targeting neutrophil 
reverse migration will be of therapeutic benefit to drive neutrophils away from 
inflammatory sites in a chronic inflammatory disease setting. Using zebrafish larvae 
expressing the photoconvertible protein Kaede in neutrophils, I demonstrated that 
inhibition of CXCR4/CXCL12 signalling by administration of AMD3100 via injection or 
incubation drives the reverse migration of neutrophils. I confirmed that this effect was 
not due to an increased number of photoconverted neutrophils in the AMD3100 
treatment group.  
It is likely that of the two Cxcr4 isoforms expressed on zebrafish neutrophils, the effects 
seen using AMD3100 are due to inhibition of Cxcr4b, which my data suggests are 
expressed at significantly higher levels than Cxcr4a.  AMD3100 can also act as an allosteric 
agonist of CXCR7 (Kalatskaya et al., 2009), which functions as a decoy receptor for 
CXCL12, with a role in cell generation of self-gradients which is crucial for proper 
migration of primordial germ cells toward their targets in zebrafish (Boldajipour et al., 
2008). Activation of CXCR7 fails to couple to G-proteins and to induce chemokine 
receptor mediated cellular responses, so AMD3100 is unlikely to activate downstream 
signalling pathways (Naumann et al., 2010).  Cxcr7 may modulate neutrophil sensitivity to 
Cxcl12 concentration, through its scavenging of the chemokine which reduces the level 
of the Cxcl12 in the local tissue environment (Bussmann and Raz, 2015). The function of 
Cxcr7 in this context could be investigated in future using CRISPR/Cas9.  
Taken together these data demonstrate that inhibition of the CXCR4/CXCL12 signalling 
axis drives the resolution of inflammation by increasing neutrophil reverse migration, and 
support the hypothesis that neutrophil desensitisation to gradients at the wound site 
results in their passive migration away from the wound site (Holmes et al., 2012). These 
data add to the existing evidence that neutrophil reverse migration can be targeted 
pharmacologically to drive the resolution of inflammation. A similar effect to that 
reported in larvae treated with Tanshinone IIA in a similar assay is seen in larvae treated 
with AMD3100 (Robertson et al., 2014). The target of Tanshinone IIA is unknown but 
perhaps interferes with signalling pathways associated with CXCR4 signalling. Inhibition 
of CXCR4 signalling using AMD3100 is sufficient to promote neutrophil reverse migration 
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away from the wound site, but not to mobilise them from the CHT. I propose that the 
bioavailability of AMD3100 in these assays is sufficient to compete with the tissue 
concentration of Cxcl12a at the wound site, whereas Cxcl12a in the CHT might be 
markedly higher, reducing the ability of the compound to bind to receptors. 
Furthermore, Cxcr4 expression on the neutrophil surface may be different in activated 
neutrophils at the wound site compared to resting neutrophils in the CHT, which could 
further explain why interruption of neutrophil retention through CXCR4/CXCL12 
signalling causes an effect in one assay and not another.   
A recent role for neutrophil chemokinesis at the wound site has been implicated in 
modulating neutrophil reverse migration from the wound site (Powell et al., 2017). 
Reverse migration is impaired in Cxcr2 deficient zebrafish larvae where neutrophils are 
inappropriately retained at the wound site. It has been proposed that altered 
susceptibility of neutrophils to gradients at the wound site in Cxcr2 deficient larvae 
drives their passive migration away from the wound site (Powell et al., 2017). As the 
CXCR4 and CXCR2 signalling axis is known to antagonistically regulate neutrophil 
retention in other models (Eash et al., 2010), I propose that the combined outcome of 
CXCR4 and CXCR2 signalling could modulate the migration of neutrophils during 
inflammation resolution. It would be interesting to combine CXCR4 and CXCR2 inhibition 
using both chemical and genetic approaches to determine the outcome on reverse 
migration. Furthermore, it would be interesting to determine the difference observed in 
a whole-embryo knock down of Cxcr4b compared to knocking out the receptor 
specifically in neutrophils. This work is now possible due to the generation of a zebrafish 
line expressing a dead Cas9 under the neutrophil specific mpx promoter (Renshaw 
group, unpublished).   
In future, I would like to investigate the role of AMD3100 in driving neutrophil apoptosis 
to determine the relative contribution of reverse migration compared to apoptosis in 
driving inflammation resolution when the CXCR4/CXCL12 signalling axis is inhibited.  
These data are exciting as they provide the first evidence that CXCR4 signalling directly 
regulates neutrophil retention at inflammatory sites. Before drawing firm conclusions 
about the role for CXCR4 signalling in neutrophil retention it is important that these 
findings can be recapitulated. Using a second CXCR4 inhibitor as well as genetically 
manipulating cxcr4b and cxcl12a would consolidate these findings.  For now, these data 
provide the first evidence that that CXCR4/CXCL12 signalling axis may regulate 









5 Final discussion and future work 
Tissue cues derived from injured cells, recruited blood cells, tissue resident cells and 
potential pathogens direct neutrophil responses in inflamed tissue. With the relatively 
recent identification of neutrophil swarming and neutrophil reverse migration, the layers 
of regulation involved in neutrophil migration in inflamed tissues are becoming 
increasingly more complex. Understanding the mechanisms which modulate the 
migration of neutrophils throughout the entirety of the inflammatory response may help 
to identify novel pathways which may serve as targets for therapeutic intervention in 
chronic inflammatory diseases. Here I investigated the migratory behaviours of 
neutrophils during the inflammatory response using a well characterised tail-fin 
transection model to induce inflammation in zebrafish. The tail-fin transection model is 
suitable for observing neutrophil behaviour throughout the entirety of the inflammatory 
response, as transgenic zebrafish reporter lines enable the visualisation of both 
neutrophil recruitment to and removal from the wound site. To this end I studied 
neutrophil swarming behaviour of neutrophils which arises following the coordinated 
migration of neutrophils during their recruitment to the wound site, and the reverse 
migration of neutrophils away from the wound site during the resolution phase of 
inflammation. This approach utilised the high resolution achieved by imaging zebrafish 
tissue and the ability to study neutrophil migration at the single-cell level.  
5.1 Characterisation of the neutrophil swarming response in 
zebrafish  
Using in vivo imaging to visualise neutrophil migration towards wound sites in transgenic 
zebrafish larvae, I identified that neutrophil swarming occurs at sites of tissue injury in 
zebrafish. This study provides the first report of an endogenous neutrophil swarming 
response in a physiologically relevant in vivo tissue injury model. I have performed in 
depth characterisation of the swarming response and identified similarities between 
swarming of zebrafish neutrophils with mammalian neutrophils. I have identified a multi 
stage series of events leading to swarm formation. These experiments illustrate that 
tissue wounding induces the migration of neutrophils proximal to the wound site 
(scouting). I have described that a swarm-initiating pioneer neutrophil changes its 
behaviour at the wound site to adopt a phenotype markedly different to neutrophils in 
the same tissue context. The migration of neutrophils towards the pioneer neutrophil is 
then observed, resulting in the swarming of neutrophils in large aggregates at the wound 
site. The stages described have overlap with those identified in mouse models of 
swarming, and suggest that the swarming response is likely to occur with similar 
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dynamics between species. The variation in models used to study swarming makes this 
difficult to determine for certain.  
Many of the inflammatory mediators which promote the swarming response and 
maintain neutrophil aggregation in clusters are likely to overlap with the signals produced 
by damaged cells at the wound site, which are a prerequisite for neutrophil recruitment 
to the wound site (Lämmermann et al., 2013; Reátegui et al., 2017). Limitations in inducing 
an endogenous swarming response in the zebrafish model include the difficulties 
associated with the loss-of-function studies required to determine the precise role of 
signaling in modulating swarming at each stage. Here depleting key signaling pathways 
required for neutrophil extravasation or initial recruitment to wound sites may inhibit 
the neutrophilic response. The protocol used to study neutrophil swarming in mice 
bypasses the extravasation step, enabling the role for these signaling pathways in 
modulating tissue migration to be established. The zebrafish provides an experimental 
advantage when studying neutrophil swarm initiation. The neutrophil transplant models 
used to study swarming in mice circumvent a large proportion of the neutrophil 
recruitment cascade, making swarm initiation difficult to study. Here the zebrafish has 
been identified as a strong model to study the initiation of the swarming response, and 
the tools available to study mechanisms of swarm initiation are promising.  
Finally, I identified that the spatiotemporal aspects of neutrophil swarming highlight a 
role for a tissue context in swarm initiation. From my own observations and evidence in 
the literature, I hypothesise that pioneer neutrophils encounter a tissue context at the 
wound site which induces their programmed cell death and subsequent neutrophil 
swarming. Here I utilised the tools available in our group to begin to study hydrogen 
peroxide signaling at the wound site. I developed an assay to measure hydrogen peroxide 
concentration in pioneer neutrophils prior to the swarming response, which in future 
will be used to determine whether hydrogen peroxide plays a role in swarm initiation.  
5.2 Investigating cell death signalling in the context of swarm 
initiation 
I have identified the advantages of using the zebrafish to study the initiation of neutrophil 
swarming and developed assays to investigate cell death signalling in the context of 
neutrophil swarm induction. Using a combination of transgenic reporter lines and cell 
viability stains I have begun to investigate the role of cell death signalling in swarm 
initiation.  
Here I have identified that pioneer neutrophils do not become propidium iodide positive 
prior to swarm formation. This is contrary to the evidence from mouse studies which 
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correlates the appearance of propidium iodide positive neutrophils at the wound site 
with the amplification of neutrophil recruitment to the wound site (Lämmermann et al., 
2013). As discussed previously, the neutrophil transfer model to study swarming in mice 
circumvents the extravasation stage of neutrophil recruitment to the wound. I propose 
that studying the initiation of the swarming response in a model which bypasses a large 
part of this stage is sub-optimal. The zebrafish is a more appropriate model to observe 
the initiation of neutrophil swarming as the behaviour of endogenous neutrophil 
recruitment can be tracked within minutes following initiation of the inflammatory 
response. Using this model, I observed the recruitment of swarm-initiating pioneer 
neutrophils prior to the initiation of the swarming response. Here propidium iodide 
stained a population of cells at the wound site and often staining was observed deeper 
into the tissue at the wound edge than the pioneer neutrophil, eradicating any issues 
associated with the tissue penetration depth of propidium iodide. Propidium iodide 
labels cells which have lost their membrane integrity, so cell death by primary or 
secondary necrosis are ruled out to some extent as initiators of neutrophil swarm 
formation, although further non-related assays to study this type of cell death should be 
employed before drawing this conclusion. Furthermore the release of nuclear material 
from the cell, for example during NETosis, would be labelled with propidium iodide, 
although I propose that a higher dose of PI would be required to visualise these fragments 
of nuclear material in comparison to the rupture of a cell and release of the entire 
contents of the nucleus.  In future it would be good to confirm these findings using 
another cell viability assay.  
After observing that pioneer neutrophils did not become propidium iodide positive prior 
to swarm formation I hypothesised that pioneer neutrophils were apoptotic. My data 
illustrates that the initiation phase of swarming can persist for up to an hour, so I 
proposed that a programmed cell death may be relevant. Furthermore, apoptotic cells 
may release ‘find me’ cues to recruit macrophages to ensure the rapid removal of 
apoptotic corpses, so I proposed that ‘find me’ cues could be involved in the 
chemoattraction of neutrophils towards the pioneer. However, here I demonstrated that 
pioneer neutrophils do not undergo caspase-3 mediated apoptosis prior to neutrophil 
swarming. Moreover, cell death by apoptosis does not induce neutrophil swarms. It 
would be useful to recapitulate these findings using secondary assays as discussed 
previously. The limitations with using the FRET reporter line to study apoptosis in these 
assays is that only a read out for caspase-3 mediated apoptosis is provided. Apoptosis 
can occur independently of caspases; the release of apoptosis-inducing factor from 
mitochondria also drives cells down the apoptotic pathway (Candé et al., n.d.). This form 
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of cell death cannot be ruled out from these experiments. The main limitation associated 
with these assays to study cell death is that multiple methods to confirm one cell death 
mechanism should be employed before conclusions are made. Furthermore, imaging of 
transgenic zebrafish lines is relatively low throughput. Imaging of larvae is time 
consuming which limits the number of larvae, and thus the number of examples of 
neutrophil swarming, observed per experiment. Currently there is no alternative 
approach to study swarming, hence assays should be repeated in future to generate 
ample evidence.  
In future, the study of alternative cell death mechanisms including NETosis, pyroptosis, 
necroptosis and caspase-3 independent apoptosis should be investigated. Once the 
behaviour of pioneer neutrophils has been identified, the signalling molecules which 
mediate the initiation of neutrophil swarming could begin to be investigated.  
5.3 Elucidating the mechanisms governing neutrophil reverse 
migration 
I next investigated neutrophil migration in the context of inflammation resolution. I 
investigated the hypothesis that neutrophils are held at inflammatory sites by retention 
signals, the interruption of which results in their stochastic redistribution into the 
tissue by reverse migration. I have investigated the expression of candidate G protein 
coupled receptor Cxcr4b and its ligand Cxcl12a at the wound site in zebrafish larvae.   
 
 Cxcr4b and Cxcl12a are strong candidates for retention signaling in 
zebrafish  
I sought to determine whether the molecular components required to generate a 
retention signal were expressed in the context of inflammation in zebrafish larvae. The 
molecular candidates investigated were the CXCR4 receptor and its ligand CXCL12. Here 
I identified that during early development neutrophils predominantly express the Cxcr4b 
isoform, in keeping with evidence in the literature (Walters et al., 2010). Together with 
existing evidence the data illustrated here suggest that the components required for 
retention signaling between neutrophils and the wound site are present. There exists 
mounting evidence to implicate the CXCR4/CXCL12 signaling axis in modulating 
neutrophil retention at inflammatory sites (Paredes-Zúñiga et al., 2017; Yamada et al., 
2011), so it is likely that a degree of conservation exists between species. Aside from the 
CXCR4/CXCL12 signaling axis being present at the wound site in zebrafish larvae, is not 
clear from these studies how retention signaling works. The previously described 
stochastic redistribution of neutrophils into the tissue during reverse migration  in 
zebrafish (Holmes et al., 2012) could be attributed to changes in neutrophil sensitivity to 
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local gradients. Neutrophil sensitivity could be altered by a change in Cxcl12a 
concentration at the wound site, reduced Cxcr4b expression on the neutrophil surface, 
or a combination of the two. As Cxcl12a expression seems to increase throughout the 
time course, it could be that ligand-induced receptor internalisation characteristic of 
GPCR signaling, modulates neutrophil sensitivity to Cxcl12a through reducing Cxcr4b 
expression on the neutrophil surface.  The temporal expression of Cxcl12a at the wound 
site remains to be quantified and the development of a functional Cxcr4b.GFP reporter 
line may provide insight into how retention signals are generated. From these 
experiments I can conclude that the CXCR4/CXCL12 signaling axis is expressed at the 
wound site during inflammation, and could therefore play a role in its modulation.  
 Inhibition of the CXCR4/CXCL12 signaling axis accelerates inflammation 
resolution  
In this section of work I used a pharmacological approach to inhibit the CXCR4/CXCL12 
signaling axis using AMD3100 to antagonize the CXCR4 receptor. I aimed to determine 
the effect of CXCR4 on inflammation using our well characterized mpx:GFP reporter 
line (Renshaw and Loynes, 2006), and to look specifically at neutrophil reverse 
migration using a photoconvertible system where neutrophils at the wound site can be 
tracked following photoconversion (Elks et al., 2011; Ellett et al., 2015; Robertson et al., 
2014).   Using AMD3100 I recapitulated the phenotype observed in Cxcr4b and Cxcl12a 
mutant zebrafish larvae, where neutrophil recruitment to the wound site is increased.  
Perhaps the most significant finding was the identification that inhibition of the 
CXCR4/CXCL12 signaling axis accelerates inflammation resolution. Here I found that 
reverse migration of neutrophils was increased in larvae where the CXCR4 signaling 
axis was inhibited. This is exciting as it provides the first evidence to directly implicate 
the CXCR4/CXCL12 signaling axis in modulating neutrophil retention at wound sites.  
These findings could fit into the current paradigm  that CXCR2 signaling drives neutrophil 
reverse  migration through modulating neutrophil  sensitivity to other gradients (Powell 
et al., 2017). Here Cxcr2 could modulate neutrophil sensitivity to Cxcl12 gradients, 
resulting in their desensitization subsequent reverse migration by passively 
redistributing into the tissue. Much work is required to investigate the dual role for 
CXCR4 and CXCR2 signaling, although antagonistic regulation by these two receptors in 
combination modulates neutrophil retention in other systems, so this could be the case 
here. The limitations associated with using pharmacological compounds to inhibit 
signaling pathways can be overcome by using a genetic approach to study the 
CXCR4/CXCL12 signaling axis. To investigate the role of Cxcr4b specifically in retention 
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signalling, CRISPRi will be used to achieve a neutrophil specific knock down of the Cxcr4b 
receptor.  
 Final conclusions and closing remarks  
To summarise, I have described the migratory behaviour of neutrophils during the 
swarming response which has not yet been characterised in zebrafish and have begun to 
investigate cell death signalling in the context of neutrophil swarm initiation. The in depth 
characterisation of neutrophil swarming in this study has identified that the zebrafish 
model can be used to study the neutrophil swarming response at all of its stages. I have 
identified that the Cxcr4b receptor is expressed on zebrafish neutrophils and its ligand 
Cxcl12a is expressed at wound sites.  Finally this study implicates the CXCR4/CXCL12 
signalling axis in modulating neutrophil retention at inflammatory sites, as inhibition of 
the CXCR4 receptor accelerates inflammation resolution by promoting reverse 
migration. Together these findings have demonstrate that neutrophil migratory 
behaviours during the inflammatory response can be targeted at multiple points to 
produce a favourable outcome in terms of inflammation.  
The identification of novel neutrophil migration patterns including neutrophil swarming 
and reverse migration add complexity to the modulation of neutrophil migration and 
retention within inflamed tissue. The precise physiological role for neutrophil swarming 
has not yet been determined, and thus the outcome of the swarming response in tissue 
is unknown. The recent identification that neutrophil swarms may modulate their own 
resolution through the release of lipids and proteins, suggests that swarm resolution may 
be important an important driver of inflammation resolution (Reátegui et al., 2017). A role 
for neutrophil retention signalling within neutrophil clusters is reasonable to suggest. 
Perhaps neutrophil swarming is modulated by retention signals generated through 
CXCR4/CXCL12, where AMD3100 could interrupt the clustering of neutrophils and drive 
their reverse migration. Future studies should combine the study of neutrophil swarm 
resolution with dissecting the drivers of neutrophil removal from the wound site.  
 
Expanding our knowledge on the precise modulators of neutrophil migration both to and 
from sites of inflammation is essential, and may help to identify novel targets to drive the 
resolution of inflammation in the context of chronic inflammation. Much work is required 
to further confirm the role for the CXCR4/CXCL12 signalling axis in modulating 
neutrophil retention at inflammatory sites, although this study provides evidence that 
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